tokens	ner_tags	text
['As', 'demonstrated', 'by', 'in', 'vitro', 'studies', ',', 'cisplatin', '(', 'CDDP', ')', 'is', 'able', 'to', 'down-regulate', 'the', 'AGAT', 'activity', ',', 'suggesting', 'that', 'CDDP', 'could', 'enhance', 'the', 'antitumor', 'activity', 'of', 'TMZ', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O']	As demonstrated by in vitro studies , cisplatin ( CDDP ) is able to down-regulate the AGAT activity , suggesting that CDDP could enhance the antitumor activity of TMZ .
['Patient', 'and', 'tumor', 'characteristics', 'were', 'well', 'balanced', 'between', 'the', 'two', 'arms', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Patient and tumor characteristics were well balanced between the two arms .
['Patients', 'with', 'cerebral', 'metastases', 'were', 'included', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Patients with cerebral metastases were included .
['There', 'was', 'significantly', 'more', 'grade', '3', 'and', '4', 'emesis', 'in', 'the', 'combination', 'arm', '.']	['O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O']	There was significantly more grade 3 and 4 emesis in the combination arm .
['CONCLUSIONS', 'No', 'clear', 'benefit', 'in', 'terms', 'of', 'response', 'rates', ',', 'median', 'TTP', 'or', 'OS', 'was', 'shown', 'with', 'the', 'combination', 'of', 'TMZ', '+', 'CDDP', '.']	['O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I']	CONCLUSIONS No clear benefit in terms of response rates , median TTP or OS was shown with the combination of TMZ + CDDP .
['Additionally', ',', 'the', 'combination', 'was', 'associated', 'with', 'higher', 'incidence', 'of', 'grade', '3', 'and', '4', 'emesis', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	Additionally , the combination was associated with higher incidence of grade 3 and 4 emesis .
['The', 'control', 'toothpaste', 'was', 'a', 'conventional', ',', 'moderately', 'abrasive', 'paste', 'containing', '0.8', '%', 'sodium', 'monofluorophosphate', '.']	['O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I']	The control toothpaste was a conventional , moderately abrasive paste containing 0.8 % sodium monofluorophosphate .
['The', 'children', 'were', 'examined', 'clinically', 'and', 'radiologically', 'each', 'year', '.']	['O', 'B-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The children were examined clinically and radiologically each year .
['Caries', 'increments', 'after', '3', 'years', ',', 'in', 'terms', 'of', 'DMF', 'teeth', 'and', 'DMF', 'surfaces', ',', 'showed', 'no', 'significant', 'differences', 'between', 'the', 'MFP', 'test', 'group', '(', '444', 'children', ')', 'and', 'the', 'MFP', 'control', 'group', '(', '450', 'children', ')', '.']	['B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-I', 'I-I', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-I', 'I-I', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O']	Caries increments after 3 years , in terms of DMF teeth and DMF surfaces , showed no significant differences between the MFP test group ( 444 children ) and the MFP control group ( 450 children ) .
['However', ',', 'the', 'TMP', 'test', 'group', '(', '425', 'children', ')', 'had', 'significantly', 'higher', 'caries', 'increments', 'than', 'the', 'MFP', 'control', 'group', '.']	['O', 'O', 'O', 'B-I', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'B-I', 'I-I', 'O', 'O']	However , the TMP test group ( 425 children ) had significantly higher caries increments than the MFP control group .
['Therapeutic', 'recommendations', 'in', 'polycythemia', 'vera', 'based', 'on', 'Polycythemia', 'Vera', 'Study', 'Group', 'protocols', '.']	['O', 'B-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols .
['With', 'respect', 'to', 'the', 'final', 'question', ',', 'the', 'optimal', 'treatment', 'for', 'polycythemia', 'vera', ',', 'it', 'is', 'apparent', 'that', 'the', 'expectation', 'of', 'a', 'single', 'optimal', 'therapy', 'that', 'would', 'apply', 'to', 'all', 'patients', 'at', 'all', 'ages', 'and', 'stages', 'of', 'the', 'disease', 'was', 'naive', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	With respect to the final question , the optimal treatment for polycythemia vera , it is apparent that the expectation of a single optimal therapy that would apply to all patients at all ages and stages of the disease was naive .
['Moreover', ',', 'the', 'group', 'has', 'defined', 'more', 'precisely', 'than', 'ever', 'before', 'the', 'nature', 'of', 'the', 'complications', 'of', 'the', 'disease', 'and', 'the', 'association', 'of', 'the', 'risks', 'of', 'specific', 'complications', 'with', 'specific', 'forms', 'of', 'therapy', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O']	Moreover , the group has defined more precisely than ever before the nature of the complications of the disease and the association of the risks of specific complications with specific forms of therapy .
['Environmental', 'enrichment', 'as', 'a', 'therapy', 'for', 'autism', ':', 'A', 'clinical', 'trial', 'replication', 'and', 'extension', '.']	['B-I', 'I-I', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Environmental enrichment as a therapy for autism : A clinical trial replication and extension .
['In', 'an', 'initial', 'randomized', 'controlled', 'trial', ',', 'children', 'with', 'autism', 'who', 'received', 'sensorimotor', 'enrichment', 'at', 'home', 'for', '6', 'months', 'had', 'significant', 'improvements', 'in', 'both', 'their', 'cognitive', 'ability', 'and', 'the', 'severity', 'of', 'their', 'autism', 'symptoms', '(', 'Woo', '&', 'Leon', ',', '2013', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-I', 'I-I', 'I-I', 'I-I', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	In an initial randomized controlled trial , children with autism who received sensorimotor enrichment at home for 6 months had significant improvements in both their cognitive ability and the severity of their autism symptoms ( Woo & Leon , 2013 ) .
['We', 'now', 'report', 'the', 'outcomes', 'of', 'a', 'similar', 'randomized', 'controlled', 'trial', 'in', 'which', 'children', 'with', 'autism', ',', '3', 'to', '6', 'years', 'old', ',', 'were', 'randomly', 'assigned', 'to', 'groups', 'that', 'received', 'either', 'daily', 'sensorimotor', 'enrichment', ',', 'administered', 'by', 'their', 'parents', ',', 'along', 'with', 'standard', 'care', ',', 'or', 'they', 'received', 'standard', 'care', 'alone', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I']	We now report the outcomes of a similar randomized controlled trial in which children with autism , 3 to 6 years old , were randomly assigned to groups that received either daily sensorimotor enrichment , administered by their parents , along with standard care , or they received standard care alone .
['After', '6', 'months', ',', 'enriched', 'children', 'showed', 'statistically', 'significant', 'gains', 'in', 'their', 'IQ', 'scores', ',', 'a', 'decline', 'in', 'their', 'atypical', 'sensory', 'responses', ',', 'and', 'an', 'improvement', 'in', 'their', 'receptive', 'language', 'performance', ',', 'compared', 'to', 'controls', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O']	After 6 months , enriched children showed statistically significant gains in their IQ scores , a decline in their atypical sensory responses , and an improvement in their receptive language performance , compared to controls .
['RESULT', '(', 'S', ')', 'No', 'statistically', 'significant', 'difference', 'was', 'detected', 'between', 'the', 'two', 'groups', 'in', 'terms', 'of', 'survival', 'rate', ',', 'but', 'a', 'significantly', 'higher', 'percentage', 'of', 'detectable', 'spindle', 'was', 'observed', 'in', 'group', 'B', '(', 'completely', 'denuded', 'oocytes', ')', ',', 'either', 'immediately', 'after', 'warming', 'or', '3', 'hours', 'after', 'incubation', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	RESULT ( S ) No statistically significant difference was detected between the two groups in terms of survival rate , but a significantly higher percentage of detectable spindle was observed in group B ( completely denuded oocytes ) , either immediately after warming or 3 hours after incubation .
['Racemic', 'epinephrine', 'has', 'been', 'advocated', 'for', 'the', 'treatment', 'of', 'croup', ',', 'but', 'controlled', 'studies', 'have', 'not', 'proved', 'it', 'more', 'effective', 'than', 'saline', '.']	['B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Racemic epinephrine has been advocated for the treatment of croup , but controlled studies have not proved it more effective than saline .
['Twenty', 'patients', '(', 'aged', '4', 'months', 'to', '5', 'years', ')', 'hospitalized', 'with', 'acute', 'croup', 'and', 'persistent', 'inspiratory', 'stridor', 'at', 'rest', 'were', 'randomly', 'assigned', 'to', 'one', 'of', 'two', 'treatment', 'groups', ':', 'saline', 'or', 'racemic', 'epinephrine', ',', 'both', 'nebulized', 'and', 'delivered', 'by', 'intermittent', 'positive', 'pressure', 'breathing', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Twenty patients ( aged 4 months to 5 years ) hospitalized with acute croup and persistent inspiratory stridor at rest were randomly assigned to one of two treatment groups : saline or racemic epinephrine , both nebulized and delivered by intermittent positive pressure breathing .
['Racemic', 'epinephrine', 'was', 'significantly', 'more', 'effective', 'than', 'saline', 'at', '10', '(', 'P', 'less', 'than', '.01', ')', 'and', '30', 'minutes', '(', 'P', 'less', 'than', '.05', ')', 'but', 'not', 'at', '120', 'minutes', 'after', 'the', 'treatment', '.']	['B-I', 'I-I', 'O', 'O', 'O', 'B-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Racemic epinephrine was significantly more effective than saline at 10 ( P less than .01 ) and 30 minutes ( P less than .05 ) but not at 120 minutes after the treatment .
['A', 'double-blind', 'comparison', 'of', 'clomipramine', ',', 'desipramine', ',', 'and', 'placebo', 'in', 'the', 'treatment', 'of', 'autistic', 'disorder', '.']	['O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P']	A double-blind comparison of clomipramine , desipramine , and placebo in the treatment of autistic disorder .
['DESIGN', 'Following', 'a', '2-week', ',', 'single-blind', 'placebo', 'washout', 'phase', ',', '12', 'autistic', 'subjects', 'completed', 'a', '10-week', ',', 'double-blind', ',', 'crossover', 'comparison', 'of', 'clomipramine', 'and', 'placebo', ',', 'and', '12', 'different', 'subjects', 'completed', 'a', 'similar', 'comparison', 'of', 'clomipramine', 'and', 'desipramine', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'B-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'B-I', 'I-I']	DESIGN Following a 2-week , single-blind placebo washout phase , 12 autistic subjects completed a 10-week , double-blind , crossover comparison of clomipramine and placebo , and 12 different subjects completed a similar comparison of clomipramine and desipramine .
['PATIENTS', 'A', 'referral', 'sample', 'of', '30', 'male', 'and', 'female', 'autistic', 'patients', 'were', 'enrolled', ',', 'and', '24', 'completed', 'the', 'study', '.']	['O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	PATIENTS A referral sample of 30 male and female autistic patients were enrolled , and 24 completed the study .
['CONCLUSION', 'Biological', 'links', 'between', 'compulsions', 'and', 'stereotyped', ',', 'repetitive', 'behaviors', 'in', 'autistic', 'disorder', 'should', 'be', 'explored', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'O', 'O', 'O', 'O']	CONCLUSION Biological links between compulsions and stereotyped , repetitive behaviors in autistic disorder should be explored .
['OBJECTIVE', 'To', 'compare', 'the', 'effects', 'of', 'a', 'pill', 'containing', 'drospirenone', 'with', 'those', 'of', 'a', 'combined', 'contraceptive', 'vaginal', 'ring', 'on', 'the', 'lipid', 'and', 'carbohydrate', 'metabolism', 'and', 'on', 'the', 'surrogate', 'markers', 'of', 'arterial', 'function', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	OBJECTIVE To compare the effects of a pill containing drospirenone with those of a combined contraceptive vaginal ring on the lipid and carbohydrate metabolism and on the surrogate markers of arterial function .
['SETTING', 'Bologna', 'University', 'School', 'of', 'Medicine', '.']	['O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	SETTING Bologna University School of Medicine .
['The', '6-month', 'treatment', 'with', 'the', 'vaginal', 'ring', 'significantly', 'improved', 'the', 'area', 'under', 'the', 'curve', 'for', 'glucose', ',', 'insulin', ',', 'and', 'C-peptide', ',', 'whereas', 'the', 'drospirenone+ethinylestradiol', 'pill', 'induced', 'an', 'increase', 'in', 'the', 'insulinogenic', 'index', 'and', 'homeostatic', 'model', 'assessment', 'estimate', 'for', 'insulin', 'resistance', 'values', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	The 6-month treatment with the vaginal ring significantly improved the area under the curve for glucose , insulin , and C-peptide , whereas the drospirenone+ethinylestradiol pill induced an increase in the insulinogenic index and homeostatic model assessment estimate for insulin resistance values .
['The', 'number', 'of', 'patients', 'who', 'needed', 'a', 'second', 'blood', 'patch', 'did', 'not', 'differ', 'significantly', 'between', 'the', 'two', 'groups', ':', '6', '(', '10.0', '%', ')', 'for', 'prophylactic', 'epidural', 'blood', 'patch', 'and', '4', '(', '11.1', '%', ')', 'for', 'therapeutic', 'epidural', 'blood', 'patch', '.']	['O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I']	The number of patients who needed a second blood patch did not differ significantly between the two groups : 6 ( 10.0 % ) for prophylactic epidural blood patch and 4 ( 11.1 % ) for therapeutic epidural blood patch .
['The', 'effect', 'of', 'acebutolol', 'on', 'left', 'ventricular', 'performance', 'was', 'examined', 'by', 'various', 'noninvasive', 'means', 'in', 'three', 'studies', '.']	['O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The effect of acebutolol on left ventricular performance was examined by various noninvasive means in three studies .
['In', '13', 'patients', 'with', 'stable', 'angina', 'pectoris', ',', 'single-pass', 'studies', 'of', 'left', 'ventricular', 'function', 'with', 'indium', '113', 'under', 'double-blind', ',', 'placebo-controlled', 'conditions', 'similarly', 'showed', 'acebutolol', 'to', 'have', 'no', 'clinically', 'significant', 'negative', 'inotropic', 'effects', '.']	['O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	In 13 patients with stable angina pectoris , single-pass studies of left ventricular function with indium 113 under double-blind , placebo-controlled conditions similarly showed acebutolol to have no clinically significant negative inotropic effects .
['[', 'Effects', 'of', 'electroacupuncture', 'combined', 'with', 'behavior', 'therapy', 'on', 'intelligence', 'and', 'behavior', 'of', 'children', 'of', 'autism', ']', '.']	['O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'O']	[ Effects of electroacupuncture combined with behavior therapy on intelligence and behavior of children of autism ] .
['METHODS', 'Sixty', 'children', 'of', 'autism', 'were', 'randomly', 'divided', 'into', 'an', 'electroacupuncture', '(', 'EA', ')', 'plus', 'behavior', 'therapy', 'group', 'and', 'a', 'behavior', 'therapy', 'group', ',', '30', 'cases', 'in', 'each', 'group', '.']	['O', 'B-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	METHODS Sixty children of autism were randomly divided into an electroacupuncture ( EA ) plus behavior therapy group and a behavior therapy group , 30 cases in each group .
['The', 'patients', 'in', 'the', 'two', 'groups', 'were', 'treated', 'with', 'routine', 'behavior', ',', 'with', 'EA', 'at', 'Baihui', '(', 'GV', '20', ')', ',', 'Sishencong', '(', 'EX-HN', '1', ')', ',', 'Shenting', '(', 'GV', '24', ')', ',', 'Benshen', '(', 'GB', '13', ')', ',', 'Yintang', '(', 'EX-HN', '3', ')', ',', 'Naohu', '(', 'GV', '17', ')', ',', 'Naokong', '(', 'GB', '19', ')', ',', 'Neiguan', '(', 'PC', '6', ')', 'and', 'scalp', 'acupuncture', 'at', 'Speech', 'Areas', 'I', ',', 'II', ',', 'III', 'added', 'for', 'the', 'EA', 'plus', 'behavior', 'therapy', 'group', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O']	The patients in the two groups were treated with routine behavior , with EA at Baihui ( GV 20 ) , Sishencong ( EX-HN 1 ) , Shenting ( GV 24 ) , Benshen ( GB 13 ) , Yintang ( EX-HN 3 ) , Naohu ( GV 17 ) , Naokong ( GB 19 ) , Neiguan ( PC 6 ) and scalp acupuncture at Speech Areas I , II , III added for the EA plus behavior therapy group .
['Their', 'therapeutic', 'effects', 'were', 'observed', ',', 'and', 'the', 'picture', 'and', 'vocabulary', 'scale', '(', 'PPVT', ')', 'and', 'behavior', 'ability', 'were', 'detected', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'B-O', 'I-O', 'O', 'O', 'O']	Their therapeutic effects were observed , and the picture and vocabulary scale ( PPVT ) and behavior ability were detected .
['CONCLUSION', 'EA', 'combined', 'with', 'behavior', 'therapy', 'can', 'significantly', 'improve', 'clinical', 'symptoms', 'of', 'autism', ',', 'but', 'does', 'not', 'improve', 'intelligence', '.']	['O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	CONCLUSION EA combined with behavior therapy can significantly improve clinical symptoms of autism , but does not improve intelligence .
['Clinical', 'hypnosis', 'versus', 'cognitive', 'behavioral', 'training', 'for', 'pain', 'management', 'with', 'pediatric', 'cancer', 'patients', 'undergoing', 'bone', 'marrow', 'aspirations', '.']	['B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'B-O', 'I-O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Clinical hypnosis versus cognitive behavioral training for pain management with pediatric cancer patients undergoing bone marrow aspirations .
['Patients', 'were', 'randomized', 'to', 'one', 'of', 'three', 'groups', ':', 'hypnosis', ',', 'a', 'package', 'of', 'CB', 'coping', 'skills', ',', 'and', 'no', 'intervention', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I']	Patients were randomized to one of three groups : hypnosis , a package of CB coping skills , and no intervention .
['Forty-seven', 'children', 'were', 'randomly', 'assigned', 'to', 'treatment', 'and', 'wait-list', 'control', 'groups', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Forty-seven children were randomly assigned to treatment and wait-list control groups .
['Treatment', 'group', 'children', 'received', 'the', 'parent-delivered', 'program', 'for', '4', 'mo', '.']	['O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I']	Treatment group children received the parent-delivered program for 4 mo .
['Trained', 'therapists', 'provided', 'parent', 'training', 'and', 'support', '.']	['O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I']	Trained therapists provided parent training and support .
['Results', 'showed', 'that', 'the', 'parent-delivered', 'program', 'was', 'effective', 'in', 'improving', 'measures', 'of', 'autism', '(', 'medium', 'effect', 'size', ')', 'and', 'sensory', 'and', 'self-regulatory', 'responses', '(', 'large', 'effect', 'size', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O']	Results showed that the parent-delivered program was effective in improving measures of autism ( medium effect size ) and sensory and self-regulatory responses ( large effect size ) .
['At', 'the', 'end', 'of', 'treatment', '86', '%', 'of', 'patients', 'in', 'the', 'CHOP', 'arm', 'had', 'responded', 'with', '58', '%', 'in', 'CR', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	At the end of treatment 86 % of patients in the CHOP arm had responded with 58 % in CR .
['Treatment', 'studies', 'document', 'the', 'efficacy', 'of', 'precessation', 'NRT', 'and', 'support', 'important', 'roles', 'for', 'level', 'of', 'nicotine', 'dependence', 'and', 'precessation', 'smoking', 'reduction', 'in', 'successful', 'quitting', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Treatment studies document the efficacy of precessation NRT and support important roles for level of nicotine dependence and precessation smoking reduction in successful quitting .
['We', 'now', 'report', 'influences', 'of', 'v1.0', 'quit-success', 'genotype', 'score', ',', 'level', 'of', 'dependence', 'and', 'precessation', 'smoking', 'reduction', 'in', 'a', 'smoking', 'cessation', 'trial', 'that', 'examined', 'effects', 'of', '21', 'versus', '42', 'mg/24', 'h', 'precessation', 'NRT', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I']	We now report influences of v1.0 quit-success genotype score , level of dependence and precessation smoking reduction in a smoking cessation trial that examined effects of 21 versus 42 mg/24 h precessation NRT .
['Four', 'hundred', 'seventy-nine', 'smokers', 'were', 'randomized', 'to', '21', 'or', '42', 'mg', 'NRT', ',', 'initiated', '2', 'wks', 'prior', 'to', 'target', 'quit', 'dates', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Four hundred seventy-nine smokers were randomized to 21 or 42 mg NRT , initiated 2 wks prior to target quit dates .
['Genotyping', 'used', 'Affymetrix', 'arrays', '(', 'Santa', 'Clara', ',', 'CA', ',', 'USA', ')', '.']	['B-P', 'I-P', 'I-O', 'I-O', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Genotyping used Affymetrix arrays ( Santa Clara , CA , USA ) .
['The', 'primary', 'outcome', 'was', '10-wk', 'continuous', 'smoking', 'abstinence', '.']	['O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O']	The primary outcome was 10-wk continuous smoking abstinence .
['NRT', 'dose', ',', 'level', 'of', 'nicotine', 'dependence', 'and', 'genotype', 'scores', 'displayed', 'significant', 'interactive', 'effects', 'on', 'successful', 'quitting', '.']	['B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O']	NRT dose , level of nicotine dependence and genotype scores displayed significant interactive effects on successful quitting .
['Successful', 'abstinence', 'also', 'was', 'predicted', 'by', 'CO', 'reductions', 'during', 'precessation', 'NRT', '.']	['B-O', 'I-O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'B-I', 'I-I']	Successful abstinence also was predicted by CO reductions during precessation NRT .
['Eleven', 'healthy', 'tobacco', 'smoking', 'adult', 'male', 'volunteers', 'of', 'mixed', 'race', 'were', 'tobacco', 'abstinent', 'overnight', 'for', 'this', 'study', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O']	Eleven healthy tobacco smoking adult male volunteers of mixed race were tobacco abstinent overnight for this study .
['Nicotine', 'caused', 'a', 'small', 'overall', 'reduction', 'in', 'global', 'cerebral', 'metabolism', 'of', 'glucose', 'but', ',', 'when', 'the', 'data', 'were', 'normalized', ',', 'several', 'brain', 'regions', 'showed', 'relative', 'increases', 'in', 'activity', '.']	['B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O']	Nicotine caused a small overall reduction in global cerebral metabolism of glucose but , when the data were normalized , several brain regions showed relative increases in activity .
['Structures', 'with', 'a', 'decrease', 'in', 'regional', 'cerebral', 'metabolism', 'of', 'glucose', '(', 'pepper', 'minus', 'nicotine', ')', 'were', 'the', 'left', 'insula', 'and', 'right', 'inferior', 'occipital', 'gyrus', ',', 'with', 'Z', 'scores', '>', '3.5', '.']	['O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Structures with a decrease in regional cerebral metabolism of glucose ( pepper minus nicotine ) were the left insula and right inferior occipital gyrus , with Z scores > 3.5 .
['Study', 'patients', 'were', 'randomized', 'to', 'the', 'two', 'treatment', 'arms', ',', 'Er', ':', 'YAG', '(', '3.8', 'J/cm', '(', '2', ')', ',', '30', '%', 'pattern', 'overlap', ',', '0', '%', 'interpulse', 'overlap', ',', '15', 'microm', 'per', 'pass', 'with', 'no', 'coagulation', ')', 'and', 'IPL', '(', '560-nm', 'filter', ',', '30', 'J/cm', '(', '2', ')', ',', '2.4/4.0-ms', 'pulse', 'with', '10-ms', 'delay', ')', ',', 'each', 'receiving', 'three', 'sequential', 'treatments', 'spaced', '1', 'month', 'apart', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Study patients were randomized to the two treatment arms , Er : YAG ( 3.8 J/cm ( 2 ) , 30 % pattern overlap , 0 % interpulse overlap , 15 microm per pass with no coagulation ) and IPL ( 560-nm filter , 30 J/cm ( 2 ) , 2.4/4.0-ms pulse with 10-ms delay ) , each receiving three sequential treatments spaced 1 month apart .
['Baseline', 'subjective', 'and', 'blinded', 'physician', 'dyschromia', 'and', 'rhytid', 'scores', 'revealed', 'no', 'significant', 'difference', 'between', 'the', 'IPL', 'and', 'Er', ':', 'YAG', 'randomly', 'assigned', 'sides', '.']	['O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Baseline subjective and blinded physician dyschromia and rhytid scores revealed no significant difference between the IPL and Er : YAG randomly assigned sides .
['Subjective', 'global', 'facial', 'appearance', 'scores', 'worsened', 'by', '5', '%', 'while', 'blinded', 'physician', 'scores', 'improved', 'by', '16', '%', '3', 'months', 'after', '3', 'Er', ':', 'YAG', 'treatments', ',', 'but', 'by', '28', 'and', '20', '%', 'for', 'IPL', ',', 'respectively', '.']	['B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Subjective global facial appearance scores worsened by 5 % while blinded physician scores improved by 16 % 3 months after 3 Er : YAG treatments , but by 28 and 20 % for IPL , respectively .
['The', 'overall', 'incidence', 'of', 'adverse', 'events', 'and', 'subsequent', 'downtime', 'was', 'increased', 'for', 'Er', ':', 'YAG', '(', '1/10', 'patients', 'experienced', 'hyperpigmentation', ',', '3/10', 'exfoliation', ',', '1/10', 'blistering', ',', 'and', '5/10', 'discomfort', ')', 'compared', 'to', 'IPL', '(', '1/10', 'exfoliation', 'and', '1/10', 'discomfort', ')', ',', 'although', 'no', 'permanent', 'side', 'effects', 'were', 'observed', 'with', 'either', 'treatment', 'arm', '.']	['O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'O', 'O', 'B-O', 'O', 'O', 'B-O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The overall incidence of adverse events and subsequent downtime was increased for Er : YAG ( 1/10 patients experienced hyperpigmentation , 3/10 exfoliation , 1/10 blistering , and 5/10 discomfort ) compared to IPL ( 1/10 exfoliation and 1/10 discomfort ) , although no permanent side effects were observed with either treatment arm .
['This', 'study', 'tested', 'the', 'effects', 'of', 'a', 'parent-mediated', 'intervention', 'on', 'parental', 'responsiveness', 'with', 'their', 'toddlers', 'at', 'high', 'risk', 'for', 'an', 'autism', 'spectrum', 'disorder', '(', 'ASD', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	This study tested the effects of a parent-mediated intervention on parental responsiveness with their toddlers at high risk for an autism spectrum disorder ( ASD ) .
['There', 'were', 'no', 'treatment', 'effects', 'on', 'child', 'outcomes', 'of', 'joint', 'attention', 'or', 'language', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O']	There were no treatment effects on child outcomes of joint attention or language .
['Children', 'in', 'both', 'groups', 'made', 'significant', 'developmental', 'gains', 'in', 'cognition', 'and', 'language', 'skills', 'over', 'one', 'year', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O']	Children in both groups made significant developmental gains in cognition and language skills over one year .
['These', 'results', 'support', 'parental', 'responsiveness', 'as', 'an', 'important', 'intervention', 'target', 'given', 'its', 'general', 'association', 'with', 'child', 'outcomes', 'in', 'the', 'extant', 'literature', ';', 'however', ',', 'additional', 'supports', 'are', 'likely', 'needed', 'to', 'fully', 'maintain', 'the', 'treatment', 'effect', 'and', 'to', 'affect', 'child', 'outcomes', '.']	['O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	These results support parental responsiveness as an important intervention target given its general association with child outcomes in the extant literature ; however , additional supports are likely needed to fully maintain the treatment effect and to affect child outcomes .
['Pharmacologic', 'treatment', 'is', 'usually', 'begun', 'with', 'nonopioid', 'analgesics', ',', 'most', 'frequently', 'acetaminophen', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I']	Pharmacologic treatment is usually begun with nonopioid analgesics , most frequently acetaminophen .
"['If', 'pain', 'relief', 'is', 'not', 'achieved', ',', 'the', 'so-called', '""', 'weak', '""', 'opioids', ',', 'such', 'as', 'codeine', 'and', 'hydrocodone', ',', 'may', 'be', 'used', 'in', 'combination', 'with', 'acetaminophen', '.']"	['O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I']	"If pain relief is not achieved , the so-called "" weak "" opioids , such as codeine and hydrocodone , may be used in combination with acetaminophen ."
['OBJECTIVE', 'The', 'purpose', 'of', 'this', 'study', 'was', 'to', 'compare', 'the', 'analgesic', 'efficacy', 'and', 'tolerability', 'of', 'codeine', 'phosphate', 'versus', 'hydrocodone', 'bitartrate', 'in', 'combination', 'with', 'acetaminophen', 'in', 'the', 'relief', 'of', 'cancer-related', 'pain', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	OBJECTIVE The purpose of this study was to compare the analgesic efficacy and tolerability of codeine phosphate versus hydrocodone bitartrate in combination with acetaminophen in the relief of cancer-related pain .
['Outpatients', 'with', 'cancer', 'were', 'eligible', 'for', 'the', 'study', 'if', 'they', 'were', 'aged', '>', '-18', 'years', 'and', 'had', 'chronic', '(', 'duration', ',', '>', '/=', '3', 'months', ')', 'moderate', 'to', 'severe', 'cancer-related', 'pain', '(', 'score', 'on', '10-cm', 'visual', 'analog', 'scale', '[', 'VAS', ']', ',', '>', '3', 'cm', '[', 'moderate', ']', ';', 'score', 'on', 'a', '4-point', 'verbal', 'pain-intensity', 'scale', ',', '>', '1', '[', 'moderate', ']', ')', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Outpatients with cancer were eligible for the study if they were aged > -18 years and had chronic ( duration , > /= 3 months ) moderate to severe cancer-related pain ( score on 10-cm visual analog scale [ VAS ] , > 3 cm [ moderate ] ; score on a 4-point verbal pain-intensity scale , > 1 [ moderate ] ) .
['Eligible', 'patients', 'were', 'randomly', 'assigned', 'to', 'receive', '1', 'tablet', 'of', 'codeine/acetaminophen', '(', 'C/A', ')', '30/500', 'mg', 'or', 'hydrocodone/acetaminophen', '(', 'H/A', ')', '5/500', 'mg', 'PO', 'q4h', '(', 'total', 'daily', 'doses', ',', '150/2500', 'and', '25/2500', 'mg', ',', 'respectively', ')', 'for', '23', 'days', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Eligible patients were randomly assigned to receive 1 tablet of codeine/acetaminophen ( C/A ) 30/500 mg or hydrocodone/acetaminophen ( H/A ) 5/500 mg PO q4h ( total daily doses , 150/2500 and 25/2500 mg , respectively ) for 23 days .
['The', 'primary', 'end', 'point', 'was', 'the', 'proportion', 'of', 'patients', 'who', 'achieved', 'pain', 'relief', '(', 'defined', 'as', 'a', 'score', 'of', '>', '1', 'on', 'a', '5-point', 'verbal', 'rating', 'scale', '[', 'VRS', ']', '(', '0', '=', 'none', ';', '1', '=', 'a', 'little', ';', '2', '=', 'some', ';', '3', '=', 'a', 'lot', ';', 'and', '4', '=', 'complete', ')', 'on', 'study', 'days', '1', 'and', '2', 'and', 'weeks', '1', ',', '2', ',', 'and', '3', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The primary end point was the proportion of patients who achieved pain relief ( defined as a score of > 1 on a 5-point verbal rating scale [ VRS ] ( 0 = none ; 1 = a little ; 2 = some ; 3 = a lot ; and 4 = complete ) on study days 1 and 2 and weeks 1 , 2 , and 3 .
['The', 'secondary', 'end', 'point', 'was', 'the', 'proportion', 'of', 'patients', 'in', 'whom', 'pain', 'was', 'decreased', '(', 'VAS', 'score', ',', '<', '-', '3', 'cm', ')', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The secondary end point was the proportion of patients in whom pain was decreased ( VAS score , < - 3 cm ) .
['Of', 'the', 'total', 'number', 'of', 'cases', ',', '59', '%', 'were', 'aged', '60', 'to', '89', 'years', ',', 'and', '55', '%', 'were', 'men', '.']	['B-P', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O']	Of the total number of cases , 59 % were aged 60 to 89 years , and 55 % were men .
['The', 'most', 'common', 'AEs', 'in', 'the', 'C/A', 'and', 'H/A', 'groups', 'were', 'constipation', '(', '36', '%', 'and', '29', '%', ',', 'respectively', ')', ',', 'dizziness', '(', '24', '%', 'and', '19', '%', ')', ',', 'vomiting', '(', '24', '%', 'and', '16', '%', ')', ',', 'and', 'dry', 'mouth', '(', '15', '%', 'and', '18', '%', ')', ',', 'with', 'no', 'significant', 'differences', 'between', 'groups', '.']	['O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The most common AEs in the C/A and H/A groups were constipation ( 36 % and 29 % , respectively ) , dizziness ( 24 % and 19 % ) , vomiting ( 24 % and 16 % ) , and dry mouth ( 15 % and 18 % ) , with no significant differences between groups .
['MF101', ',', 'a', 'selective', 'estrogen', 'receptor', 'beta', 'modulator', 'for', 'the', 'treatment', 'of', 'menopausal', 'hot', 'flushes', ':', 'a', 'phase', 'II', 'clinical', 'trial', '.']	['B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	MF101 , a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes : a phase II clinical trial .
['After', '12', 'weeks', ',', 'the', 'mean', 'percent', 'decrease', 'in', 'frequency', 'of', 'hot', 'flushes', 'in', 'the', '10', 'g/day', 'group', 'was', '12.9', '%', 'greater', 'than', 'that', 'in', 'the', 'placebo', 'group', '(', 'P', '=', '0.15', ')', ',', 'the', 'median', 'percent', 'decrease', 'was', '11.7', '%', 'greater', 'than', 'that', 'in', 'the', 'placebo', 'group', '(', 'P', '=', '0.05', ')', ',', 'and', 'the', 'proportion', 'of', 'women', 'with', 'at', 'least', 'a', '50', '%', 'reduction', 'in', 'hot', 'flushes', 'was', '16.2', '%', 'greater', 'than', 'that', 'in', 'the', 'placebo', 'group', '(', 'P', '=', '0.03', ')', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	After 12 weeks , the mean percent decrease in frequency of hot flushes in the 10 g/day group was 12.9 % greater than that in the placebo group ( P = 0.15 ) , the median percent decrease was 11.7 % greater than that in the placebo group ( P = 0.05 ) , and the proportion of women with at least a 50 % reduction in hot flushes was 16.2 % greater than that in the placebo group ( P = 0.03 ) .
['CONCLUSIONS', 'Treatment', 'with', '10', 'g/day', 'of', 'MF101', 'reduces', 'the', 'frequency', 'of', 'hot', 'flushes', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	CONCLUSIONS Treatment with 10 g/day of MF101 reduces the frequency of hot flushes .
['The', 'effect', 'of', 'a', 'combined', 'intervention', 'including', 'MP', 'plus', 'a', 'nursing', 'telephone', 'intervention', '(', 'NTI', ')', 'was', 'also', 'assessed', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O']	The effect of a combined intervention including MP plus a nursing telephone intervention ( NTI ) was also assessed .
['Median', 'FACIT-F', 'fatigue', 'scores', 'improved', 'from', 'baseline', 'to', 'day', '15', 'in', 'all', 'groups', ':', 'MP+NTI', '(', 'median', 'score', ',', '4.5', ';', 'P', '=', '.005', ')', ',', 'PL+NTI', '(', 'median', 'score', ',', '8.0', ';', 'P', '<', '.001', ')', ',', 'MP+CTI', '(', 'median', 'score', ',', '7.0', ';', 'P', '=', '.004', ')', ',', 'and', 'PL+CTI', '(', 'median', 'score', ',', '5.0', ';', 'P', '=', '.03', ')', '.']	['B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Median FACIT-F fatigue scores improved from baseline to day 15 in all groups : MP+NTI ( median score , 4.5 ; P = .005 ) , PL+NTI ( median score , 8.0 ; P < .001 ) , MP+CTI ( median score , 7.0 ; P = .004 ) , and PL+CTI ( median score , 5.0 ; P = .03 ) .
['However', ',', 'there', 'were', 'no', 'significant', 'differences', 'in', 'the', 'median', 'improvement', 'in', 'FACIT-F', 'fatigue', 'between', 'the', 'MP', 'and', 'PL', 'groups', '(', '5.5', 'v', '6.0', ',', 'respectively', ';', 'P', '=', '.69', ')', 'and', 'among', 'all', 'four', 'groups', '(', 'P', '=', '.16', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O']	However , there were no significant differences in the median improvement in FACIT-F fatigue between the MP and PL groups ( 5.5 v 6.0 , respectively ; P = .69 ) and among all four groups ( P = .16 ) .
['Fatigue', '(', 'P', '<', '.001', ')', ',', 'nausea', '(', 'P', '=', '.01', ')', ',', 'depression', '(', 'P', '=', '.02', ')', ',', 'anxiety', '(', 'P', '=', '.01', ')', ',', 'drowsiness', '(', 'P', '<', '.001', ')', ',', 'appetite', '(', 'P', '=', '.009', ')', ',', 'sleep', '(', 'P', '<', '.001', ')', ',', 'and', 'feeling', 'of', 'well-being', '(', 'P', '<', '.001', ')', ',', 'as', 'measured', 'by', 'the', 'ESAS', ',', 'significantly', 'improved', 'in', 'patients', 'who', 'received', 'NTI', '.']	['B-O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O']	Fatigue ( P < .001 ) , nausea ( P = .01 ) , depression ( P = .02 ) , anxiety ( P = .01 ) , drowsiness ( P < .001 ) , appetite ( P = .009 ) , sleep ( P < .001 ) , and feeling of well-being ( P < .001 ) , as measured by the ESAS , significantly improved in patients who received NTI .
['CONCLUSION', 'MP', 'and', 'NTI', 'alone', 'or', 'combined', 'were', 'not', 'superior', 'to', 'placebo', 'in', 'improving', 'CRF', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'B-O', 'O', 'O']	CONCLUSION MP and NTI alone or combined were not superior to placebo in improving CRF .
['The', 'effect', 'of', 'the', 'video', 'game', 'Mindlight', 'on', 'anxiety', 'symptoms', 'in', 'children', 'with', 'an', 'Autism', 'Spectrum', 'Disorder', '.']	['O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'B-O', 'I-O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	The effect of the video game Mindlight on anxiety symptoms in children with an Autism Spectrum Disorder .
['BACKGROUND', 'In', 'the', 'clinical', 'setting', ',', 'a', 'large', 'proportion', 'of', 'children', 'with', 'an', 'autism', 'spectrum', 'disorder', '(', 'ASD', ')', 'experience', 'anxiety', 'symptoms', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-O', 'I-O', 'I-O']	BACKGROUND In the clinical setting , a large proportion of children with an autism spectrum disorder ( ASD ) experience anxiety symptoms .
['This', 'approach', 'is', 'based', 'on', 'recent', 'research', 'suggesting', 'that', 'video', 'games', 'might', 'be', 'suitable', 'as', 'an', 'intervention', 'vehicle', 'to', 'enhance', 'mental', 'health', 'in', 'children', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	This approach is based on recent research suggesting that video games might be suitable as an intervention vehicle to enhance mental health in children .
['It', 'is', 'expected', 'that', 'children', 'in', 'the', 'experimental', 'condition', 'will', 'show', 'lower', 'levels', 'of', 'anxiety', 'symptoms', 'at', '3-months', 'follow-up', ',', 'compared', 'to', 'children', 'in', 'the', 'control', 'condition', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	It is expected that children in the experimental condition will show lower levels of anxiety symptoms at 3-months follow-up , compared to children in the control condition .
['[', 'Acute', 'cardiovascular', 'and', 'metabolic', 'changes', 'in', 'interval', 'and', 'endurance', 'training', 'in', 'selected', 'patients', 'following', 'aortocoronary', 'bypass', 'operation', ']', '.']	['B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O']	[ Acute cardiovascular and metabolic changes in interval and endurance training in selected patients following aortocoronary bypass operation ] .
['UNLABELLED', 'This', 'study', 'compared', 'the', 'acute', 'changes', 'of', 'cardiovascular', 'and', 'metabolic', 'reactions', 'during', 'interval', 'and', 'continuous', 'training', 'after', 'coronary', 'bypass', 'surgery', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O']	UNLABELLED This study compared the acute changes of cardiovascular and metabolic reactions during interval and continuous training after coronary bypass surgery .
[')', 'each', 'trained', 'on', 'bicycle', 'ergometer', 'start', 'on', 'post-operative', 'days', '24', 'and', '26', ',', 'resp', '.']	['B-P', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I']	) each trained on bicycle ergometer start on post-operative days 24 and 26 , resp .
['In', 'the', 'last', 'week', 'of', 'training', 'the', 'exercise', 'intensity', 'in', 'the', 'group', 'of', 'patients', 'who', 'were', 'trained', 'by', 'the', 'continuous', 'method', 'was', 'at', '83', 'watts', ',', 'and', 'at', '20:121', 'watts', 'in', 'the', 'group', 'of', 'patients', 'who', 'were', 'trained', 'by', 'interval', 'method', '(', 'rest', ':', 'work', 'each', '1:1', 'min', ')', '.']	['B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I']	In the last week of training the exercise intensity in the group of patients who were trained by the continuous method was at 83 watts , and at 20:121 watts in the group of patients who were trained by interval method ( rest : work each 1:1 min ) .
['RESULTS', 'In', 'both', 'methods', 'there', 'were', 'no', 'significant', 'differences', 'in', 'systolic', 'and', 'diastolic', 'pressure', ',', 'rate-pressure', 'product', ',', 'in', 'glucose', 'or', 'catecholamine', 'levels', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	RESULTS In both methods there were no significant differences in systolic and diastolic pressure , rate-pressure product , in glucose or catecholamine levels .
['Moderate-intensity', 'exercise', 'training', 'with', 'elements', 'of', 'step', 'aerobics', 'in', 'patients', 'with', 'severe', 'chronic', 'heart', 'failure', '.']	['B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Moderate-intensity exercise training with elements of step aerobics in patients with severe chronic heart failure .
['OBJECTIVE', 'To', 'evaluate', 'whether', 'a', 'specific', 'program', 'of', 'moderate-intensity', 'step', 'aerobics', 'training', 'may', 'be', 'sufficient', 'to', 'improve', 'the', 'exercise', 'tolerance', 'of', 'patients', 'with', 'severe', 'chronic', 'heart', 'failure', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	OBJECTIVE To evaluate whether a specific program of moderate-intensity step aerobics training may be sufficient to improve the exercise tolerance of patients with severe chronic heart failure .
['The', 'control', 'group', 'did', 'not', 'perform', 'a', 'training', 'program', '.']	['O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I']	The control group did not perform a training program .
['MAIN', 'OUTCOME', 'MEASURES', 'Peak', 'oxygen', 'uptake', ',', 'peak', 'workload', ',', 'percent', 'of', 'predicted', 'power', 'ability', '.']	['O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	MAIN OUTCOME MEASURES Peak oxygen uptake , peak workload , percent of predicted power ability .
['RESULTS', 'Significant', 'increases', 'in', 'peak', 'oxygen', 'uptake', '(', '15', '+/-', '3.4', 'to', '18.5', '+/-', '2.9mL/kg/min', ';', 'p', '=', '.001', ')', ',', 'peak', 'workload', '(', '77', '+/-', '26', 'to', '99', '+/-', '31', 'watts', ';', 'p', '=', '.000', ')', ',', 'and', 'percent', 'of', 'predicted', 'power', 'ability', '(', '43', '%', '+/-', '10', '%', 'to', '56', '%', '+/-', '13', '%', ';', 'p', '=', '.000', ')', 'were', 'observed', 'in', 'the', 'exercise', 'group', '.']	['O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	RESULTS Significant increases in peak oxygen uptake ( 15 +/- 3.4 to 18.5 +/- 2.9mL/kg/min ; p = .001 ) , peak workload ( 77 +/- 26 to 99 +/- 31 watts ; p = .000 ) , and percent of predicted power ability ( 43 % +/- 10 % to 56 % +/- 13 % ; p = .000 ) were observed in the exercise group .
['There', 'were', 'no', 'critical', 'changes', 'in', 'heart', 'rate', 'or', 'blood', 'pressure', 'in', 'either', 'group', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O']	There were no critical changes in heart rate or blood pressure in either group .
['Following', 'priming', ',', 'an', 'automatic', 'imitation', 'paradigm', 'was', 'used', 'to', 'acquire', 'an', 'index', 'of', 'imitation', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O']	Following priming , an automatic imitation paradigm was used to acquire an index of imitation .
['Whereas', 'imitation', 'levels', 'were', 'higher', 'for', 'pro-socially', 'primed', 'relative', 'to', 'non-socially', 'primed', 'control', 'participants', ',', 'there', 'was', 'no', 'difference', 'between', 'pro-', 'and', 'non-', 'socially', 'primed', 'individuals', 'with', 'ASC', '.']	['O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P']	Whereas imitation levels were higher for pro-socially primed relative to non-socially primed control participants , there was no difference between pro- and non- socially primed individuals with ASC .
['We', 'conclude', 'that', 'high-functioning', 'adults', 'with', 'ASC', 'demonstrate', 'atypical', 'social', 'modulation', 'of', 'imitation', '.']	['O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	We conclude that high-functioning adults with ASC demonstrate atypical social modulation of imitation .
['A', 'limited', 'sampling', 'model', 'has', 'been', 'developed', 'for', 'flunarizine', 'following', 'a', '30', 'mg', 'oral', 'dose', 'in', 'epileptic', 'patients', 'who', 'were', 'receiving', 'phenytoin', 'or', 'carbamazepine', 'or', 'both', ',', 'to', 'estimate', 'the', 'area', 'under', 'the', 'curve', '(', 'AUC', ')', 'and', 'maximum', 'plasma', 'concentration', '(', 'Cmax', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	A limited sampling model has been developed for flunarizine following a 30 mg oral dose in epileptic patients who were receiving phenytoin or carbamazepine or both , to estimate the area under the curve ( AUC ) and maximum plasma concentration ( Cmax ) .
['The', 'model', 'was', 'developed', 'using', 'training', 'data', 'sets', 'from', '30', ',', '20', ',', '15', ',', 'or', '10', 'patients', 'at', 'one', 'or', 'two', 'time', 'points', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	The model was developed using training data sets from 30 , 20 , 15 , or 10 patients at one or two time points .
['The', 'model', 'provided', 'reasonably', 'good', 'estimates', 'for', 'both', 'AUC', 'and', 'Cmax', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	The model provided reasonably good estimates for both AUC and Cmax .
['The', 'bias', 'of', 'the', 'prediction', 'was', '2', '%', 'and', 'precision', 'was', '28', '%', '.']	['O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The bias of the prediction was 2 % and precision was 28 % .
['The', 'mean', 'predicted', 'Cmax', 'of', 'flunarizine', 'was', '86', '+/-', '32', 'ng', 'mL-1', 'as', 'compared', 'to', 'an', 'observed', 'mean', 'Cmax', 'of', '90', '+/-', '42', 'ng', 'mL-1', '.']	['O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The mean predicted Cmax of flunarizine was 86 +/- 32 ng mL-1 as compared to an observed mean Cmax of 90 +/- 42 ng mL-1 .
['Naltrexone', 'in', 'young', 'autistic', 'children', ':', 'a', 'double-blind', ',', 'placebo-controlled', 'crossover', 'study', '.']	['B-I', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O']	Naltrexone in young autistic children : a double-blind , placebo-controlled crossover study .
['OBJECTIVE', 'This', 'study', 'evaluated', 'the', 'efficacy', 'and', 'safety', 'of', 'naltrexone', ',', 'an', 'opiate', 'blocker', ',', 'in', 'the', 'treatment', 'of', 'autism', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P']	OBJECTIVE This study evaluated the efficacy and safety of naltrexone , an opiate blocker , in the treatment of autism .
['Dependent', 'measures', 'included', 'parent', 'and', 'teacher', 'Clinical', 'Global', 'Impressions', '(', 'CGI', ')', ',', 'Conners', 'Rating', 'Scales', ',', 'and', 'Naltrexone', 'Side-Effects', '(', 'SE', ')', 'Rating', 'Scale', ';', 'laboratory', 'CGI', ',', 'movement', 'actometer', 'readings', ',', 'and', 'a', '10-second', 'interval', 'recording', 'system', 'analysis', 'of', 'on-task', ',', 'communication', 'initiations', ',', 'disruptive', 'behavior', ',', 'and', 'self-stimulation', '.']	['B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	Dependent measures included parent and teacher Clinical Global Impressions ( CGI ) , Conners Rating Scales , and Naltrexone Side-Effects ( SE ) Rating Scale ; laboratory CGI , movement actometer readings , and a 10-second interval recording system analysis of on-task , communication initiations , disruptive behavior , and self-stimulation .
['Adverse', 'side', 'effects', 'were', 'behavioral', ',', 'mild', ',', 'and', 'transient', '.']	['B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Adverse side effects were behavioral , mild , and transient .
['Frequent', 'treatment-emergent', 'grade', '3/4', 'hematologic', 'abnormalities', 'were', 'lymphopenia', '(', '20', '%', 'v', '11', '%', ')', ',', 'anemia', '(', '9', '%', 'v', '8', '%', ')', ',', 'and', 'neutropenia', '(', '6', '%', 'v', '<', '1', '%', ')', '.']	['O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'B-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Frequent treatment-emergent grade 3/4 hematologic abnormalities were lymphopenia ( 20 % v 11 % ) , anemia ( 9 % v 8 % ) , and neutropenia ( 6 % v < 1 % ) .
['RESULTS', 'all-E-Zeaxanthin', 'concentrations', 'increased', 'from', '0.048', '+/-', '0.026', 'micro', 'mol/L', 'at', 'baseline', 'to', '0.20', '+/-', '0.07', 'and', '0.92', '+/-', '0.28', 'micro', 'mol/L', 'with', '1', 'and', '10', 'mg', 'zeaxanthin', ',', 'respectively', '.']	['O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O']	RESULTS all-E-Zeaxanthin concentrations increased from 0.048 +/- 0.026 micro mol/L at baseline to 0.20 +/- 0.07 and 0.92 +/- 0.28 micro mol/L with 1 and 10 mg zeaxanthin , respectively .
['The', 'dose-normalized', 'bioavailability', 'of', 'all-E-zeaxanthin', 'after', 'the10-mg', 'dose', 'was', '40', '%', 'lower', '(', 'P', '<', '0.001', ')', 'than', 'after', 'the', '1-mg', 'dose', '.']	['O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The dose-normalized bioavailability of all-E-zeaxanthin after the10-mg dose was 40 % lower ( P < 0.001 ) than after the 1-mg dose .
['Other', 'kinetic', 'parameters', 'did', 'not', 'differ', 'significantly', 'between', 'groups', '.']	['O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Other kinetic parameters did not differ significantly between groups .
"['The', 'time', 'course', 'of', 'plasma', ""all-E-3-'dehydro-lutein"", 'concentrations', 'resembled', 'that', 'of', 'all-E-zeaxanthin', '.']"	['O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'B-I', 'I-I']	The time course of plasma all-E-3-'dehydro-lutein concentrations resembled that of all-E-zeaxanthin .
['Concentrations', 'of', 'other', 'carotenoids', 'were', 'not', 'affected', '.']	['B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O']	Concentrations of other carotenoids were not affected .
['AIMS', 'We', 'therefore', 'used', 'functional', 'magnetic', 'resonance', 'imaging', '(', 'fMRI', ')', 'to', 'investigate', 'the', 'so', 'far', 'unknown', 'shared', 'and', 'disorder-specific', 'inhibitory', 'brain', 'dysfunctions', 'in', 'these', 'two', 'disorders', ',', 'as', 'well', 'as', 'the', 'effects', 'of', 'a', 'single', 'dose', 'of', 'the', 'selective', 'serotonin', 'reuptake', 'inhibitor', 'fluoxetine', '.']	['O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	AIMS We therefore used functional magnetic resonance imaging ( fMRI ) to investigate the so far unknown shared and disorder-specific inhibitory brain dysfunctions in these two disorders , as well as the effects of a single dose of the selective serotonin reuptake inhibitor fluoxetine .
['Repeated', 'measures', 'analyses', 'within', 'patients', 'assessed', 'drug', 'effects', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O']	Repeated measures analyses within patients assessed drug effects .
['CONCLUSIONS', 'The', 'findings', 'show', 'that', 'fluoxetine', 'normalises', 'frontal', 'lobe', 'dysfunctions', 'in', 'both', 'disorders', 'via', 'inverse', 'effects', ',', 'downregulating', 'abnormally', 'increased', 'frontal', 'activation', 'in', 'ASD', 'and', 'upregulating', 'abnormally', 'decreased', 'frontal', 'activation', 'in', 'ADHD', ',', 'potentially', 'reflecting', 'inverse', 'baseline', 'serotonin', 'levels', 'in', 'both', 'disorders', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	CONCLUSIONS The findings show that fluoxetine normalises frontal lobe dysfunctions in both disorders via inverse effects , downregulating abnormally increased frontal activation in ASD and upregulating abnormally decreased frontal activation in ADHD , potentially reflecting inverse baseline serotonin levels in both disorders .
['A', 'randomized', 'trial', 'of', 'immunotherapy', 'for', 'persistent', 'genital', 'warts', '.']	['O', 'O', 'O', 'O', 'B-I', 'O', 'B-P', 'I-P', 'I-P', 'I-P']	A randomized trial of immunotherapy for persistent genital warts .
['RESULTS', 'Of', '33', 'protocol', 'compliant', 'Brisbane', 'recipients', 'of', 'placebo', 'immunotherapy', ',', '11', 'were', 'disease', 'free', 'at', 'two', 'months', ',', 'and', 'a', 'further', '9', 'demonstrated', 'reduction', 'of', '>', '50', '%', 'in', 'total', 'wart', 'area', '.']	['O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O']	RESULTS Of 33 protocol compliant Brisbane recipients of placebo immunotherapy , 11 were disease free at two months , and a further 9 demonstrated reduction of > 50 % in total wart area .
['Wart', 'area', 'reduction', 'following', 'destructive', 'treatment', 'correlated', 'with', 'prior', 'duration', 'of', 'disease', '.']	['B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Wart area reduction following destructive treatment correlated with prior duration of disease .
['Prior', 'disease', 'duration', 'was', 'much', 'shorter', 'in', 'Wenzhou', 'subject', '(', '8.1', '±', '1.1', 'mo', ')', 'than', 'in', 'Brisbane', 'subjects', '(', '53.7', '±', '5.5', 'mo', ')', '.']	['B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Prior disease duration was much shorter in Wenzhou subject ( 8.1 ± 1.1 mo ) than in Brisbane subjects ( 53.7 ± 5.5 mo ) .
['No', 'significant', 'reduction', 'in', 'mean', 'wart', 'area', 'was', 'observed', 'for', 'the', '168', 'Wenzhou', 'protocol', 'compliant', 'subjects', 'who', 'also', 'received', 'VLP', 'immunotherapy', '.']	['O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O']	No significant reduction in mean wart area was observed for the 168 Wenzhou protocol compliant subjects who also received VLP immunotherapy .
['CONCLUSIONS', 'This', 'study', 'confirms', 'the', 'findings', 'in', 'a', 'previous', 'open', 'label', 'trial', 'that', 'administration', 'of', 'VLP', 'immunotherapy', 'may', 'assist', 'in', 'clearance', 'of', 'recurrent', 'genital', 'warts', 'in', 'patients', 'for', 'whom', 'destructive', 'therapy', 'is', 'unsuccessful', 'and', 'that', 'unsuccessful', 'destructive', 'therapy', 'is', 'more', 'common', 'with', 'increasing', 'prior', 'disease', 'duration', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	CONCLUSIONS This study confirms the findings in a previous open label trial that administration of VLP immunotherapy may assist in clearance of recurrent genital warts in patients for whom destructive therapy is unsuccessful and that unsuccessful destructive therapy is more common with increasing prior disease duration .
['The', 'aim', 'of', 'this', 'study', 'was', 'to', 'compare', 'the', 'effect', 'of', 'extracorporeal', 'shock', 'wave', 'therapy', '(', 'ESWT', ')', 'in', 'patients', 'with', 'chronically', 'painful', 'proximal', 'plantar', 'fasciitis', 'with', 'a', 'further', 'conventional', 'conservative', 'treatment', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The aim of this study was to compare the effect of extracorporeal shock wave therapy ( ESWT ) in patients with chronically painful proximal plantar fasciitis with a further conventional conservative treatment .
['Forty-seven', 'patients', '(', '49', 'feet', ')', 'with', 'a', 'previously', 'unsuccessful', 'nonsurgical', 'treatment', 'of', 'at', 'least', '6', 'months', 'were', 'randomized', 'to', 'two', 'groups', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Forty-seven patients ( 49 feet ) with a previously unsuccessful nonsurgical treatment of at least 6 months were randomized to two groups .
['Heel', 'cups', 'had', 'to', 'be', 'worn', 'throughout', 'the', 'study', '.']	['B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Heel cups had to be worn throughout the study .
['At', '12', 'weeks', 'after', 'ESWT', ',', 'the', 'pain', 'estimation', 'on', 'the', 'visual', 'analogue', 'scale', '(', 'VAS', ')', 'for', 'activities', 'of', 'daily', 'living', 'diminished', 'significantly', 'by', '62.9', '%', 'in', 'group', '1', 'and', 'by', '63.0', '%', 'in', 'group', '2', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	At 12 weeks after ESWT , the pain estimation on the visual analogue scale ( VAS ) for activities of daily living diminished significantly by 62.9 % in group 1 and by 63.0 % in group 2 .
['The', 'comfortable', 'walking', 'time', 'had', 'increased', 'significantly', 'in', 'both', 'groups', '.']	['O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The comfortable walking time had increased significantly in both groups .
['A', 'pilot', 'study', 'on', 'the', 'efficacy', 'of', 'melodic', 'based', 'communication', 'therapy', 'for', 'eliciting', 'speech', 'in', 'nonverbal', 'children', 'with', 'autism', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'B-O', 'I-O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P']	A pilot study on the efficacy of melodic based communication therapy for eliciting speech in nonverbal children with autism .
['The', 'purpose', 'of', 'this', 'study', 'was', 'to', 'compare', 'the', 'efficacy', 'of', 'melodic', 'based', 'communication', 'therapy', '(', 'MBCT', ')', 'to', 'traditional', 'speech', 'and', 'language', 'therapy', 'for', 'eliciting', 'speech', 'in', 'nonverbal', 'children', 'with', 'autism', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'B-O', 'I-O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P']	The purpose of this study was to compare the efficacy of melodic based communication therapy ( MBCT ) to traditional speech and language therapy for eliciting speech in nonverbal children with autism .
['The', 'MBCT', 'group', 'progressed', 'significantly', 'in', 'number', 'of', 'verbal', 'attempts', 'after', 'weeks', '1', 'through', '4', 'and', 'number', 'of', 'correct', 'words', 'after', 'weeks', '1', 'and', '3', ',', 'while', 'the', 'traditional', 'group', 'progressed', 'significantly', 'after', 'weeks', '4', 'and', '5', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The MBCT group progressed significantly in number of verbal attempts after weeks 1 through 4 and number of correct words after weeks 1 and 3 , while the traditional group progressed significantly after weeks 4 and 5 .
['No', 'significant', 'differences', 'in', 'number', 'of', 'verbal', 'attempts', 'or', 'number', 'of', 'correct', 'words', 'were', 'noted', 'between', 'groups', 'following', 'treatment', '.']	['O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	No significant differences in number of verbal attempts or number of correct words were noted between groups following treatment .
['The', 'repeat', 'pregnancy', 'rate', 'in', 'the', 'experimental', 'group', 'was', '12', '%', 'after', '18', 'months', ',', 'and', '28', '%', 'in', 'the', 'control', 'group', '.']	['O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The repeat pregnancy rate in the experimental group was 12 % after 18 months , and 28 % in the control group .
['After', '12', 'months', ',', 'the', 'infants', 'in', 'the', 'experimental', 'group', 'were', 'more', 'likely', 'to', 'be', 'fully', 'immunized', '(', '33', '%', ')', 'than', 'the', 'infants', 'in', 'the', 'control', 'group', '(', '18', '%', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	After 12 months , the infants in the experimental group were more likely to be fully immunized ( 33 % ) than the infants in the control group ( 18 % ) .
"['Outcome', 'of', 'children', 'with', 'centrally', 'reviewed', 'low-grade', 'gliomas', 'treated', 'with', 'chemotherapy', 'with', 'or', 'without', 'radiotherapy', 'on', 'Children', ""'s"", 'Cancer', 'Group', 'high-grade', 'glioma', 'study', 'CCG-945', '.']"	['B-O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children 's Cancer Group high-grade glioma study CCG-945 .
"['BACKGROUND', 'The', 'objectives', 'of', 'the', 'current', 'study', 'were', 'to', 'determine', 'the', 'outcome', 'of', 'children', 'who', 'were', 'treated', 'with', 'chemotherapy', 'and', 'radiotherapy', 'on', 'the', 'Children', ""'s"", 'Cancer', 'Group', '(', 'CCG', ')', 'high-grade', 'glioma', 'protocol', '(', 'CCG-945', ')', 'who', 'were', 'diagnosed', 'with', 'low-grade', 'gliomas', 'on', 'post', 'hoc', 'central', 'pathologic', 'review', 'and', 'to', 'identify', 'clinical', 'and', 'biologic', 'features', 'associated', 'with', 'prognosis', '.']"	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-I', 'I-I', 'I-I', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O']	BACKGROUND The objectives of the current study were to determine the outcome of children who were treated with chemotherapy and radiotherapy on the Children 's Cancer Group ( CCG ) high-grade glioma protocol ( CCG-945 ) who were diagnosed with low-grade gliomas on post hoc central pathologic review and to identify clinical and biologic features associated with prognosis .
['METHODS', 'Between', '1985', 'and', '1991', ',', '250', 'children', 'with', 'institutionally', 'classified', 'high-grade', 'gliomas', 'were', 'enrolled', 'on', 'CCG-945', '.']	['O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	METHODS Between 1985 and 1991 , 250 children with institutionally classified high-grade gliomas were enrolled on CCG-945 .
['Central', 'independent', 'review', 'by', '5', 'neuropathologists', 'led', 'to', 'a', 'reclassification', 'of', 'low-grade', 'glioma', 'in', '70', 'patients', ',', 'who', 'were', 'the', 'focus', 'of', 'the', 'current', 'study', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Central independent review by 5 neuropathologists led to a reclassification of low-grade glioma in 70 patients , who were the focus of the current study .
['RESULTS', 'The', 'study', 'involved', '42', 'males', 'and', '28', 'females', '(', 'median', 'age', ',', '7.7', 'years', ')', 'with', 'a', 'median', 'follow-up', 'of', '10.4', 'years', '.']	['O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	RESULTS The study involved 42 males and 28 females ( median age , 7.7 years ) with a median follow-up of 10.4 years .
['CONCLUSIONS', 'The', 'current', 'report', 'calls', 'attention', 'to', 'the', 'importance', 'of', 'central', 'pathologic', 'review', 'in', 'large', 'multiinstitutional', 'trials', 'of', 'children', 'with', 'gliomas', 'and', 'suggests', 'that', 'aggressive', 'front-line', 'combined', 'chemoradiotherapy', 'does', 'not', 'confer', 'a', 'survival', 'advantage', 'in', 'this', 'highly', 'selected', 'population', 'of', 'patients', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	CONCLUSIONS The current report calls attention to the importance of central pathologic review in large multiinstitutional trials of children with gliomas and suggests that aggressive front-line combined chemoradiotherapy does not confer a survival advantage in this highly selected population of patients .
['Dalteparin', 'low', 'molecular', 'weight', 'heparin', '(', 'LMWH', ')', 'in', 'ovarian', 'cancer', ':', 'a', 'phase', 'II', 'randomized', 'study', '.']	['B-I', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O']	Dalteparin low molecular weight heparin ( LMWH ) in ovarian cancer : a phase II randomized study .
['A', 'multicentre', 'phase', 'II', 'randomized', 'trial', 'was', 'done', 'to', 'evaluate', 'the', 'antineoplastic', 'potential', 'of', 'dalteparin', 'in', 'ovarian', 'cancer', '(', 'OC', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	A multicentre phase II randomized trial was done to evaluate the antineoplastic potential of dalteparin in ovarian cancer ( OC ) .
['MATERIALS', 'AND', 'METHODS', 'Women', 'with', 'newly-diagnosed', 'epithelial', 'OC', 'were', 'randomized', 'to', 'receive', 'standard', 'chemotherapy', '(', 'CT', ')', 'and', 'one', 'of', '3', 'doses', 'of', 'dalteparin', '(', '50', 'IU/kg', ',', '100', 'IU/kg', ',', 'or', '150', 'IU/kg', ')', 'subcutaneously', 'once', 'daily', 'during', 'the', 'first', '3', 'of', '6', 'cycles', 'of', '3-weekly', 'CT', '.']	['O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	MATERIALS AND METHODS Women with newly-diagnosed epithelial OC were randomized to receive standard chemotherapy ( CT ) and one of 3 doses of dalteparin ( 50 IU/kg , 100 IU/kg , or 150 IU/kg ) subcutaneously once daily during the first 3 of 6 cycles of 3-weekly CT .
['The', 'primary', 'outcome', 'was', 'tumor', 'response', 'defined', 'by', '≥', '50', '%', 'reduction', 'in', 'serum', 'CA125', 'from', 'baseline', 'sustained', 'for', 'at', 'least', '28', 'days', '.']	['O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O']	The primary outcome was tumor response defined by ≥ 50 % reduction in serum CA125 from baseline sustained for at least 28 days .
['A', '50', '%', 'drop', 'in', 'CA125', 'at', 'the', 'end', 'of', 'cycle', '3', 'was', 'seen', 'in', '85', '%', 'of', 'the', '50', 'IU/kg', 'group', ',', '92', '%', 'of', 'the', '100', 'IU/kg', 'group', ',', 'and', '85', '%', 'of', 'the', '150', 'IU/kg', 'group', '.']	['O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	A 50 % drop in CA125 at the end of cycle 3 was seen in 85 % of the 50 IU/kg group , 92 % of the 100 IU/kg group , and 85 % of the 150 IU/kg group .
['There', 'were', 'no', 'symptomatic', 'VTE', 'or', 'major', 'bleeding', 'events', 'while', 'on', 'dalteparin', '.']	['O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O']	There were no symptomatic VTE or major bleeding events while on dalteparin .
['Women', 'on', 'dalteparin', 'had', 'lower', 'levels', 'of', 'D-dimer', 'and', 'thrombin-antithrombin', ',', 'and', 'higher', 'levels', 'of', 'tissue', 'factor', 'pathway', 'inhibitor', ',', 'relative', 'to', 'baseline', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O']	Women on dalteparin had lower levels of D-dimer and thrombin-antithrombin , and higher levels of tissue factor pathway inhibitor , relative to baseline .
['CONCLUSION', 'Dalteparin', 'is', 'safe', 'and', 'well', 'tolerated', 'in', 'women', 'receiving', 'CT', 'for', 'newly-diagnosed', 'epithelial', 'OC', '.']	['B-I', 'I-I', 'I-O', 'I-O', 'O', 'B-O', 'I-O', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O']	CONCLUSION Dalteparin is safe and well tolerated in women receiving CT for newly-diagnosed epithelial OC .
['Interferential', 'therapy', 'electrode', 'placement', 'technique', 'in', 'acute', 'low', 'back', 'pain', ':', 'a', 'preliminary', 'investigation', '.']	['B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O']	Interferential therapy electrode placement technique in acute low back pain : a preliminary investigation .
['PATIENTS', 'A', 'random', 'sample', 'of', '60', 'eligible', 'patients', 'with', 'back', 'pain', '(', '28', 'men', ',', '32', 'women', ')', 'were', 'recruited', 'by', 'general', 'practitioners', 'and', 'self-referral', 'for', 'physiotherapy', 'treatment', 'and', 'randomly', 'assigned', 'to', '1', 'of', '3', 'groups', '.']	['O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	PATIENTS A random sample of 60 eligible patients with back pain ( 28 men , 32 women ) were recruited by general practitioners and self-referral for physiotherapy treatment and randomly assigned to 1 of 3 groups .
"['INTERVENTIONS', '(', '1', ')', '""', 'IFT', 'painful', 'area', '""', 'and', 'The', 'Back', 'Book', ',', '(', '2', ')', '""', 'IFT', 'spinal', 'nerve', '""', 'and', 'The', 'Back', 'Book', ',', 'and', '(', '3', ')', '""', 'Control', ',', '""', 'The', 'Back', 'Book', 'only', '.']"	['O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O']	"INTERVENTIONS ( 1 ) "" IFT painful area "" and The Back Book , ( 2 ) "" IFT spinal nerve "" and The Back Book , and ( 3 ) "" Control , "" The Back Book only ."
"['Standardized', 'IFT', 'stimulation', 'parameters', 'were', 'used', ':', 'carrier', 'frequency', '3.85', 'kHz', ';', '140', 'Hz', 'constant', ';', 'pulse', 'duration', '130', 'micros', ';', '30', 'minutes', ""'"", 'duration', '.']"	['O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Standardized IFT stimulation parameters were used : carrier frequency 3.85 kHz ; 140 Hz constant ; pulse duration 130 micros ; 30 minutes ' duration .
['Subjects', 'managed', 'by', 'IFT', 'spinal', 'nerve', 'and', 'The', 'Back', 'Book', 'displayed', 'both', 'a', 'statistically', 'significant', '(', 'p', '=', '.030', ')', 'and', 'clinically', 'meaningful', 'reduction', 'in', 'functional', 'disability', '(', 'RMDQ', ')', ',', 'compared', 'with', 'management', 'via', 'IFT', 'painful', 'area', 'and', 'The', 'Back', 'Book', 'combined', 'or', 'The', 'Back', 'Book', 'alone', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Subjects managed by IFT spinal nerve and The Back Book displayed both a statistically significant ( p = .030 ) and clinically meaningful reduction in functional disability ( RMDQ ) , compared with management via IFT painful area and The Back Book combined or The Back Book alone .
['Men', 'and', 'women', ',', '22-36', 'years', 'old', ',', 'performed', 'a', 'synchronization-continuation', 'task', 'with', 'intertap', 'intervals', '(', 'ITI', ')', 'from', '0.4', 's', 'to', '2.2', 's.', 'ISIP', 'variability', 'was', 'partitioned', 'into', 'components', 'attributable', 'to', 'drift', 'and', '1st-order', 'serial', 'correlation', ',', 'and', 'the', 'results', 'indicate', 'that', '(', 'a', ')', 'drift', 'contributes', 'substantially', 'to', 'the', 'dispersion', 'for', 'longer', 'ITIs', ',', '(', 'b', ')', 'drift', 'and', '1st-order', 'correlation', 'are', 'different', 'functions', 'of', 'the', 'ITI', ',', 'and', '(', 'c', ')', 'drift', 'exhibits', 'break', 'close', 'to', '1.0', 's', 'and', '1.4', 's', 'ITI', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Men and women , 22-36 years old , performed a synchronization-continuation task with intertap intervals ( ITI ) from 0.4 s to 2.2 s. ISIP variability was partitioned into components attributable to drift and 1st-order serial correlation , and the results indicate that ( a ) drift contributes substantially to the dispersion for longer ITIs , ( b ) drift and 1st-order correlation are different functions of the ITI , and ( c ) drift exhibits break close to 1.0 s and 1.4 s ITI .
['A', 'randomized', ',', 'controlled', 'study', 'on', 'the', 'influence', 'of', 'acetaminophen', ',', 'diclofenac', ',', 'or', 'naproxen', 'on', 'aspirin-induced', 'inhibition', 'of', 'platelet', 'aggregation', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'B-O', 'I-O', 'I-O']	A randomized , controlled study on the influence of acetaminophen , diclofenac , or naproxen on aspirin-induced inhibition of platelet aggregation .
['Nonsteroidal', 'anti-inflammatory', 'drugs', '(', 'NSAID', ')', 'may', 'interfere', 'with', 'aspirin', '(', 'acetylsalicylic', 'acid', ')', 'and', 'increase', 'the', 'risk', 'for', 'cardiovascular', 'events', '.']	['B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O']	Nonsteroidal anti-inflammatory drugs ( NSAID ) may interfere with aspirin ( acetylsalicylic acid ) and increase the risk for cardiovascular events .
['Acetaminophen', 'had', 'no', 'effect', 'compared', 'with', 'placebo', '.']	['B-I', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I']	Acetaminophen had no effect compared with placebo .
['We', 'conclude', 'that', 'a', 'co-administration', 'of', 'NSAID', 'and', 'aspirin', 'may', 'interfere', 'with', 'platelet', 'inhibition', 'at', 'the', 'beginning', 'of', 'a', 'treatment', 'with', 'an', 'increase', 'of', 'naproxen', 'and', 'a', 'decrease', 'of', 'diclofenac', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'B-I', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'B-I', 'I-I']	We conclude that a co-administration of NSAID and aspirin may interfere with platelet inhibition at the beginning of a treatment with an increase of naproxen and a decrease of diclofenac .
['Piperacillin/tazobactam', 'plus', 'tobramycin', 'versus', 'ceftazidime', 'plus', 'tobramycin', 'as', 'empiric', 'therapy', 'for', 'fever', 'in', 'severely', 'neutropenic', 'patients', '.']	['B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'B-O', 'O', 'B-P', 'I-P', 'I-P', 'I-P']	Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients .
['The', 'objective', 'of', 'this', 'trial', 'was', 'to', 'evaluate', 'the', 'potential', 'advantages', 'of', 'the', 'combination', 'of', 'piperacillin', 'and', 'tazobactam', 'in', 'the', 'control', 'of', 'fever', 'in', 'neutropenic', 'patients', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'B-O', 'I-P', 'I-P', 'I-P', 'I-P']	The objective of this trial was to evaluate the potential advantages of the combination of piperacillin and tazobactam in the control of fever in neutropenic patients .
['In', 'this', 'single-center', 'study', ',', 'patients', 'who', 'experienced', 'a', 'total', 'of', '247', 'febrile', 'episodes', 'were', 'prospectively', 'randomized', 'to', 'receive', 'either', 'our', 'standard', 'regimen', ',', 'ceftazidime', '3', 'g/day', '(', '1', 'g', 't.i.d', '.']	['O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	In this single-center study , patients who experienced a total of 247 febrile episodes were prospectively randomized to receive either our standard regimen , ceftazidime 3 g/day ( 1 g t.i.d .
[')', ',', 'or', 'piperacillin', '12', 'g/day', 'plus', 'tazobactam', '1.5', 'g/day', '(', '4', 'g+0.5', 'g', 't.i.d', '.']	['O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	) , or piperacillin 12 g/day plus tazobactam 1.5 g/day ( 4 g+0.5 g t.i.d .
"['All', '247', 'episodes', 'were', 'evaluable', 'by', '""', 'intent-to-treat', '""', 'analysis', '.']"	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O']	"All 247 episodes were evaluable by "" intent-to-treat "" analysis ."
['This', 'trial', 'confirmed', 'the', 'efficacy', 'of', 'the', 'piperacillin/tazobactam', 'combination', 'for', 'empirical', 'treatment', 'of', 'febrile', 'neutropenic', 'patients', '.']	['O', 'O', 'O', 'O', 'B-O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P']	This trial confirmed the efficacy of the piperacillin/tazobactam combination for empirical treatment of febrile neutropenic patients .
['Qualitative', 'studies', 'suggest', 'that', 'participation', 'in', 'visual', 'arts', 'creative', 'engagement', 'interventions', '(', 'CEIs', ')', 'during', 'rehabilitation', 'after', 'stroke', 'may', 'improve', 'mood', ',', 'self-esteem', ',', 'hope', 'and', 'some', 'aspects', 'of', 'physical', 'recovery', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Qualitative studies suggest that participation in visual arts creative engagement interventions ( CEIs ) during rehabilitation after stroke may improve mood , self-esteem , hope and some aspects of physical recovery .
['Artists', 'will', 'follow', 'an', 'intervention', 'protocol', 'with', 'specific', 'components', 'that', 'enable', 'participants', 'to', 'set', ',', 'achieve', 'and', 'review', 'artistic', 'goals', '.']	['B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I']	Artists will follow an intervention protocol with specific components that enable participants to set , achieve and review artistic goals .
['Participants', 'will', 'receive', 'up', 'to', 'eight', 'intervention', 'sessions', ',', 'four', 'within', 'a', 'group', 'and', 'four', 'one-to-one', 'with', 'the', 'artist', '.']	['B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I']	Participants will receive up to eight intervention sessions , four within a group and four one-to-one with the artist .
['Stroke-related', 'health', 'status', 'is', 'the', 'primary', 'outcome', ';', 'mood', ',', 'self-esteem', ',', 'self-efficacy', ',', 'perceived', 'recovery', 'control', 'and', 'hope', 'are', 'secondary', 'outcomes', '.']	['B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O']	Stroke-related health status is the primary outcome ; mood , self-esteem , self-efficacy , perceived recovery control and hope are secondary outcomes .
['Semi-structured', 'interviews', 'will', 'be', 'conducted', 'with', 'purposively', 'selected', 'patients', ',', 'artists', 'and', 'healthcare', 'staff', 'to', 'elicit', 'views', 'and', 'experiences', 'of', 'the', 'intervention', 'and', 'feasibility', 'and', 'acceptability', 'of', 'trial', 'processes', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O']	Semi-structured interviews will be conducted with purposively selected patients , artists and healthcare staff to elicit views and experiences of the intervention and feasibility and acceptability of trial processes .
['Data', 'will', 'indicate', ',', 'with', 'confidence', 'intervals', ',', 'the', 'proportion', 'of', 'patients', 'choosing', 'or', 'refusing', 'participation', 'in', 'the', 'CEI', 'and', 'will', 'allow', 'calculation', 'of', 'recruitment', 'rates', 'for', 'a', 'future', 'definitive', 'trial', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O']	Data will indicate , with confidence intervals , the proportion of patients choosing or refusing participation in the CEI and will allow calculation of recruitment rates for a future definitive trial .
['Ambulation', 'in', 'labour', '.']	['B-I', 'O', 'O', 'O']	Ambulation in labour .
['The', 'duration', 'of', 'labour', 'was', 'significantly', 'shorter', ',', 'the', 'need', 'for', 'analgesia', 'significantly', 'less', ',', 'and', 'the', 'incidence', 'of', 'fetal', 'heart', 'abnormalities', 'significantly', 'smaller', 'in', 'the', 'ambulant', 'group', 'than', 'in', 'the', 'recumbent', 'group', '.']	['O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The duration of labour was significantly shorter , the need for analgesia significantly less , and the incidence of fetal heart abnormalities significantly smaller in the ambulant group than in the recumbent group .
['Apgar', 'scores', 'at', 'one', 'and', 'five', 'minutes', 'were', 'also', 'significantly', 'greater', 'in', 'the', 'ambulant', 'group', '.']	['B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Apgar scores at one and five minutes were also significantly greater in the ambulant group .
['More', 'patients', 'in', 'the', 'recumbent', 'group', 'required', 'augmentations', 'with', 'oxytocic', 'drugs', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O']	More patients in the recumbent group required augmentations with oxytocic drugs .
['Ambulation', 'in', 'labour', 'should', 'be', 'encouraged', ':', 'it', 'may', 'bring', 'human', 'benefits', 'while', 'allowing', 'the', 'advantages', 'of', 'hospital', 'supervision', '.']	['B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Ambulation in labour should be encouraged : it may bring human benefits while allowing the advantages of hospital supervision .
['The', 'amount', 'of', 'PGE-M', 'excreted', 'decreased', 'significantly', 'after', 'administration', 'of', 'indomethacin', 'or', 'acetyl', 'salicylic', 'acid', 'in', 'therapeutic', 'doses', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O']	The amount of PGE-M excreted decreased significantly after administration of indomethacin or acetyl salicylic acid in therapeutic doses .
['The', 'concomitant', 'reduction', 'of', 'the', 'urinary', 'excretion', 'of', 'PGE-M', '(', '68', 'to', '85', '%', 'decrease', ')', 'and', 'prostaglandin', 'E', '(', '73', 'to', '100', '%', 'decrease', ')', 'after', 'indomethacin', 'treatment', 'in', 'each', 'case', '(', 'n=8', ')', 'is', 'evidence', 'that', 'a', 'diminished', 'urinary', 'PGE-M', 'output', 'reflects', 'a', 'decrease', 'in', 'prostaglandin', 'E', 'biosynthesis', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The concomitant reduction of the urinary excretion of PGE-M ( 68 to 85 % decrease ) and prostaglandin E ( 73 to 100 % decrease ) after indomethacin treatment in each case ( n=8 ) is evidence that a diminished urinary PGE-M output reflects a decrease in prostaglandin E biosynthesis .
['Phase', 'III', 'trial', 'of', 'satraplatin', ',', 'an', 'oral', 'platinum', 'plus', 'prednisone', 'vs.', 'prednisone', 'alone', 'in', 'patients', 'with', 'hormone-refractory', 'prostate', 'cancer', '.']	['O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Phase III trial of satraplatin , an oral platinum plus prednisone vs. prednisone alone in patients with hormone-refractory prostate cancer .
['A', 'randomized', 'multicenter', 'phase', 'III', 'trial', 'with', 'a', 'target', 'sample', 'size', 'of', '380', 'patients', 'was', 'initiated', 'in', 'men', 'with', 'HRPC', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	A randomized multicenter phase III trial with a target sample size of 380 patients was initiated in men with HRPC .
['Median', 'overall', 'survival', 'was', '14.9', 'months', '(', '95', '%', 'CI', ':', '13.7-28.4', ')', 'on', 'the', 'satraplatin', 'plus', 'prednisone', 'arm', 'and', '11.9', 'months', '(', '95', '%', 'CI', ':', '8.4-23.1', ')', 'on', 'prednisone', 'alone', '(', 'hazard', 'ratio', ',', 'HR', '=', '0.84', ',', '95', '%', 'CI', ':', '0.46-1.55', ')', '.']	['B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Median overall survival was 14.9 months ( 95 % CI : 13.7-28.4 ) on the satraplatin plus prednisone arm and 11.9 months ( 95 % CI : 8.4-23.1 ) on prednisone alone ( hazard ratio , HR = 0.84 , 95 % CI : 0.46-1.55 ) .
['A', '>', '50', '%', 'decrease', 'in', 'prostrate', 'specific', 'antigen', '(', 'PSA', ')', 'was', 'seen', 'in', '9/27', '(', '33.3', '%', ')', 'in', 'the', 'satraplatin', 'plus', 'prednisone', 'arm', 'vs.', '2/23', '(', '8.7', '%', ')', 'on', 'the', 'prednisone', 'alone', 'arm', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O']	A > 50 % decrease in prostrate specific antigen ( PSA ) was seen in 9/27 ( 33.3 % ) in the satraplatin plus prednisone arm vs. 2/23 ( 8.7 % ) on the prednisone alone arm .
['It', 'is', 'unknown', 'whether', 'ST', ',', 'with', 'or', 'without', 'concurrent', 'endurance', 'training', ',', 'would', 'have', 'a', 'similar', 'effect', 'in', 'older', 'adults', 'with', 'reduced', 'baseline', 'arterial', 'compliance', '.']	['O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-O', 'I-O', 'I-O']	It is unknown whether ST , with or without concurrent endurance training , would have a similar effect in older adults with reduced baseline arterial compliance .
['DESIGN', 'Randomized', ',', 'controlled', 'intervention', 'study', 'in', 'which', '37', 'healthy', ',', 'sedentary', 'men', 'and', 'women', '(', '52+/-2', 'years', ')', 'performed', '13', 'weeks', 'of', 'ST', '(', 'n=13', ')', ',', 'ST+aerobic', 'exercise', '(', 'n=12', ')', 'or', 'stretching', 'exercises', 'as', 'a', 'control', 'group', '(', 'n=12', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-I', 'I-I', 'I-P', 'I-P', 'I-P', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O']	DESIGN Randomized , controlled intervention study in which 37 healthy , sedentary men and women ( 52+/-2 years ) performed 13 weeks of ST ( n=13 ) , ST+aerobic exercise ( n=12 ) or stretching exercises as a control group ( n=12 ) .
['RESULTS', 'ST', 'performed', 'alone', ',', 'or', 'in', 'conjunction', 'with', 'aerobic', 'exercise', ',', 'improved', 'maximal', 'muscle', 'strength', 'and', 'increased', 'total', 'lean', 'body', 'mass', '(', 'both', 'P', '<', '0.01', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	RESULTS ST performed alone , or in conjunction with aerobic exercise , improved maximal muscle strength and increased total lean body mass ( both P < 0.01 ) .
['No', 'significant', 'changes', 'were', 'observed', 'in', 'carotid', 'artery', 'compliance', 'or', 'carotid-femoral', 'pulse', 'wave', 'velocity', 'following', 'ST', 'or', 'ST+aerobic', 'exercise', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	No significant changes were observed in carotid artery compliance or carotid-femoral pulse wave velocity following ST or ST+aerobic exercise .
['Observations', 'and', 'tests', 'were', 'done', 'before', 'and', 'after', 'a', 'period', 'of', '1', 'year', '.']	['B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Observations and tests were done before and after a period of 1 year .
['This', 'is', 'the', 'first', 'phase', 'III', 'randomised', 'trial', 'to', 'evaluate', 'maintenance', 'immunotherapy', 'in', 'metastatic', 'renal', 'cell', 'cancer', '(', 'mRCC', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O']	This is the first phase III randomised trial to evaluate maintenance immunotherapy in metastatic renal cell cancer ( mRCC ) .
['Patients', 'were', 'randomised', 'to', 'receive', 'treatment', 'with', 'a', '4-week', 'cycle', 'of', 'subcutaneous', 'low', 'doses', 'IL-2', '+', 'IFN', 'in', 'months', '1', ',', '3', 'and', '5', ',', 'and', 'then', 'every', '3', 'months', 'until', 'the', 'first', 'documented', 'disease', 'progression', '(', 'arm', 'A', ',', 'suspension', ')', ',', 'or', 'the', 'same', 'regimen', ',', 'with', 'chronic', 'maintenance', 'of', 'immunotherapy', ',', 'regardless', 'of', 'tumour', 'response', ',', 'until', 'death', 'or', 'intolerable', 'toxicity', '(', 'arm', 'B', ',', 'maintenance', ')', '.']	['B-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Patients were randomised to receive treatment with a 4-week cycle of subcutaneous low doses IL-2 + IFN in months 1 , 3 and 5 , and then every 3 months until the first documented disease progression ( arm A , suspension ) , or the same regimen , with chronic maintenance of immunotherapy , regardless of tumour response , until death or intolerable toxicity ( arm B , maintenance ) .
['The', 'primary', 'endpoint', 'was', 'overall', 'survival', '(', 'OS', ')', ';', 'secondary', 'endpoints', 'were', 'time', 'from', 'first', 'progression', 'to', 'death', '(', 'TFPTD', ')', 'and', 'tolerability', '.']	['O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	The primary endpoint was overall survival ( OS ) ; secondary endpoints were time from first progression to death ( TFPTD ) and tolerability .
['After', 'a', 'median', 'follow-up', 'of', '53.9', 'months', ',', 'response', 'rate', ',', 'median', 'OS', 'and', 'median', 'TFPTD', 'were', '14.7', '%', '(', '6.3', '%', 'CR', ')', 'versus', '11.3', '%', '(', '5.5', '%', 'CR', ')', ',', '14', 'versus', '14', 'months', ',', '6', 'versus', '5', 'months', ',', 'in', 'arms', 'A', 'and', 'B', ',', 'respectively', 'with', 'no', 'significant', 'differences', 'between', 'the', 'groups', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	After a median follow-up of 53.9 months , response rate , median OS and median TFPTD were 14.7 % ( 6.3 % CR ) versus 11.3 % ( 5.5 % CR ) , 14 versus 14 months , 6 versus 5 months , in arms A and B , respectively with no significant differences between the groups .
['Cox', 'regression', 'analysis', 'showed', 'that', 'the', 'use', 'of', 'chemotherapy', 'after', 'first', 'progression', '(', 'HR', '0.54', ';', '95', '%', 'CI', '0.35-0.86', ';', 'p', '=', '0.008', ')', ',', 'PS', '=', '0', '(', 'HR', '0.53', ';', '95', '%', 'CI', '0.35-0.81', ';', 'p', '=', '0.001', ')', 'and', 'female', 'gender', '(', 'HR', '0.63', ';', '95', '%', 'CI', '0.41-0.98', ';', 'p', '=', '0.038', ')', 'were', 'significantly', 'associated', 'with', 'a', 'longer', 'TFPTD', ';', 'treatment', 'arm', 'was', 'not', 'significant', '(', 'HR', '0.88', ';', '95', '%', 'CI', '0.60-1.31', ';', 'p', '=', '0.54', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Cox regression analysis showed that the use of chemotherapy after first progression ( HR 0.54 ; 95 % CI 0.35-0.86 ; p = 0.008 ) , PS = 0 ( HR 0.53 ; 95 % CI 0.35-0.81 ; p = 0.001 ) and female gender ( HR 0.63 ; 95 % CI 0.41-0.98 ; p = 0.038 ) were significantly associated with a longer TFPTD ; treatment arm was not significant ( HR 0.88 ; 95 % CI 0.60-1.31 ; p = 0.54 ) .
['Multi-institutional', 'phase', '2', 'clinical', 'and', 'pharmacogenomic', 'trial', 'of', 'tipifarnib', 'plus', 'etoposide', 'for', 'elderly', 'adults', 'with', 'newly', 'diagnosed', 'acute', 'myelogenous', 'leukemia', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemia .
['Tipifarnib', '(', 'T', ')', 'exhibits', 'modest', 'activity', 'in', 'elderly', 'adults', 'with', 'newly', 'diagnosed', 'acute', 'myelogenous', 'leukemia', '(', 'AML', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Tipifarnib ( T ) exhibits modest activity in elderly adults with newly diagnosed acute myelogenous leukemia ( AML ) .
['Arm', 'A', '(', 'T', '600', 'mg', 'twice', 'a', 'day', '×', '14', 'days', ',', 'E', '100', 'mg', 'days', '1-3', 'and', '8-10', ')', 'and', 'arm', 'B', '(', 'T', '400', 'mg', 'twice', 'a', 'day', '×', '14', 'days', ',', 'E', '200', 'mg', 'days', '1-3', 'and', '8-10', ')', 'yielded', 'similar', 'CR', ',', 'but', 'arm', 'B', 'had', 'greater', 'toxicity', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O']	Arm A ( T 600 mg twice a day × 14 days , E 100 mg days 1-3 and 8-10 ) and arm B ( T 400 mg twice a day × 14 days , E 200 mg days 1-3 and 8-10 ) yielded similar CR , but arm B had greater toxicity .
['A', '2-gene', 'signature', 'of', 'high', 'RASGRP1', 'and', 'low', 'aprataxin', '(', 'APTX', ')', 'expression', 'previously', 'predicted', 'for', 'T', 'response', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'O']	A 2-gene signature of high RASGRP1 and low aprataxin ( APTX ) expression previously predicted for T response .
['The', 'treatment', 'of', 'gastrointestinal', 'cancer', 'was', 'studied', 'in', '20', 'phase', 'I', ',', 'II', ',', 'and', 'III', 'clinical', 'trials', 'from', '1979', 'to', '1983', 'at', '30', 'member', 'institutions', 'of', 'the', 'Southeastern', 'Cancer', 'Study', 'Group', '(', 'SECSG', ')', '.']	['O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	The treatment of gastrointestinal cancer was studied in 20 phase I , II , and III clinical trials from 1979 to 1983 at 30 member institutions of the Southeastern Cancer Study Group ( SECSG ) .
['These', 'studies', 'used', 'both', 'new', 'and', 'commercially', 'available', 'drugs', ',', 'as', 'well', 'as', 'surgery', 'and/or', 'radiation', 'therapy', 'in', '1,087', 'patients', '.']	['O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'B-P', 'I-P', 'I-P']	These studies used both new and commercially available drugs , as well as surgery and/or radiation therapy in 1,087 patients .
['No', 'significant', 'benefit', 'was', 'seen', 'from', '18', 'agents', ',', 'and', 'one', 'agent', 'is', 'still', 'under', 'evaluation', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	No significant benefit was seen from 18 agents , and one agent is still under evaluation .
['METHODS', 'AND', 'RESULTS', 'A', 'total', 'of', '979', 'ST-segment-elevation', 'myocardial', 'infarction', 'patients', 'enrolled', 'in', 'the', 'Harmonizing', 'Outcomes', 'with', 'Revascularization', 'and', 'Stents', 'in', 'Acute', 'Myocardial', 'Infarction', '(', 'HORIZONS-AMI', ')', 'trial', 'had', 'BNP', 'levels', 'measured', 'in', 'the', 'emergency', 'room', 'prior', 'to', 'primary', 'percutaneous', 'coronary', 'intervention', 'as', 'part', 'of', 'the', 'study', 'protocol', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	METHODS AND RESULTS A total of 979 ST-segment-elevation myocardial infarction patients enrolled in the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction ( HORIZONS-AMI ) trial had BNP levels measured in the emergency room prior to primary percutaneous coronary intervention as part of the study protocol .
['CI-AKI', 'was', 'defined', 'as', 'a', 'relative', 'increase', 'in', 'serum', 'creatinine', 'of', '≥25', '%', ',', 'or', 'an', 'absolute', 'increase', 'of', '≥0.5', 'mg/dL', ',', 'occurring', 'within', '48', 'hours', 'after', 'contrast', 'administration', '.']	['B-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O']	CI-AKI was defined as a relative increase in serum creatinine of ≥25 % , or an absolute increase of ≥0.5 mg/dL , occurring within 48 hours after contrast administration .
['Logistic', 'regression', 'analysis', 'was', 'used', 'to', 'estimate', 'the', 'association', 'of', 'admission', 'BNP', 'with', 'development', 'of', 'CI-AKI', '.']	['B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O']	Logistic regression analysis was used to estimate the association of admission BNP with development of CI-AKI .
['After', 'multivariable', 'adjustment', 'for', 'clinical', ',', 'laboratory', ',', 'and', 'angiographic', 'variables', ',', 'BNP', 'remained', 'a', 'significant', 'independent', 'predictor', 'of', 'CI-AKI', '(', '1.29', '[', '1.10', ',', '1.51', ']', ';', 'P', '<', '0.001', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	After multivariable adjustment for clinical , laboratory , and angiographic variables , BNP remained a significant independent predictor of CI-AKI ( 1.29 [ 1.10 , 1.51 ] ; P < 0.001 ) .
['CONCLUSIONS', 'Measurement', 'of', 'serum', 'BNP', 'at', 'hospital', 'admission', 'may', 'help', 'identify', 'patients', 'who', 'are', 'at', 'risk', 'for', 'developing', 'CI-AKI', 'after', 'primary', 'percutaneous', 'coronary', 'intervention', 'in', 'ST-segment-elevation', 'myocardial', 'infarction', '.']	['O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-P', 'I-P', 'I-P', 'I-P', 'O']	CONCLUSIONS Measurement of serum BNP at hospital admission may help identify patients who are at risk for developing CI-AKI after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction .
['The', 'use', 'of', 'vascularized', 'bone', 'grafts', 'to', 'reconstruct', 'extremity', 'and', 'mandibular', 'defects', 'is', 'now', 'commonplace', 'in', 'reconstructive', 'surgery', '.']	['O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The use of vascularized bone grafts to reconstruct extremity and mandibular defects is now commonplace in reconstructive surgery .
['Five', 'pairs', 'of', 'human', 'radii', 'were', 'used', 'for', 'the', 'control', 'in', 'the', 'pilot', 'study', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Five pairs of human radii were used for the control in the pilot study .
['PURPOSE', 'Cancer', 'related', 'fatigue', '(', 'CRF', ')', 'is', 'a', 'common', 'problem', 'for', 'cancer', 'patients', 'across', 'diagnoses', 'during', 'chemotherapy', 'and', 'is', 'associated', 'with', 'physical', 'inactivity', ',', 'lower', 'functional', 'level', 'and', 'lack', 'of', 'energy', '.']	['O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	PURPOSE Cancer related fatigue ( CRF ) is a common problem for cancer patients across diagnoses during chemotherapy and is associated with physical inactivity , lower functional level and lack of energy .
"['The', 'objective', 'of', 'this', 'study', 'is', 'to', 'evaluate', 'whether', 'a', 'six-week', 'supervised', 'multimodal', 'exercise', 'intervention', ',', 'adjunct', 'to', 'chemotherapy', 'and', 'standard', 'care', ',', 'can', 'reduce', 'the', 'patient', ""'s"", 'CRF', 'level', '.']"	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O']	The objective of this study is to evaluate whether a six-week supervised multimodal exercise intervention , adjunct to chemotherapy and standard care , can reduce the patient 's CRF level .
['213', 'cancer', 'patients', 'with', 'different', 'diagnoses', 'were', 'randomised', 'into', 'an', 'intervention', 'group', 'or', 'wait-list', 'control', 'group', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'B-P', 'O', 'B-I', 'I-I', 'O', 'B-I', 'I-I', 'I-I', 'I-I']	213 cancer patients with different diagnoses were randomised into an intervention group or wait-list control group .
['The', 'primary', 'outcome', ',', 'Fatigue', 'score', '(', 'CRF', ')', ',', 'was', 'evaluated', 'by', 'the', 'Functional', 'Assessment', 'of', 'Cancer', 'Therapy-Anaemia', 'Questionnaire', '(', 'FACT-An-', ')', '(', 'FACT-G', 'score', '&', 'FACT-An', 'Anemia', 'subscale', ')', '.']	['O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	The primary outcome , Fatigue score ( CRF ) , was evaluated by the Functional Assessment of Cancer Therapy-Anaemia Questionnaire ( FACT-An- ) ( FACT-G score & FACT-An Anemia subscale ) .
['RESULTS', 'CRF', 'was', 'significantly', 'reduced', 'in', 'the', 'intervention', 'group', ',', 'corresponding', 'to', 'a', 'Fatigue', 'score', 'reduction', 'of', '3.04', '(', 'effect', 'size', 'of', '0.44', ',', '95', '%', 'CI', '0.17-0.72', ')', '(', 'P', '=', '.002', ')', ',', 'the', 'FACT-An', 'score', 'by', '5.40', '(', 'P', '=', '.015', ')', ',', 'the', 'FACT-An', 'Toi', 'score', 'by', '5.22', '(', 'P', '=', '.009', ')', 'and', 'the', 'Anaemia-ANS', 'by', '3.76', '(', 'P', '=', '.002', ')', '.']	['O', 'B-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	RESULTS CRF was significantly reduced in the intervention group , corresponding to a Fatigue score reduction of 3.04 ( effect size of 0.44 , 95 % CI 0.17-0.72 ) ( P = .002 ) , the FACT-An score by 5.40 ( P = .015 ) , the FACT-An Toi score by 5.22 ( P = .009 ) and the Anaemia-ANS by 3.76 ( P = .002 ) .
['CONCLUSION', 'In', 'summary', ',', 'this', 'six-week', 'supervised', 'multimodal', 'exercise', 'intervention', 'can', 'lead', 'to', 'significant', 'reduction', 'in', 'self-reported', 'CRF', 'in', 'cancer', 'patients', 'undergoing', 'chemotherapy', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	CONCLUSION In summary , this six-week supervised multimodal exercise intervention can lead to significant reduction in self-reported CRF in cancer patients undergoing chemotherapy .
"['Histologic', 'conversion', 'in', 'the', 'non-Hodgkin', ""'s"", 'lymphomas', '.']"	['B-O', 'I-O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P']	Histologic conversion in the non-Hodgkin 's lymphomas .
['Among', 'patients', 'who', 'achieved', 'a', 'CR', ',', '31', '%', 'later', 'relapsed', '.']	['O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'B-O', 'I-O']	Among patients who achieved a CR , 31 % later relapsed .
['The', 'most', 'common', 'type', 'of', 'histologic', 'conversion', 'was', 'from', 'NLPD', 'to', 'diffuse', 'histiocytic', 'lymphoma', '.']	['O', 'B-O', 'I-O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O']	The most common type of histologic conversion was from NLPD to diffuse histiocytic lymphoma .
['However', ',', 'those', 'patients', 'who', 'achieved', 'a', 'CR', 'after', 'conversion', 'had', 'a', 'more', 'favorable', 'outcome', '(', 'actuarial', 'survival', '75', '%', 'at', '5', 'yr', ')', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'B-O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	However , those patients who achieved a CR after conversion had a more favorable outcome ( actuarial survival 75 % at 5 yr ) .
['OBJECTIVE', 'To', 'compare', 'elastic', 'stable', 'intramedullary', 'nailing', '(', 'ESIN', ')', 'with', 'nonoperative', 'treatment', 'of', 'fully', 'displaced', 'midshaft', 'clavicular', 'fractures', 'in', 'adults', '.']	['O', 'O', 'B-O', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'B-I', 'I-I', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	OBJECTIVE To compare elastic stable intramedullary nailing ( ESIN ) with nonoperative treatment of fully displaced midshaft clavicular fractures in adults .
['PATIENTS', 'AND', 'METHODS', 'Sixty', 'patients', 'between', '18', 'and', '65', 'years', 'of', 'age', 'participated', 'and', 'completed', 'the', 'study', '.']	['O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	PATIENTS AND METHODS Sixty patients between 18 and 65 years of age participated and completed the study .
['INTERVENTION', 'Thirty', 'patients', 'were', 'treated', 'with', 'a', 'simple', 'shoulder', 'sling', 'and', '30', 'patients', 'with', 'ESIN', 'within', '3', 'days', 'after', 'trauma', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O']	INTERVENTION Thirty patients were treated with a simple shoulder sling and 30 patients with ESIN within 3 days after trauma .
['MAIN', 'OUTCOME', 'MEASUREMENT', 'Complications', 'after', 'operative', 'and', 'nonoperative', 'treatments', ',', 'Disabilities', 'of', 'the', 'Arm', ',', 'Shoulder', 'and', 'Hand', '(', 'DASH', ')', 'score', 'and', 'Constant', 'Shoulder', 'Score', 'for', 'outcome', 'measurement', ',', 'and', 'clavicular', 'shortening', '.']	['O', 'O', 'O', 'B-O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'B-O', 'I-O', 'O', 'O', 'B-O', 'I-O', 'I-O']	MAIN OUTCOME MEASUREMENT Complications after operative and nonoperative treatments , Disabilities of the Arm , Shoulder and Hand ( DASH ) score and Constant Shoulder Score for outcome measurement , and clavicular shortening .
['RESULTS', 'Fracture', 'union', 'was', 'achieved', 'in', 'all', 'patients', 'in', 'the', 'operative', 'group', ',', 'whereas', 'nonunion', 'was', 'observed', 'in', '3', 'of', '30', 'patients', 'of', 'the', 'nonoperative', 'group', '.']	['O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	RESULTS Fracture union was achieved in all patients in the operative group , whereas nonunion was observed in 3 of 30 patients of the nonoperative group .
['Two', 'symptomatic', 'malunions', 'required', 'corrective', 'osteotomy', 'in', 'the', 'nonoperative', 'group', '.']	['O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Two symptomatic malunions required corrective osteotomy in the nonoperative group .
['Constant', 'scores', 'were', 'significantly', 'higher', 'after', '6', 'months', 'and', '2', 'years', 'after', 'intramedullary', 'stabilization', '.']	['B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Constant scores were significantly higher after 6 months and 2 years after intramedullary stabilization .
['Patients', 'in', 'the', 'operative', 'group', 'showed', 'a', 'significant', 'improvement', 'of', 'posttraumatic', 'clavicular', 'shortening', ';', 'they', 'were', 'also', 'more', 'satisfied', 'with', 'cosmetic', 'appearance', 'and', 'overall', 'outcome', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'B-O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O']	Patients in the operative group showed a significant improvement of posttraumatic clavicular shortening ; they were also more satisfied with cosmetic appearance and overall outcome .
['Clavicular', 'shortening', 'was', 'significantly', 'lower', ',', 'and', 'overall', 'satisfaction', 'was', 'higher', 'in', 'the', 'operative', 'group', '.']	['B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Clavicular shortening was significantly lower , and overall satisfaction was higher in the operative group .
['A', 'single', 'nasal', 'allergen', 'challenge', 'increases', 'induced', 'sputum', 'inflammatory', 'markers', 'in', 'non-asthmatic', 'subjects', 'with', 'seasonal', 'allergic', 'rhinitis', ':', 'correlation', 'with', 'plasma', 'interleukin-5', '.']	['O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O']	A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal allergic rhinitis : correlation with plasma interleukin-5 .
['OBJECTIVE', 'To', 'assess', 'the', 'impact', 'of', 'nasal', 'allergy', 'on', 'sputum', 'inflammatory', 'markers', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O']	OBJECTIVE To assess the impact of nasal allergy on sputum inflammatory markers .
['After', 'a', 'washout', 'period', 'of', 'at', 'least', '4', 'weeks', ',', 'the', 'procedure', 'was', 'repeated', 'with', 'placebo', 'challenge', '(', 'diluent', ')', '.']	['B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I']	After a washout period of at least 4 weeks , the procedure was repeated with placebo challenge ( diluent ) .
['The', 'absolute', 'number', 'of', 'blood', 'and', 'sputum', 'eosinophils', 'did', 'not', 'change', 'significantly', 'after', 'allergen', 'or', 'placebo', 'challenge', '(', 'P', '>', '0.07', ',', 'both', 'comparisons', ')', '.']	['O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The absolute number of blood and sputum eosinophils did not change significantly after allergen or placebo challenge ( P > 0.07 , both comparisons ) .
"['Plasma', 'levels', 'of', 'IL-5', 'increased', 'after', 'allergen', 'challenge', '(', '8.7', '+/-', '2.9', 'to', '14.5', '+/-', '3.9', 'pg/mL', ',', 'P', '=', '0.001', ')', ',', 'and', 'the', 'increase', 'in', 'plasma', 'IL-5', 'was', 'positively', 'correlated', 'with', 'the', 'rise', 'in', 'sputum', 'ECP', 'in', 'a', 'subgroup', 'of', ""'responders"", ""'"", '(', 'n', '=', '12', ',', 'r', '=', '0.71', ',', 'P', '=', '0.01', ')', '.']"	['B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Plasma levels of IL-5 increased after allergen challenge ( 8.7 +/- 2.9 to 14.5 +/- 3.9 pg/mL , P = 0.001 ) , and the increase in plasma IL-5 was positively correlated with the rise in sputum ECP in a subgroup of 'responders ' ( n = 12 , r = 0.71 , P = 0.01 ) .
['These', 'findings', 'may', 'provide', 'additional', 'explanatory', 'data', 'for', 'the', 'high', 'susceptibility', 'of', 'SAR', 'patients', 'to', 'incident', 'asthma', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'O', 'O', 'O', 'O']	These findings may provide additional explanatory data for the high susceptibility of SAR patients to incident asthma .
['Once-daily', 'MMX', '(', '®', ')', 'mesalamine', 'for', 'endoscopic', 'maintenance', 'of', 'remission', 'of', 'ulcerative', 'colitis', '.']	['O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'O']	Once-daily MMX ( ® ) mesalamine for endoscopic maintenance of remission of ulcerative colitis .
['RESULTS', 'Overall', ',', '826', 'patients', 'were', 'randomized', 'and', 'dosed', '.']	['O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O']	RESULTS Overall , 826 patients were randomized and dosed .
['At', 'month', '6', ',', '83.7', 'and', '77.8', '%', 'of', 'patients', 'receiving', 'MMX', 'mesalamine', 'in', 'the', 'PP', 'and', 'intent-to-treat', '(', 'ITT', ')', 'populations', ',', 'respectively', ',', 'had', 'maintained', 'endoscopic', 'remission', 'compared', 'with', '81.5', '%', '(', 'PP', ')', 'and', '76.9', '%', '(', 'ITT', ')', 'of', 'patients', 'receiving', 'delayed-release', 'mesalamine', '(', '95', '%', 'confidence', 'interval', 'for', 'difference', ':', '-3.9', '%', ',', '8.1', '%', '(', 'PP', ')', ';', '-5.0', '%', ',', '6.9', '%', '(', 'ITT', ')', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O']	At month 6 , 83.7 and 77.8 % of patients receiving MMX mesalamine in the PP and intent-to-treat ( ITT ) populations , respectively , had maintained endoscopic remission compared with 81.5 % ( PP ) and 76.9 % ( ITT ) of patients receiving delayed-release mesalamine ( 95 % confidence interval for difference : -3.9 % , 8.1 % ( PP ) ; -5.0 % , 6.9 % ( ITT ) ) .
['Comparison', 'of', 'four', 'continuously', 'administered', 'progestogen', 'plus', 'oestradiol', 'combinations', 'for', 'climacteric', 'complaints', '.']	['O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'B-O', 'I-O', 'I-O']	Comparison of four continuously administered progestogen plus oestradiol combinations for climacteric complaints .
['Sixty', 'women', 'with', 'climacteric', 'complaints', 'who', 'had', 'not', 'menstruated', 'for', 'at', 'least', '1', 'year', 'were', 'randomly', 'allocated', 'to', 'receive', 'one', 'of', 'four', 'hormonal', 'replacement', 'regimens', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Sixty women with climacteric complaints who had not menstruated for at least 1 year were randomly allocated to receive one of four hormonal replacement regimens .
['The', 'clinical', 'efficacy', 'was', 'the', 'same', 'although', 'the', 'alleviation', 'of', 'vasomotor', 'symptoms', 'was', 'somewhat', 'slower', 'in', 'those', 'women', 'receiving', 'preparation', 'A', '.']	['O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The clinical efficacy was the same although the alleviation of vasomotor symptoms was somewhat slower in those women receiving preparation A .
['Irregular', 'uterine', 'bleeding', 'was', 'almost', 'entirely', 'confined', 'to', 'the', 'earlier', 'phase', 'of', 'the', 'study', 'and', 'was', 'substantially', 'less', 'with', 'the', 'formulation', 'containing', '1', 'mg', 'norethisterone', 'acetate', '.']	['B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I']	Irregular uterine bleeding was almost entirely confined to the earlier phase of the study and was substantially less with the formulation containing 1 mg norethisterone acetate .
['It', 'is', 'concluded', 'that', 'a', 'continuous', 'oestradiol-progestogen', 'combination', 'can', 'be', 'used', 'for', 'long-term', 'treatment', 'of', 'climacteric', 'complaints', 'in', 'postmenopausal', 'women', 'and', 'that', 'after', '4', 'months', 'the', 'clinical', 'efficacy', 'is', 'the', 'same', 'irrespective', 'of', 'the', 'type', 'and', 'dose', 'of', 'progestogen', 'administered', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O']	It is concluded that a continuous oestradiol-progestogen combination can be used for long-term treatment of climacteric complaints in postmenopausal women and that after 4 months the clinical efficacy is the same irrespective of the type and dose of progestogen administered .
['Self-reported', 'smoking', 'and', 'drinking', 'and', 'the', 'number', 'of', 'substance', 'using', 'friends', 'were', 'assessed', '5', 'times', 'over', '3', 'years', '.']	['B-O', 'I-O', 'I-O', 'I-O', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Self-reported smoking and drinking and the number of substance using friends were assessed 5 times over 3 years .
['The', 'relationship', 'between', 'peer', 'and', 'adolescent', 'substance', 'use', 'were', 'assessed', 'in', 'parallel', 'processes', 'as', 'part', 'of', 'an', 'autoregressive', 'latent', 'trajectory', 'model', '.']	['O', 'B-I', 'I-I', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I']	The relationship between peer and adolescent substance use were assessed in parallel processes as part of an autoregressive latent trajectory model .
['Bivariate', ',', 'lagged', 'autoregressive', 'analyses', 'of', 'the', 'successive', 'relationships', 'from', 'one', 'assessment', 'to', 'the', 'next', 'showed', 'consistent', ',', 'significant', 'associations', 'from', 'peer', 'use', 'to', 'adolescent', 'substance', 'use', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	Bivariate , lagged autoregressive analyses of the successive relationships from one assessment to the next showed consistent , significant associations from peer use to adolescent substance use .
['The', 'association', 'from', 'adolescent', 'to', 'peer', 'use', 'was', 'significant', 'only', 'from', '7th', 'to', '8th', 'grade', '.']	['O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The association from adolescent to peer use was significant only from 7th to 8th grade .
['Peptide', 'T', ':', 'negative', 'trial', 'result', '.']	['B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	Peptide T : negative trial result .
['While', 'there', 'was', 'no', 'statistically', 'significant', 'in', 'the', 'number', 'of', 'lymph', 'node', 'dissection', ',', 'operative', 'time', 'and', 'postoperative', 'chest', 'tube', 'drainage', 'time', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	While there was no statistically significant in the number of lymph node dissection , operative time and postoperative chest tube drainage time .
['The', 'effect', 'of', 'surgical', 'trauma', 'and', 'insulin', 'on', 'whole-body', 'protein', 'turnover', 'in', 'parenterally-fed', 'undernourished', 'patients', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'B-O', 'I-O', 'I-O', 'O', 'B-P', 'I-P', 'I-P', 'I-P']	The effect of surgical trauma and insulin on whole-body protein turnover in parenterally-fed undernourished patients .
['Pre-operatively', ',', 'and', '2', 'h', 'after', 'commencing', 'their', 'post-operative', 'feeds', ',', 'rates', 'of', 'whole-body', 'protein', 'synthesis', 'and', 'breakdown', 'were', 'measured', 'over', 'a', '9-h', 'period', 'following', 'intravenous', 'injection', 'of', 'a', 'single', 'tracer', 'dose', 'of', '15N-glycine', 'by', 'the', 'ammonia', 'and', 'urea', 'end-product', 'methods', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Pre-operatively , and 2 h after commencing their post-operative feeds , rates of whole-body protein synthesis and breakdown were measured over a 9-h period following intravenous injection of a single tracer dose of 15N-glycine by the ammonia and urea end-product methods .
['Blood', 'glucose', 'and', 'plasma', 'insulin', 'and', 'glucagon', 'concentrations', 'rose', 'post-operatively', 'whether', 'or', 'not', 'insulin', 'was', 'given', ',', 'but', 'the', 'increment', 'in', 'insulin', 'concentration', 'was', 'significantly', 'greater', 'when', 'insulin', 'was', 'given', '.']	['B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O']	Blood glucose and plasma insulin and glucagon concentrations rose post-operatively whether or not insulin was given , but the increment in insulin concentration was significantly greater when insulin was given .
['Apparent', 'nitrogen', 'balance', 'was', 'positive', 'pre-operatively', 'and', 'became', 'less', 'so', 'post-operatively', 'whether', 'insulin', 'was', 'given', 'or', 'not', '.']	['B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O']	Apparent nitrogen balance was positive pre-operatively and became less so post-operatively whether insulin was given or not .
['Similarly', ',', 'post-operative', 'increments', 'in', 'urinary', 'excretion', 'of', 'ammonia', ',', 'creatinine', 'and', '3-methylhistidine', 'were', 'not', 'altered', 'by', 'addition', 'of', 'insulin', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I']	Similarly , post-operative increments in urinary excretion of ammonia , creatinine and 3-methylhistidine were not altered by addition of insulin .
['The', 'urea', 'end-product', 'method', 'suggested', 'that', 'there', 'was', 'no', 'change', 'in', 'whole-body', 'protein', 'turnover', 'after', 'surgery', ',', 'whether', 'or', 'not', 'insulin', 'was', 'given', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O']	The urea end-product method suggested that there was no change in whole-body protein turnover after surgery , whether or not insulin was given .
['This', 'study', 'does', 'not', 'support', 'the', 'clinical', 'use', 'of', 'insulin', 'as', 'a', 'means', 'of', 'modifying', 'protein', 'metabolic', 'losses', 'after', 'major', 'surgery', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P']	This study does not support the clinical use of insulin as a means of modifying protein metabolic losses after major surgery .
['Impact', 'of', 'work', 'site', 'health', 'promotion', 'on', 'stages', 'of', 'dietary', 'change', ':', 'the', 'Working', 'Well', 'Trial', '.']	['O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O']	Impact of work site health promotion on stages of dietary change : the Working Well Trial .
['This', 'report', 'examines', 'associations', 'of', 'stages', 'of', 'change', 'with', 'diet', 'prospectively', 'and', 'addresses', 'whether', '(', '1', ')', 'baseline', 'stage', 'of', 'change', 'predicts', 'participation', ',', '(', '2', ')', 'forward', 'changes', 'in', 'stage', 'movement', 'were', 'greater', 'in', 'treatment', 'work', 'sites', ',', 'and', '(', '3', ')', 'change', 'in', 'stage', 'was', 'associated', 'with', 'adoption', 'of', 'healthful', 'diets', ',', 'using', 'data', 'from', 'a', 'cohort', 'of', '11,237', 'employees', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	This report examines associations of stages of change with diet prospectively and addresses whether ( 1 ) baseline stage of change predicts participation , ( 2 ) forward changes in stage movement were greater in treatment work sites , and ( 3 ) change in stage was associated with adoption of healthful diets , using data from a cohort of 11,237 employees .
['Findings', 'indicate', 'that', 'persons', 'in', 'later', 'stages', 'of', 'change', 'reported', 'higher', 'participation', 'levels', '.']	['O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O']	Findings indicate that persons in later stages of change reported higher participation levels .
['Net', 'change', 'in', 'diet', 'due', 'to', 'the', 'intervention', 'was', 'modest', '.']	['B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Net change in diet due to the intervention was modest .
['Drug', 'preference', 'in', 'normal', 'volunteers', ':', 'effects', 'of', 'age', 'and', 'time', 'of', 'day', '.']	['O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Drug preference in normal volunteers : effects of age and time of day .
['Three', 'groups', 'of', 'subjects', 'were', 'tested', ':', 'i', ')', 'a', 'group', 'of', '40-55-year-old', 'subjects', '(', 'AGE', 'group', ';', 'N', '=', '11', ')', 'who', 'were', 'tested', 'in', 'the', 'morning', ',', 'ii', ')', 'a', 'group', 'of', '21-35-year-old', 'subjects', '(', 'CTL', 'group', ';', 'N', '=', '12', ')', 'who', 'were', 'also', 'tested', 'in', 'the', 'morning', ',', 'and', 'iii', ')', 'a', 'group', 'of', '21-35-year-olds', 'who', 'were', 'tested', 'in', 'the', 'late', 'afternoon', '(', 'AFT', 'group', ';', 'N', '=', '13', ')', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Three groups of subjects were tested : i ) a group of 40-55-year-old subjects ( AGE group ; N = 11 ) who were tested in the morning , ii ) a group of 21-35-year-old subjects ( CTL group ; N = 12 ) who were also tested in the morning , and iii ) a group of 21-35-year-olds who were tested in the late afternoon ( AFT group ; N = 13 ) .
['Disclosure', 'of', 'HSV-2', 'serological', 'test', 'results', 'in', 'the', 'context', 'of', 'an', 'adolescent', 'HIV', 'prevention', 'trial', 'in', 'Kenya', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Disclosure of HSV-2 serological test results in the context of an adolescent HIV prevention trial in Kenya .
['OBJECTIVES', 'Herpes', 'simplex', 'virus', 'type', '2', '(', 'HSV-2', ')', 'biomarkers', 'are', 'often', 'used', 'in', 'adolescent', 'sub-Saharan', 'HIV', 'prevention', 'studies', ',', 'but', 'evaluations', 'of', 'test', 'performance', 'and', 'disclosure', 'outcomes', 'are', 'rare', 'in', 'the', 'published', 'literature', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	OBJECTIVES Herpes simplex virus type 2 ( HSV-2 ) biomarkers are often used in adolescent sub-Saharan HIV prevention studies , but evaluations of test performance and disclosure outcomes are rare in the published literature .
['METHODS', 'In', '2011', ',', '837', 'Kenyan', 'orphan', 'youth', 'in', 'grades', '7', 'and', '8', 'enrolled', 'in', 'an', 'HIV', 'prevention', 'clinical', 'trial', 'with', 'HSV-2', 'biomarker', 'outcomes', '.']	['O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	METHODS In 2011 , 837 Kenyan orphan youth in grades 7 and 8 enrolled in an HIV prevention clinical trial with HSV-2 biomarker outcomes .
['Of', 'these', ',', '22', 'positive', 'and', 'all', 'indeterminates', 'were', 'WB', 'tested', ';', '20', 'and', '5', ',', 'respectively', ',', 'were', 'confirmed', 'positive', '.']	['O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O']	Of these , 22 positive and all indeterminates were WB tested ; 20 and 5 , respectively , were confirmed positive .
['Self-reported', 'virginity', 'was', 'highly', 'inconsistent', 'with', 'WB-confirmed', 'positives', '.']	['B-O', 'I-O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O']	Self-reported virginity was highly inconsistent with WB-confirmed positives .
['Determinants', 'of', 'total', 'and', 'specific', 'IgE', 'in', 'infants', 'with', 'atopic', 'dermatitis', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P']	Determinants of total and specific IgE in infants with atopic dermatitis .
['In', 'infancy', ',', 'increased', 'total', 'IgE', 'is', 'more', 'affected', 'by', 'factors', 'increasing', 'risk', 'of', 'intercurrent', 'infection', 'and', 'non-specific', 'airway', 'inflammation', ',', 'such', 'as', 'environmental', 'tobacco', 'smoke', 'exposure', '(', 'p', '<', '0.001', ')', 'and', 'the', 'use', 'of', 'gas', 'cookers', '(', 'p', '=', '0.02', ')', '.']	['O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	In infancy , increased total IgE is more affected by factors increasing risk of intercurrent infection and non-specific airway inflammation , such as environmental tobacco smoke exposure ( p < 0.001 ) and the use of gas cookers ( p = 0.02 ) .
['Specific', 'allergen', 'sensitization', 'as', 'represented', 'by', 'detectable', 'IgE', 'antibodies', 'is', 'influenced', 'primarily', 'by', 'allergen', 'exposure', '.']	['O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Specific allergen sensitization as represented by detectable IgE antibodies is influenced primarily by allergen exposure .
['[', 'Median', 'and', 'mediolateral', 'episiotomy', ']', '.']	['B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-P']	[ Median and mediolateral episiotomy ] .
['One', 'intervention', 'involved', 'a', 'peer-mediated', 'approach', '(', 'PEER', ')', 'and', 'the', 'other', 'involved', 'a', 'child-assisted', 'approach', '(', 'CHILD', ')', '.']	['O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I']	One intervention involved a peer-mediated approach ( PEER ) and the other involved a child-assisted approach ( CHILD ) .
['Sixty', 'children', 'participated', 'from', '56', 'classrooms', 'in', '30', 'schools', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O']	Sixty children participated from 56 classrooms in 30 schools .
['CONCLUSIONS', 'These', 'data', 'suggest', 'that', 'significant', 'improvements', 'can', 'be', 'made', 'in', 'peer', 'social', 'connections', 'for', 'children', 'with', 'autism', 'spectrum', 'disorders', 'in', 'general', 'education', 'classrooms', 'with', 'a', 'brief', 'intervention', ',', 'and', 'that', 'these', 'gains', 'persist', 'over', 'time', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	CONCLUSIONS These data suggest that significant improvements can be made in peer social connections for children with autism spectrum disorders in general education classrooms with a brief intervention , and that these gains persist over time .
['Lower', 'relapse', 'rates', 'after', 'neighbourhood', 'injection', 'of', 'Corynebacterium', 'parvum', 'in', 'operable', 'cervix', 'carcinoma', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O']	Lower relapse rates after neighbourhood injection of Corynebacterium parvum in operable cervix carcinoma .
['All', 'patients', 'had', 'carcinoma', 'confined', 'to', 'the', 'cervix', ',', 'the', 'upper', 'part', 'of', 'the', 'vagina', 'or', 'the', 'parametrial', 'region', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	All patients had carcinoma confined to the cervix , the upper part of the vagina or the parametrial region .
['Only', 'minor', 'side', 'effects', 'of', 'CP', 'were', 'encountered', '.']	['O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O']	Only minor side effects of CP were encountered .
['A', 'further', '15', 'patients', 'with', 'more', 'advanced', 'malignancies', 'were', 'added', 'to', 'our', 'studies', '.']	['O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	A further 15 patients with more advanced malignancies were added to our studies .
['In', 'these', ',', 'CP', 'stimulation', 'had', 'no', 'effect', 'on', 'relapse', 'rates', ',', 'but', 'the', 'relapse-free', 'intervals', 'were', 'longer', 'after', 'immune', 'stimulation', ':', 'control', '3.5', 'months', '(', 'mean', ')', '+/-', '1.5', '(', 's.d', '.']	['O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	In these , CP stimulation had no effect on relapse rates , but the relapse-free intervals were longer after immune stimulation : control 3.5 months ( mean ) +/- 1.5 ( s.d .
['The', 'potential', 'interaction', 'between', 'racemic', 'warfarin', 'given', 'as', 'a', '25', 'mg', 'single', 'oral', 'dose', 'and', 'chronically', 'administered', 'ketorolac', 'was', 'studied', 'in', '12', 'young', 'healthy', 'male', 'volunteers', '.']	['O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	The potential interaction between racemic warfarin given as a 25 mg single oral dose and chronically administered ketorolac was studied in 12 young healthy male volunteers .
['Ketorolac', 'produced', 'no', 'major', 'change', 'in', 'the', 'pharmacokinetics', 'of', '(', 'R', ')', '-', 'or', '(', 'S', ')', '-warfarin', '.']	['B-I', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	Ketorolac produced no major change in the pharmacokinetics of ( R ) - or ( S ) -warfarin .
['Ketorolac', 'increased', 'template', 'bleeding', 'time', 'by', 'a', 'factor', 'of', '1.35', 'as', 'compared', 'with', 'placebo', '.']	['B-I', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Ketorolac increased template bleeding time by a factor of 1.35 as compared with placebo .
['Positive', 'impact', 'of', 'crisis', 'resource', 'management', 'training', 'on', 'no-flow', 'time', 'and', 'team', 'member', 'verbalisations', 'during', 'simulated', 'cardiopulmonary', 'resuscitation', ':', 'a', 'randomised', 'controlled', 'trial', '.']	['O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O']	Positive impact of crisis resource management training on no-flow time and team member verbalisations during simulated cardiopulmonary resuscitation : a randomised controlled trial .
['RESULTS', 'NFT', 'rates', 'were', 'significantly', 'lower', 'in', 'the', 'CRM-training', 'group', '(', '31.4±6.1', '%', 'vs.', '36.3±6.6', '%', ',', 'p=0.014', ')', '.']	['B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	RESULTS NFT rates were significantly lower in the CRM-training group ( 31.4±6.1 % vs. 36.3±6.6 % , p=0.014 ) .
['OBJECTIVE', 'To', 'investigate', 'the', 'effect', 'of', 'exercise', 'training', 'and', 'dietary', 'macronutrient', 'composition', 'on', '24', 'h', 'substrate', 'oxidation', 'in', 'male', ',', 'obese', 'subjects', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P']	OBJECTIVE To investigate the effect of exercise training and dietary macronutrient composition on 24 h substrate oxidation in male , obese subjects .
['DESIGN', 'A', '16', 'month', 'exercise', 'intervention', 'study', 'was', 'executed', ',', 'including', 'a', 'weight', 'loss', 'period', 'with', 'a', 'very', 'low', 'energy', 'diet', '(', 'VLED', ')', 'for', '2', 'months', 'at', 'the', 'start', 'of', 'the', 'study', '.']	['O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	DESIGN A 16 month exercise intervention study was executed , including a weight loss period with a very low energy diet ( VLED ) for 2 months at the start of the study .
['MEASUREMENTS', 'Substrate', 'oxidation', 'was', 'measured', 'during', 'a', 'standardized', '36', 'h', 'stay', 'in', 'the', 'respiration', 'chamber', 'at', 'the', 'start', 'of', 'the', 'study', '(', '0', 'months', ')', ',', 'and', 'at', '4', ',', '10', 'and', '16', 'months', '.']	['O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	MEASUREMENTS Substrate oxidation was measured during a standardized 36 h stay in the respiration chamber at the start of the study ( 0 months ) , and at 4 , 10 and 16 months .
['In', 'the', 'respiration', 'chamber', 'subjects', 'were', 'randomly', 'assigned', 'to', 'a', 'high-fat', '(', 'Hi.F', ')', 'diet', '(', '60', '%', 'of', 'energy', '(', 'En', '%', ')', 'fat', ')', 'or', 'a', 'reduced-fat', '(', 'Red.F', ')', 'diet', '(', '30', 'En', '%', 'fat', ')', '.']	['O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I']	In the respiration chamber subjects were randomly assigned to a high-fat ( Hi.F ) diet ( 60 % of energy ( En % ) fat ) or a reduced-fat ( Red.F ) diet ( 30 En % fat ) .
['In', 'the', 'well-trained', 'group', 'the', '24h', 'CHO', 'balance', 'was', 'even', 'more', 'negative', 'for', 'both', 'types', 'of', 'diet', '(', '-103', 'to', '-185', 'g/d', 'for', 'the', 'Red.F', 'and', 'Hi.F', 'diet', ',', 'respectively', ')', 'under', 'similar', 'conditions', 'compared', 'with', 'the', 'trained', 'obese', 'group', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	In the well-trained group the 24h CHO balance was even more negative for both types of diet ( -103 to -185 g/d for the Red.F and Hi.F diet , respectively ) under similar conditions compared with the trained obese group .
['CONCLUSION', 'The', 'changes', 'in', '24', 'h', 'substrate', 'utilization', 'in', 'the', 'obese', ',', 'as', 'well', 'as', 'in', 'the', 'well-trained', 'group', ',', 'suggest', 'that', 'endurance', 'training', 'increased', 'the', 'reliance', 'on', 'carbohydrate', 'oxidation', 'and', 'therefore', 'did', 'not', 'increase', '24', 'fat', 'oxidation', '.']	['O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O']	CONCLUSION The changes in 24 h substrate utilization in the obese , as well as in the well-trained group , suggest that endurance training increased the reliance on carbohydrate oxidation and therefore did not increase 24 fat oxidation .
['DESIGN', 'Two', 'randomized', ',', 'double-blind', ',', 'placebo-controlled', 'trials', 'conducted', 'between', 'June', 'and', 'July', '1997', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	DESIGN Two randomized , double-blind , placebo-controlled trials conducted between June and July 1997 .
['SETTING', 'Individual', 'hotel', 'rooms', ';', '2', 'large', 'US', 'university', 'medical', 'schools', '.']	['O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	SETTING Individual hotel rooms ; 2 large US university medical schools .
['PARTICIPANTS', 'A', 'total', 'of', '117', 'healthy', 'adult', 'volunteers', '(', 'aged', '18-40', 'years', ';', 'median', 'age', ',', '21', 'years', ')', 'who', 'were', 'susceptible', '(', 'hemagglutination-inhibition', 'antibody', 'titer', '<', 'or', '=1:8', ')', '.']	['O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	PARTICIPANTS A total of 117 healthy adult volunteers ( aged 18-40 years ; median age , 21 years ) who were susceptible ( hemagglutination-inhibition antibody titer < or =1:8 ) .
['For', 'the', 'prophylaxis', 'study', ',', 'oral', 'oseltamivir', '(', '100', 'mg', 'once', 'daily', '[', 'n', '=', '12', ']', ',', '100', 'mg', 'twice', 'daily', '[', 'n', '=', '12', ']', ',', 'or', 'matching', 'placebo', '[', 'n', '=', '13', ']', ',', 'starting', '26', 'hours', 'before', 'virus', 'inoculation', ')', 'was', 'administered', '.']	['O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	For the prophylaxis study , oral oseltamivir ( 100 mg once daily [ n = 12 ] , 100 mg twice daily [ n = 12 ] , or matching placebo [ n = 13 ] , starting 26 hours before virus inoculation ) was administered .
['For', 'the', 'treatment', 'study', ',', 'the', 'same', 'drug', 'was', 'given', '(', '20', 'mg', ',', '100', 'mg', ',', 'or', '200', 'mg', 'twice', 'daily', ',', '200', 'mg', 'once', 'daily', ',', 'or', 'matching', 'placebo', '[', 'n', '=', '16', ']', ',', 'in', 'each', 'group', 'starting', '28', 'hours', 'after', 'inoculation', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	For the treatment study , the same drug was given ( 20 mg , 100 mg , or 200 mg twice daily , 200 mg once daily , or matching placebo [ n = 16 ] , in each group starting 28 hours after inoculation ) .
['MAIN', 'OUTCOME', 'MEASURES', 'Comparing', 'placebo', 'groups', 'with', 'pooled', 'treatment', 'groups', ',', 'for', 'prophylaxis', ',', 'outcomes', 'included', 'frequency', 'of', 'infection', 'and', 'viral', 'shedding', ';', 'for', 'treatment', ',', 'viral', 'shedding', 'in', 'titers', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	MAIN OUTCOME MEASURES Comparing placebo groups with pooled treatment groups , for prophylaxis , outcomes included frequency of infection and viral shedding ; for treatment , viral shedding in titers .
['Oseltamivir', 'treatment', 'also', 'reduced', 'symptom', 'scores', '(', 'median', '[', 'IQR', ']', 'score-hours', ',', '225', '[', '97-349', ']', 'vs', '400', '[', '189-645', ']', ';', 'P', '=', '.05', ')', ',', 'and', 'nasal', 'proinflammatory', 'cytokine', 'levels', '.']	['O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O']	Oseltamivir treatment also reduced symptom scores ( median [ IQR ] score-hours , 225 [ 97-349 ] vs 400 [ 189-645 ] ; P = .05 ) , and nasal proinflammatory cytokine levels .
['CONCLUSIONS', 'In', 'these', 'trials', ',', 'prophylaxis', 'and', 'early', 'treatment', 'with', 'oral', 'oseltamivir', 'were', 'both', 'associated', 'with', 'significant', 'antiviral', 'and', 'clinical', 'effects', 'in', 'experimental', 'human', 'influenza', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'O']	CONCLUSIONS In these trials , prophylaxis and early treatment with oral oseltamivir were both associated with significant antiviral and clinical effects in experimental human influenza .
['Antazoline', 'is', 'a', 'first', 'generation', 'antihistaminic', 'agent', 'with', 'chinidin-like', 'properties', '.']	['B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Antazoline is a first generation antihistaminic agent with chinidin-like properties .
['When', 'administered', 'intravenously', ',', 'antazoline', 'exerts', 'a', 'strong', 'antiarrhythmic', 'effect', 'on', 'supraventricular', 'arrhythmia', ',', 'especially', 'on', 'AF', ',', 'facilitating', 'rapid', 'conversion', 'to', 'sinus', 'rhythm', '.']	['O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'B-O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	When administered intravenously , antazoline exerts a strong antiarrhythmic effect on supraventricular arrhythmia , especially on AF , facilitating rapid conversion to sinus rhythm .
['METHODS/DESIGN', 'A', 'randomized', ',', 'double', 'blind', ',', 'placebo-controlled', ',', 'superiority', 'clinical', 'trial', 'was', 'designed', 'to', 'assess', 'clinical', 'efficacy', 'of', 'antazoline', 'in', 'rapid', 'conversion', 'of', 'AF', 'to', 'sinus', 'rhythm', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	METHODS/DESIGN A randomized , double blind , placebo-controlled , superiority clinical trial was designed to assess clinical efficacy of antazoline in rapid conversion of AF to sinus rhythm .
['Eligible', 'patients', 'will', 'present', 'AF', 'lasting', 'less', 'than', '43', 'hours', ',', 'will', 'be', 'in', 'stable', 'cardio-pulmonary', 'condition', 'and', 'will', 'have', 'no', 'prior', 'history', 'of', 'advanced', 'heart', 'failure', 'or', 'significant', 'valvular', 'disease', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Eligible patients will present AF lasting less than 43 hours , will be in stable cardio-pulmonary condition and will have no prior history of advanced heart failure or significant valvular disease .
['Primary', 'end', 'point', 'will', 'be', 'the', 'conversion', 'of', 'AF', 'to', 'sinus', 'rhythm', 'confirmed', 'in', 'an', 'electrocardiogram', '(', 'ECG', ')', 'during', 'the', 'observation', 'period', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O']	Primary end point will be the conversion of AF to sinus rhythm confirmed in an electrocardiogram ( ECG ) during the observation period .
['Special', 'consideration', 'will', 'be', 'given', 'to', 'the', 'observation', 'of', 'any', 'adverse', 'events', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O']	Special consideration will be given to the observation of any adverse events .
['Effective', 'strategies', 'included', '(', 'a', ')', 'the', 'use', 'of', 'choral', 'responding', ';', '(', 'b', ')', 'the', 'use', 'of', 'student-to-student', 'responding', ';', '(', 'c', ')', 'the', 'rotation', 'of', 'materials', 'every', '5', 'minutes', 'during', 'the', '30-minute', 'group', 'while', 'teaching', '2', 'to', '3', 'concepts', ';', 'and', '(', 'd', ')', 'the', 'use', 'of', 'random', ',', 'unpredictable', 'trials', 'for', 'student', 'responding', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I']	Effective strategies included ( a ) the use of choral responding ; ( b ) the use of student-to-student responding ; ( c ) the rotation of materials every 5 minutes during the 30-minute group while teaching 2 to 3 concepts ; and ( d ) the use of random , unpredictable trials for student responding .
['Migration', 'of', 'the', 'acetabular', 'component', ':', 'effect', 'of', 'cement', 'pressurization', 'and', 'significance', 'of', 'early', 'radiolucency', ':', 'a', 'randomized', '5-year', 'study', 'using', 'radiostereometry', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I']	Migration of the acetabular component : effect of cement pressurization and significance of early radiolucency : a randomized 5-year study using radiostereometry .
['BACKGROUND', 'Cementing', 'technique', 'is', 'a', 'crucial', 'factor', 'in', 'prosthesis', 'fixation', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P']	BACKGROUND Cementing technique is a crucial factor in prosthesis fixation .
['Postoperative', 'radiolucent', 'lines', 'around', 'the', 'cup', 'were', 'correlated', 'to', 'later', 'RSA', 'results', '.']	['O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	Postoperative radiolucent lines around the cup were correlated to later RSA results .
['Level', 'of', 'intervention', 'was', 'controlled', 'by', 'systematically', 'varying', 'the', 'manner', 'and', 'frequency', 'with', 'which', 'objects', 'were', 'presented', ',', 'the', 'extent', 'to', 'which', 'the', 'experimenter', 'talked', 'to', 'the', 'infant', ',', 'and', 'physical', 'proximity', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I']	Level of intervention was controlled by systematically varying the manner and frequency with which objects were presented , the extent to which the experimenter talked to the infant , and physical proximity .
['Infant', 'attention', 'was', 'defined', 'as', 'duration', 'of', 'time', 'spent', 'examining', 'objects', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	Infant attention was defined as duration of time spent examining objects .
['Aftermath', 'of', 'a', 'clinical', 'trial', ':', 'evaluating', 'the', 'sustainability', 'of', 'a', 'medical', 'device', 'intervention', 'in', 'Ghana', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-P', 'I-P', 'I-P']	Aftermath of a clinical trial : evaluating the sustainability of a medical device intervention in Ghana .
['First-generation', 'trainees', 'scored', 'significantly', 'higher', 'than', 'second-generation', 'trainees', 'on', 'both', 'skills', 'and', 'knowledge', 'assessments', '(', 'p', '=', '0.003', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O']	First-generation trainees scored significantly higher than second-generation trainees on both skills and knowledge assessments ( p = 0.003 ) .
['Protocolization', 'of', 'the', 'training', 'program', ',', 'in', 'conjunction', 'with', 'skills', 'and', 'knowledge', 'assessment', ',', 'may', 'improve', 'acquisition', 'and', 'retention', 'among', 'second-', 'and', 'future-generation', 'trainees', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O']	Protocolization of the training program , in conjunction with skills and knowledge assessment , may improve acquisition and retention among second- and future-generation trainees .
['Consecutive', 'procedural', 'angiograms', 'of', 'patients', 'randomly', 'assigned', 'to', 'EES', '(', 'n=669', ')', 'or', 'PES', '(', 'n=333', ')', 'were', 'analysed', 'by', 'an', 'independent', 'angiographic', 'core', 'laboratory', '.']	['B-I', 'I-I', 'I-I', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-I', 'I-P', 'I-P', 'I-P', 'I-I', 'I-I', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Consecutive procedural angiograms of patients randomly assigned to EES ( n=669 ) or PES ( n=333 ) were analysed by an independent angiographic core laboratory .
['Promoting', 'gynecologic', 'cancer', 'awareness', 'at', 'a', 'critical', 'juncture', '--', 'where', 'women', 'and', 'providers', 'meet', '.']	['O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Promoting gynecologic cancer awareness at a critical juncture -- where women and providers meet .
['BACKGROUND', 'Omeprazole', 'and', 'famotidine', 'both', 'reduce', 'severity', 'of', 'exercise-induced', 'gastritis', ',', 'but', 'administering', 'famotidine', 'is', 'easier', 'than', 'administering', 'omeprazole', 'during', 'racing', 'competition', '.']	['O', 'B-I', 'O', 'B-I', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	BACKGROUND Omeprazole and famotidine both reduce severity of exercise-induced gastritis , but administering famotidine is easier than administering omeprazole during racing competition .
['METHODS', 'Experiment', '1', ':', 'Equal', 'numbers', 'of', 'dogs', 'randomly', 'assigned', 'to', 'famotidine', '(', '20', 'mg', 'q24h', ')', 'or', 'no', 'treatment', 'groups', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O']	METHODS Experiment 1 : Equal numbers of dogs randomly assigned to famotidine ( 20 mg q24h ) or no treatment groups .
['Mucosal', 'appearance', 'was', 'blindly', 'scored', 'by', 'previously', 'described', 'scoring', 'system', '.']	['B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Mucosal appearance was blindly scored by previously described scoring system .
['CONCLUSIONS', 'AND', 'CLINICAL', 'RELEVANCE', 'Although', 'famotidine', 'provides', 'some', 'benefit', 'in', 'the', 'prevention', 'of', 'exercise-induced', 'gastric', 'lesions', ',', 'omeprazole', 'is', 'superior', 'to', 'famotidine', 'in', 'preventing', 'gastritis', 'in', 'dogs', 'running', '300', 'miles', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'O', 'B-P', 'O', 'O', 'O', 'O']	CONCLUSIONS AND CLINICAL RELEVANCE Although famotidine provides some benefit in the prevention of exercise-induced gastric lesions , omeprazole is superior to famotidine in preventing gastritis in dogs running 300 miles .
['Routine', 'administration', 'of', 'omeprazole', 'is', 'recommended', 'to', 'prevent', 'stress-associated', 'gastric', 'disease', 'in', 'exercising', 'and', 'racing', 'Alaskan', 'sled', 'dogs', '.']	['O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Routine administration of omeprazole is recommended to prevent stress-associated gastric disease in exercising and racing Alaskan sled dogs .
['Esomeprazole', 'resolves', 'chronic', 'heartburn', 'in', 'patients', 'without', 'erosive', 'oesophagitis', '.']	['B-I', 'O', 'B-O', 'I-O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P']	Esomeprazole resolves chronic heartburn in patients without erosive oesophagitis .
['AIM', 'To', 'assess', 'the', 'efficacy', 'and', 'safety', 'of', 'esomeprazole', 'in', 'patients', 'with', 'frequent', 'heartburn', 'for', '>', 'or', '=', '6', 'months', 'and', 'no', 'evidence', 'of', 'erosive', 'oesophagitis', 'on', 'endoscopy', '.']	['O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'B-I', 'O', 'B-P', 'I-P', 'I-O', 'I-O', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	AIM To assess the efficacy and safety of esomeprazole in patients with frequent heartburn for > or = 6 months and no evidence of erosive oesophagitis on endoscopy .
['Secondary', 'end-points', 'included', 'the', 'percentage', 'of', 'heartburn-free', 'days', 'and', 'the', 'time', 'to', 'first', 'and', 'sustained', 'resolution', 'of', 'heartburn', '.']	['O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	Secondary end-points included the percentage of heartburn-free days and the time to first and sustained resolution of heartburn .
['RESULTS', 'Patients', 'treated', 'with', 'either', 'dose', 'of', 'esomeprazole', 'were', 'two', 'to', 'three', 'times', 'more', 'likely', 'to', 'achieve', 'complete', 'resolution', 'of', 'heartburn', 'than', 'patients', 'treated', 'with', 'placebo', '(', 'P', '<', '0.001', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O']	RESULTS Patients treated with either dose of esomeprazole were two to three times more likely to achieve complete resolution of heartburn than patients treated with placebo ( P < 0.001 ) .
['CONCLUSIONS', 'Esomeprazole', ',', 'at', 'daily', 'doses', 'of', '40', 'mg', 'or', '20', 'mg', ',', 'is', 'effective', 'and', 'safe', 'for', 'the', 'treatment', 'of', 'chronic', 'heartburn', 'in', 'patients', 'without', 'erosive', 'oesophagitis', '.']	['O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P']	CONCLUSIONS Esomeprazole , at daily doses of 40 mg or 20 mg , is effective and safe for the treatment of chronic heartburn in patients without erosive oesophagitis .
['The', 'results', 'are', 'discussed', 'with', 'respect', 'to', 'the', 'concept', 'of', 'illness', 'and', 'pain', 'as', 'a', 'setting', 'event', 'for', 'problem', 'behavior', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The results are discussed with respect to the concept of illness and pain as a setting event for problem behavior .
['The', 'need', 'for', 'research', 'to', 'develop', 'algorithms', 'that', 'allow', 'one', 'to', 'select', 'the', 'best', 'combination', 'of', 'medical', 'and', 'behavioral', 'interventions', 'for', 'specific', 'illnesses', 'and', 'contexts', 'is', 'noted', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The need for research to develop algorithms that allow one to select the best combination of medical and behavioral interventions for specific illnesses and contexts is noted .
['An', 'evaluation', 'of', 'chemical', 'arthrodesis', 'of', 'the', 'proximal', 'interphalangeal', 'joint', 'in', 'the', 'horse', 'by', 'using', 'monoiodoacetate', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'B-I', 'I-I']	An evaluation of chemical arthrodesis of the proximal interphalangeal joint in the horse by using monoiodoacetate .
['The', 'use', 'of', 'monoiodoacetate', '(', 'MIA', ')', 'for', 'arthrodesis', 'of', 'the', 'proximal', 'interphalangeal', 'joint', '(', 'PIJ', ')', 'and', 'the', 'effect', 'of', 'exercise', 'on', 'the', 'degree', 'of', 'fusion', 'were', 'investigated', '.']	['O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The use of monoiodoacetate ( MIA ) for arthrodesis of the proximal interphalangeal joint ( PIJ ) and the effect of exercise on the degree of fusion were investigated .
['Eight', 'horses', 'received', '3', 'injections', '(', 'Weeks', '0', ',', '3', ',', '6', ')', 'of', 'MIA', '(', '2', 'mL', ';', '60', 'mg/mL', ')', 'into', 'the', 'right', 'or', 'left', 'front', 'PIJ', '.']	['B-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Eight horses received 3 injections ( Weeks 0 , 3 , 6 ) of MIA ( 2 mL ; 60 mg/mL ) into the right or left front PIJ .
['All', '5', 'horses', 'showed', 'radiographic', 'evidence', 'of', 'bony', 'fusion', ',', 'however', ',', 'no', 'fusion', 'was', 'present', 'when', 'injected', 'joints', 'were', 'examined', 'on', 'postmortem', 'examination', '.']	['B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	All 5 horses showed radiographic evidence of bony fusion , however , no fusion was present when injected joints were examined on postmortem examination .
['INTRODUCTION', 'Current', 'evidence', 'suggests', 'that', 'Social', 'Stories', 'can', 'be', 'effective', 'in', 'tackling', 'problem', 'behaviours', 'exhibited', 'by', 'children', 'with', 'autism', 'spectrum', 'disorder', '.']	['O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	INTRODUCTION Current evidence suggests that Social Stories can be effective in tackling problem behaviours exhibited by children with autism spectrum disorder .
['Case', 'reports', 'in', 'children', 'with', 'autism', 'have', 'suggested', 'that', 'these', 'stories', 'can', 'lead', 'to', 'a', 'number', 'of', 'benefits', 'including', 'improvements', 'in', 'social', 'interactions', 'and', 'choice', 'making', 'in', 'educational', 'settings', '.']	['O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O']	Case reports in children with autism have suggested that these stories can lead to a number of benefits including improvements in social interactions and choice making in educational settings .
['Participants', '(', 'n=50', ')', 'will', 'be', 'randomised', 'to', 'either', 'the', 'Social', 'Stories', 'intervention', 'or', 'a', 'comparator', 'group', 'where', 'they', 'will', 'be', 'read', 'standard', 'stories', 'for', 'an', 'equivalent', 'amount', 'of', 'time', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Participants ( n=50 ) will be randomised to either the Social Stories intervention or a comparator group where they will be read standard stories for an equivalent amount of time .
['Statistics', 'will', 'be', 'calculated', 'for', 'recruitment', 'rates', ',', 'follow-up', 'rates', 'and', 'attrition', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	Statistics will be calculated for recruitment rates , follow-up rates and attrition .
['Qualitative', 'analysis', 'will', 'ascertain', 'information', 'on', 'perceptions', 'about', 'the', 'feasibility', 'and', 'acceptability', 'of', 'the', 'intervention', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O']	Qualitative analysis will ascertain information on perceptions about the feasibility and acceptability of the intervention .
['Humans', 'have', 'a', 'remarkable', 'ability', 'to', 'understand', 'spoken', 'language', 'despite', 'the', 'large', 'amount', 'of', 'variability', 'in', 'speech', '.']	['B-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Humans have a remarkable ability to understand spoken language despite the large amount of variability in speech .
['Role', 'of', 'warm', 'saline', 'mouth', 'rinse', 'in', 'prevention', 'of', 'alveolar', 'osteitis', ':', 'a', 'randomized', 'controlled', 'trial', '.']	['O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O']	Role of warm saline mouth rinse in prevention of alveolar osteitis : a randomized controlled trial .
['BACKGROUND', 'The', 'present', 'study', 'was', 'aimed', 'at', 'determining', 'the', 'role', 'warm', 'saline', 'rinse', 'in', 'the', 'prevention', 'of', 'alveolar', 'osteitis', 'following', 'dental', 'extractions', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O']	BACKGROUND The present study was aimed at determining the role warm saline rinse in the prevention of alveolar osteitis following dental extractions .
['MATERIALS', 'AND', 'METHODS', 'Apparently', 'patients', 'aged', '16', 'and', 'above', 'who', 'were', 'referred', 'to', 'the', 'Oral', 'Surgery', 'Clinic', 'of', 'our', 'institution', ',', 'with', 'an', 'indication', 'for', 'non-surgical', 'extraction', 'of', 'pathologic', 'teeth', 'were', 'prospectively', 'and', 'uniformly', 'randomized', 'into', 'warm', 'saline', 'group', 'and', 'control', '.']	['O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'B-I', 'I-I']	MATERIALS AND METHODS Apparently patients aged 16 and above who were referred to the Oral Surgery Clinic of our institution , with an indication for non-surgical extraction of pathologic teeth were prospectively and uniformly randomized into warm saline group and control .
['The', 'experimental', 'group', '(', 'n', '=', '80', ')', 'were', 'instructed', 'to', 'gargle', '6', 'times', 'daily', 'with', 'warm', 'saline', 'and', 'no', 'such', 'instructions', 'were', 'given', 'to', 'the', 'second', 'group', '(', 'n', '=', '80', ')', 'to', 'serve', 'as', 'controls', '.']	['O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'B-I', 'I-I']	The experimental group ( n = 80 ) were instructed to gargle 6 times daily with warm saline and no such instructions were given to the second group ( n = 80 ) to serve as controls .
['CONCLUSION', 'Warm', 'saline', 'mouth', 'rinse', 'instruction', 'is', 'beneficial', 'in', 'the', 'prevention', 'of', 'development', 'of', 'alveolar', 'osteitis', 'after', 'dental', 'extractions', '.']	['O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O']	CONCLUSION Warm saline mouth rinse instruction is beneficial in the prevention of development of alveolar osteitis after dental extractions .
['Subjects/Study', 'interventions', ':', 'Forty-one', '(', '41', ')', 'patients', 'were', 'studied', '.']	['O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Subjects/Study interventions : Forty-one ( 41 ) patients were studied .
['CONCLUSIONS', 'Acupuncture', 'of', 'CV24', 'is', 'an', 'easy', 'to', 'apply', 'and', 'effective', 'method', 'to', 'reduce', 'gag', 'reflex', 'during', 'TEE', '.']	['O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O']	CONCLUSIONS Acupuncture of CV24 is an easy to apply and effective method to reduce gag reflex during TEE .
['A', 'rigorous', 'statistical', 'method', 'of', 'scale', 'construction', 'consisting', 'of', 'a', 'modification', 'of', 'the', 'scale', 'discrimination', 'technique', 'was', 'employed', ',', 'resulting', 'in', 'a', '45-item', 'questionnaire', 'representing', 'three', 'orthogonally', 'derived', 'scales', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O']	A rigorous statistical method of scale construction consisting of a modification of the scale discrimination technique was employed , resulting in a 45-item questionnaire representing three orthogonally derived scales .
['The', 'Physiological', 'Tension', 'Scale', 'detected', 'significant', 'increases', 'in', 'tension', 'following', 'tension', 'inducement', ',', 'whereas', 'the', 'Physical', 'Assessment', 'Scale', 'and', 'Cognitive', 'Tension', 'Scale', 'detected', 'increases', 'in', 'relaxation', 'following', 'relaxation', 'training', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'O', 'B-I', 'I-I', 'I-I']	The Physiological Tension Scale detected significant increases in tension following tension inducement , whereas the Physical Assessment Scale and Cognitive Tension Scale detected increases in relaxation following relaxation training .
['Randomized', 'trial', 'of', 'a', 'secondhand', 'smoke', 'exposure', 'reduction', 'intervention', 'among', 'hospital-based', 'pregnant', 'women', '.']	['O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'B-P', 'I-P', 'I-P', 'I-P']	Randomized trial of a secondhand smoke exposure reduction intervention among hospital-based pregnant women .
['OBJECTIVE', 'This', 'study', 'sought', 'to', 'assess', 'the', 'effectiveness', 'of', 'a', 'secondhand', 'tobacco', 'smoke', '(', 'SHS', ')', 'prevention', 'program', 'based', 'on', 'an', 'expanded', 'Health', 'Belief', 'Model', '(', 'HBM', ')', 'incorporating', 'self-efficacy', 'among', 'pregnant', 'women', 'in', 'a', 'hospital', 'setting', 'in', 'Taiwan', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	OBJECTIVE This study sought to assess the effectiveness of a secondhand tobacco smoke ( SHS ) prevention program based on an expanded Health Belief Model ( HBM ) incorporating self-efficacy among pregnant women in a hospital setting in Taiwan .
['METHODOLOGY', 'This', 'study', 'utilized', 'a', 'two-group', 'longitudinal', 'randomized', 'controlled', 'trial', 'design', '.']	['O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O']	METHODOLOGY This study utilized a two-group longitudinal randomized controlled trial design .
['Both', 'groups', 'were', 'given', 'questionnaires', 'as', 'a', 'pre-test', ',', 'two', 'weeks', 'into', 'the', 'intervention', ',', 'and', 'one', 'month', 'following', 'the', 'conclusion', 'of', 'the', 'intervention', '.']	['B-I', 'I-I', 'I-I', 'I-I', 'I-O', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I']	Both groups were given questionnaires as a pre-test , two weeks into the intervention , and one month following the conclusion of the intervention .
['CONCLUSIONS', 'These', 'results', 'should', 'encourage', 'health', 'professionals', 'to', 'educate', 'pregnant', 'women', 'regarding', 'the', 'harms', 'of', 'SHS', 'while', 'both', 'empowering', 'and', 'equipping', 'them', 'with', 'the', 'tools', 'to', 'confront', 'their', 'family', 'members', 'and', 'effectively', 'reduce', 'their', 'SHS', 'exposure', 'while', 'promoting', 'smoke-free', 'social', 'norms', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O']	CONCLUSIONS These results should encourage health professionals to educate pregnant women regarding the harms of SHS while both empowering and equipping them with the tools to confront their family members and effectively reduce their SHS exposure while promoting smoke-free social norms .
"['BACKGROUND', 'AND', 'OBJECTIVE', 'This', 'study', 'was', 'designed', 'to', 'evaluate', 'the', 'efficacy', 'and', 'toxicity', 'of', 'monthly', 'alternating', 'ABVD/MOPP', 'compared', 'to', 'ABVD/OPP', 'regimens', 'in', 'patients', 'with', 'advanced', 'stage', 'Hodgkin', ""'s"", 'disease', '(', 'HD', ')', ',', 'as', 'well', 'as', 'in', 'early', 'stage', 'patients', 'with', 'systemic', 'symptoms', 'and/or', 'bulky', 'disease', '.']"	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	BACKGROUND AND OBJECTIVE This study was designed to evaluate the efficacy and toxicity of monthly alternating ABVD/MOPP compared to ABVD/OPP regimens in patients with advanced stage Hodgkin 's disease ( HD ) , as well as in early stage patients with systemic symptoms and/or bulky disease .
['DESIGN', 'AND', 'METHODS', '218', 'patients', 'with', 'previously', 'untreated', 'HD', 'entered', 'this', 'study', ':', '106', 'patients', 'in', 'arm', 'A', '(', 'ABVD/MOPP', ')', 'and', '112', 'in', 'arm', 'B', '(', 'ABVD/OPP', ')', '.']	['O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-I', 'I-I', 'I-I', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-I', 'I-I', 'I-I', 'I-I']	DESIGN AND METHODS 218 patients with previously untreated HD entered this study : 106 patients in arm A ( ABVD/MOPP ) and 112 in arm B ( ABVD/OPP ) .
['RESULTS', 'No', 'statistically', 'significant', 'differences', 'were', 'observed', 'between', 'the', 'two', 'arms', 'in', 'terms', 'of', 'CR', 'rate', 'and', 'toxicity', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O']	RESULTS No statistically significant differences were observed between the two arms in terms of CR rate and toxicity .
['INTERPRETATION', 'AND', 'CONCLUSIONS', 'Both', 'schemes', 'of', 'chemotherapy', 'followed', 'by', 'radiotherapy', 'produce', 'high', 'percentages', 'of', 'CR', ',', 'low', 'risk', 'of', 'relapse', 'and', 'an', 'acceptable', 'toxicity', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	INTERPRETATION AND CONCLUSIONS Both schemes of chemotherapy followed by radiotherapy produce high percentages of CR , low risk of relapse and an acceptable toxicity .
['METHODS', 'AND', 'MATERIALS', 'Toxicity', 'data', 'of', '512', 'patients', '(', 'conformally', 'treated', 'to', '68', 'Gy', '[', 'n', '=', '284', ']', 'and', '78', 'Gy', '[', 'n', '=', '228', ']', ')', 'with', 'complete', 'follow-up', 'at', '3', 'years', 'after', 'radiotherapy', 'were', 'studied', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-I', 'I-P', 'I-P', 'I-P']	METHODS AND MATERIALS Toxicity data of 512 patients ( conformally treated to 68 Gy [ n = 284 ] and 78 Gy [ n = 228 ] ) with complete follow-up at 3 years after radiotherapy were studied .
['High', 'stool', 'frequency', 'fits', 'only', 'benefitted', 'significantly', '(', 'p', '=', '0.003-0.006', ')', 'from', 'the', 'inclusion', 'of', 'the', 'baseline', 'toxicity', 'score', '.']	['B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	High stool frequency fits only benefitted significantly ( p = 0.003-0.006 ) from the inclusion of the baseline toxicity score .
['The', 'primary', 'outcome', 'measure', 'was', 'recurrence', 'of', 'fits', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O']	The primary outcome measure was recurrence of fits .
['The', 'recurrence', 'of', 'fits', 'and', 'other', 'maternal', 'complications', 'were', 'similar', 'in', 'the', 'two', 'groups', '.']	['O', 'B-O', 'I-O', 'I-O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'B-O', 'O', 'O', 'O', 'O', 'O']	The recurrence of fits and other maternal complications were similar in the two groups .
['PoC', 'tests', 'measured', '(', 'and', 'devices', 'used', ')', 'in', 'the', 'trial', 'were', 'haemoglobin', 'A1c', 'and', 'urine', 'albumin', ':', 'creatinine', 'ratio', '(', 'DCA', '2000', ')', ',', 'lipids', '(', 'Cholestech', 'LDX', ')', 'and', 'international', 'normalized', 'ratio', '(', 'CoaguChek', 'S', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	PoC tests measured ( and devices used ) in the trial were haemoglobin A1c and urine albumin : creatinine ratio ( DCA 2000 ) , lipids ( Cholestech LDX ) and international normalized ratio ( CoaguChek S ) .
['Median', 'within-practice', 'imprecision', 'met', 'the', 'analytical', 'goals', 'for', 'all', 'PoC', 'tests', ',', 'except', 'for', 'high-density', 'lipoprotein-cholesterol', '(', 'HDL-C', ')', 'where', 'observed', 'performance', 'was', 'outside', 'the', 'minimum', 'goal', 'for', 'one', 'level', 'and', 'one', 'lot', 'number', 'of', 'QC', '.']	['B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Median within-practice imprecision met the analytical goals for all PoC tests , except for high-density lipoprotein-cholesterol ( HDL-C ) where observed performance was outside the minimum goal for one level and one lot number of QC .
['Most', 'practices', 'achieved', 'the', 'imprecision', 'goals', 'for', 'all', 'analytes', ',', 'with', 'the', 'principal', 'exception', 'of', 'HDL-C', '.']	['O', 'O', 'O', 'O', 'B-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O']	Most practices achieved the imprecision goals for all analytes , with the principal exception of HDL-C .
['RESULTS', 'CS', 'gel', 'was', 'safe', 'with', 'no', 'reported', 'severe', 'or', 'life-threatening', 'adverse', 'events', '(', 'AE', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	RESULTS CS gel was safe with no reported severe or life-threatening adverse events ( AE ) .
['The', 'majority', '(', '51', '%', ')', 'of', 'these', 'participants', 'reported', 'only', 'mild', 'events', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O']	The majority ( 51 % ) of these participants reported only mild events .
['Fewer', 'women', '(', '62', '%', ')', 'who', 'used', 'CS', 'experienced', 'urogenital', 'AE', 'than', 'those', 'assigned', 'to', 'placebo', 'gel', '(', '70', '%', ')', '(', 'P', '=', '0.59', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Fewer women ( 62 % ) who used CS experienced urogenital AE than those assigned to placebo gel ( 70 % ) ( P = 0.59 ) .
['There', 'was', 'no', 'increase', 'in', 'AE', 'by', 'frequency', 'of', 'gel', 'use', 'or', 'sexual', 'activity', 'with', 'the', 'exception', 'of', 'abdominal/pelvic', 'pain', 'which', 'was', 'noted', 'more', 'frequently', 'with', 'twice', 'daily', 'use', 'among', 'sexually', 'abstinent', 'women', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	There was no increase in AE by frequency of gel use or sexual activity with the exception of abdominal/pelvic pain which was noted more frequently with twice daily use among sexually abstinent women .
['CONCLUSIONS', 'This', 'Phase', 'I', 'study', 'demonstrated', 'that', 'CS', 'vaginal', 'gel', 'was', 'safe', ',', 'well', 'tolerated', 'and', 'acceptable', 'by', 'HIV-infected', 'women', 'and', 'their', 'male', 'partners', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	CONCLUSIONS This Phase I study demonstrated that CS vaginal gel was safe , well tolerated and acceptable by HIV-infected women and their male partners .
['Detection', 'of', 'traumatic', 'arthrotomy', 'of', 'the', 'knee', 'using', 'the', 'saline', 'solution', 'load', 'test', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I']	Detection of traumatic arthrotomy of the knee using the saline solution load test .
['RESULTS', 'The', 'study', 'group', 'included', 'thirty-one', 'female', 'patients', 'and', 'twenty-five', 'male', 'patients', 'with', 'a', 'combined', 'average', 'age', 'of', 'fifty', 'years', 'and', 'an', 'average', 'body', 'mass', 'index', 'of', '30.9', '.']	['O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-O', 'I-O', 'I-O', 'I-O', 'I-P', 'I-P', 'I-P']	RESULTS The study group included thirty-one female patients and twenty-five male patients with a combined average age of fifty years and an average body mass index of 30.9 .
['There', 'was', 'no', 'correlation', 'between', 'necessary', 'injection', 'volume', 'and', 'sex', ',', 'body', 'mass', 'index', ',', 'or', 'knee', 'circumference', '.']	['O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	There was no correlation between necessary injection volume and sex , body mass index , or knee circumference .
['AIM', 'To', 'investigate', 'the', 'sustained', 'effect', 'on', 'quality', 'of', 'life', 'during', 'the', 'grass', 'pollen', 'season', '1', 'year', 'after', '3', 'years', 'of', 'treatment', 'with', 'the', 'SQ-standardized', 'grass', 'allergy', 'immunotherapy', 'tablet', '(', 'AIT', ')', ',', 'Graza', '(', 'Phleum', 'pratense', '75,000', 'SQ-T/2800', 'BAU', ';', 'ALK', ',', 'Denmark', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	AIM To investigate the sustained effect on quality of life during the grass pollen season 1 year after 3 years of treatment with the SQ-standardized grass allergy immunotherapy tablet ( AIT ) , Graza ( Phleum pratense 75,000 SQ-T/2800 BAU ; ALK , Denmark ) .
['Subjects', 'received', '3', 'years', 'of', 'grass', 'AIT', '(', 'n', '=', '157', ')', 'or', 'placebo', '(', 'n', '=', '126', ')', ',', 'followed', 'by', '1', 'year', 'of', 'follow-up', '.']	['B-P', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Subjects received 3 years of grass AIT ( n = 157 ) or placebo ( n = 126 ) , followed by 1 year of follow-up .
['RESULTS', 'During', 'follow-up', ',', 'the', 'overall', 'RQLQ', '(', 'S', ')', 'score', 'for', 'the', 'entire', 'grass', 'pollen', 'season', 'was', 'significantly', 'improved', 'in', 'the', 'active', 'group', '(', 'relative', 'difference', 'to', 'placebo', ':', '23', '%', ',', 'P', '=', '0.004', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	RESULTS During follow-up , the overall RQLQ ( S ) score for the entire grass pollen season was significantly improved in the active group ( relative difference to placebo : 23 % , P = 0.004 ) .
['Improvements', 'were', 'found', 'in', 'all', 'seven', 'RQLQ', '(', 'S', ')', 'domains', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	Improvements were found in all seven RQLQ ( S ) domains .
['The', 'RQLQ', '(', 'S', ')', 'as', 'a', 'function', 'of', 'the', 'weekly', 'average', 'pollen', 'counts', 'showed', 'a', 'clear', 'separation', 'between', 'the', 'treatment', 'groups', '(', 'P', '<', '0.001', ')', '.']	['O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The RQLQ ( S ) as a function of the weekly average pollen counts showed a clear separation between the treatment groups ( P < 0.001 ) .
['Standard', 'Trauma', 'Focused', 'Cognitive', 'Behavioral', 'Therapy', 'may', 'be', 'insufficient', 'for', 'children', 'traumatized', 'by', 'exposure', 'to', 'interparental', 'violence', ',', 'given', 'the', 'pervasive', 'impact', 'of', 'interparental', 'violence', 'on', 'the', 'family', 'system', '.']	['O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Standard Trauma Focused Cognitive Behavioral Therapy may be insufficient for children traumatized by exposure to interparental violence , given the pervasive impact of interparental violence on the family system .
['HORIZON', 'is', 'a', 'trauma', 'focused', 'cognitive', 'behavioral', 'therapy', 'based', 'group', 'program', 'with', 'the', 'added', 'component', 'of', 'a', 'preparatory', 'parenting', 'program', 'aimed', 'at', 'improving', 'parental', 'availability', ';', 'and', 'the', 'added', 'component', 'of', 'parent-child', 'sessions', 'to', 'improve', 'parent-child', 'interaction', '.']	['O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	HORIZON is a trauma focused cognitive behavioral therapy based group program with the added component of a preparatory parenting program aimed at improving parental availability ; and the added component of parent-child sessions to improve parent-child interaction .
"['To', 'address', 'this', 'secondary', 'aim', ',', 'the', 'main', 'parameters', 'are', 'observational', 'and', 'questionnaire', 'measures', 'of', 'parental', 'availability', ',', 'parent-child', 'relationship', 'variables', ',', 'children', ""'s"", 'adjustment', 'problems', 'and', 'children', ""'s"", 'responses', 'to', 'interparental', 'violence', '.']"	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O']	To address this secondary aim , the main parameters are observational and questionnaire measures of parental availability , parent-child relationship variables , children 's adjustment problems and children 's responses to interparental violence .
['Perioperative', 'myocardial', 'infarctions', 'are', 'common', 'and', 'often', 'unrecognized', 'in', 'patients', 'undergoing', 'hip', 'fracture', 'surgery', '.']	['B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Perioperative myocardial infarctions are common and often unrecognized in patients undergoing hip fracture surgery .
['BACKGROUND', 'The', 'aim', 'of', 'this', 'prospective', 'cohort', 'study', 'was', 'to', 'assess', 'the', 'incidence', 'and', 'characteristics', 'of', 'acute', 'myocardial', 'infarction', 'in', 'patients', 'undergoing', 'surgery', 'for', 'acute', 'hip', 'fracture', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	BACKGROUND The aim of this prospective cohort study was to assess the incidence and characteristics of acute myocardial infarction in patients undergoing surgery for acute hip fracture .
['TnT', 'elevation', 'was', 'observed', 'in', '36', 'patients', '(', '51', '%', ')', 'already', 'before', 'surgery', '.']	['B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	TnT elevation was observed in 36 patients ( 51 % ) already before surgery .
['Seven', 'patients', '(', '10', '%', ')', 'had', 'ST', 'elevation', 'myocardial', 'infarction', ',', '23', 'patients', '(', '32', '%', ')', 'had', 'new', 'ST', 'depressions', ',', 'and', '21', 'patients', '(', '30', '%', ')', 'had', 'no', 'new', 'ST', 'segment', 'changes', 'in', 'the', 'serial', 'electrocardiographic', 'recordings', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Seven patients ( 10 % ) had ST elevation myocardial infarction , 23 patients ( 32 % ) had new ST depressions , and 21 patients ( 30 % ) had no new ST segment changes in the serial electrocardiographic recordings .
['How', 'to', 'establish', 'equivalence', 'when', 'data', 'are', 'censored', ':', 'a', 'randomized', 'trial', 'of', 'treatments', 'for', 'B', 'non-Hodgkin', 'lymphoma', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	How to establish equivalence when data are censored : a randomized trial of treatments for B non-Hodgkin lymphoma .
['An', 'equivalence', 'trial', 'of', 'maintenance', 'therapy', 'was', 'carried', 'out', 'in', 'children', 'with', 'B', 'non-Hodgkin', 'lymphoma', ',', 'and', 'serves', 'as', 'an', 'illustration', '.']	['O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	An equivalence trial of maintenance therapy was carried out in children with B non-Hodgkin lymphoma , and serves as an illustration .
['There', 'were', 'four', 'randomised', 'treatment', 'phases', ',', 'each', 'of', '4', 'weeks', 'duration', '.']	['O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	There were four randomised treatment phases , each of 4 weeks duration .
['Ambulatory', 'BP', 'was', 'performed', 'in', 'the', 'final', 'week', 'of', 'each', 'phase', '.']	['B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Ambulatory BP was performed in the final week of each phase .
['There', 'was', 'a', 'dose-dependent', 'decrease', 'in', 'ambulatory', 'daytime', 'diastolic', 'and', 'mean', 'arterial', 'BP', 'with', 'the', 'progestogen', 'treatments', 'compared', 'with', 'placebo', '(', 'P', '<', '0.05', ')', '.']	['O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	There was a dose-dependent decrease in ambulatory daytime diastolic and mean arterial BP with the progestogen treatments compared with placebo ( P < 0.05 ) .
['The', 'authors', 'assessed', 'the', 'safety', 'and', 'effectiveness', 'of', 'atomoxetine', 'monotherapy', 'compared', 'with', 'combined', 'atomoxetine/fluoxetine', 'therapy', 'in', 'a', 'population', 'of', 'children', 'and', 'adolescents', 'with', 'ADHD', 'and', 'concurrent', 'symptoms', 'of', 'depression', 'or', 'anxiety', '.']	['O', 'O', 'O', 'O', 'B-O', 'O', 'B-O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	The authors assessed the safety and effectiveness of atomoxetine monotherapy compared with combined atomoxetine/fluoxetine therapy in a population of children and adolescents with ADHD and concurrent symptoms of depression or anxiety .
['RESULTS', 'At', 'end', 'point', ',', 'reductions', 'in', 'ADHD', ',', 'depressive', ',', 'and', 'anxiety', 'symptoms', 'were', 'marked', 'for', 'both', 'treatment', 'groups', '(', 'p', '<', '.001', 'for', 'the', 'relevant', 'scale', 'in', 'each', 'symptom', 'cluster', ')', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	RESULTS At end point , reductions in ADHD , depressive , and anxiety symptoms were marked for both treatment groups ( p < .001 for the relevant scale in each symptom cluster ) .
['CONCLUSIONS', 'In', 'pediatric', 'patients', 'with', 'ADHD', 'and', 'comorbid', 'symptoms', 'of', 'depression', 'or', 'anxiety', ',', 'atomoxetine', 'monotherapy', 'appears', 'to', 'be', 'effective', 'for', 'treating', 'ADHD', '.']	['O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	CONCLUSIONS In pediatric patients with ADHD and comorbid symptoms of depression or anxiety , atomoxetine monotherapy appears to be effective for treating ADHD .
['Anxiety', 'and', 'depressive', 'symptoms', 'also', 'improved', ',', 'but', 'the', 'absence', 'of', 'a', 'placebo-only', 'arm', 'does', 'not', 'allow', 'us', 'to', 'conclude', 'that', 'these', 'effects', 'are', 'specifically', 'the', 'result', 'of', 'treatment', 'with', 'atomoxetine', '.']	['B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I']	Anxiety and depressive symptoms also improved , but the absence of a placebo-only arm does not allow us to conclude that these effects are specifically the result of treatment with atomoxetine .
['Double-blind', 'comparison', 'of', 'the', 'efficacy', 'and', 'safety', 'of', 'trandolapril', '2', 'mg', 'and', 'hydrochlorothiazide', '25', 'mg', 'in', 'patients', 'with', 'mild-to-moderate', 'essential', 'hypertension', '.']	['O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'B-I', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Double-blind comparison of the efficacy and safety of trandolapril 2 mg and hydrochlorothiazide 25 mg in patients with mild-to-moderate essential hypertension .
['This', 'multicenter', 'international', 'trial', 'recruited', '205', 'patients', 'from', '16', 'investigators', '.']	['O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	This multicenter international trial recruited 205 patients from 16 investigators .
['After', 'a', '4-week', ',', 'single-blind', 'placebo', 'run-in', ',', 'patients', 'were', 'randomized', 'to', 'receive', '16', 'weeks', 'of', 'trandolapril', '2', 'mg/day', '(', '68', 'patients', ')', ',', 'hydrochlorothiazide', '(', 'HCTZ', ')', '25', 'mg/day', '(', '68', 'patients', ')', ',', 'or', 'the', 'combination', '(', '69', 'patients', ')', '.']	['O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O']	After a 4-week , single-blind placebo run-in , patients were randomized to receive 16 weeks of trandolapril 2 mg/day ( 68 patients ) , hydrochlorothiazide ( HCTZ ) 25 mg/day ( 68 patients ) , or the combination ( 69 patients ) .
['Intention-to-treat', 'analysis', 'showed', 'significant', 'decreases', 'in', 'all', 'three', 'groups', 'in', 'mean', '(', '+/-', 'SEM', ')', 'supine', 'DBP', 'throughout', 'the', 'study', ',', 'with', 'no', 'significant', 'differences', 'at', 'week', '16', 'between', 'trandolapril', '(', '-10.6', '+/-', '1.3', 'mm', 'Hg', ')', 'and', 'HCTZ', '(', '-10.9', '+/-', '1.3', 'mm', 'Hg', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Intention-to-treat analysis showed significant decreases in all three groups in mean ( +/- SEM ) supine DBP throughout the study , with no significant differences at week 16 between trandolapril ( -10.6 +/- 1.3 mm Hg ) and HCTZ ( -10.9 +/- 1.3 mm Hg ) .
['Blood', 'pressure', 'was', 'normalized', 'in', 'the', 'combination', 'group', 'in', '67', '%', 'of', 'patients', ',', 'a', 'significantly', 'higher', 'proportion', 'than', 'either', 'trandolapril', '(', '63', '%', ')', 'or', 'HCTZ', '(', '60', '%', ';', 'p', '=', '0.04', ')', '.']	['B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Blood pressure was normalized in the combination group in 67 % of patients , a significantly higher proportion than either trandolapril ( 63 % ) or HCTZ ( 60 % ; p = 0.04 ) .
['PURPOSE', 'To', 'evaluate', 'the', 'effects', 'of', 'diltiazem', 'and', 'propranolol', 'in', 'patients', 'with', 'unstable', 'angina', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P']	PURPOSE To evaluate the effects of diltiazem and propranolol in patients with unstable angina .
['A', 'coronary', 'arteriography', 'was', 'done', 'on', 'study', 'entry', '.']	['O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O']	A coronary arteriography was done on study entry .
['RESULTS', 'A', 'significative', 'reduction', 'of', 'angina', 'crisis', 'number', ',', 'duration', ',', 'intensity', 'and', 'the', 'number', 'of', 'sublingual', 'nitrates', 'doses', 'were', 'observed', 'equally', 'in', 'both', 'groups', '.']	['O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	RESULTS A significative reduction of angina crisis number , duration , intensity and the number of sublingual nitrates doses were observed equally in both groups .
['The', 'SAP', ',', 'DAP', ',', 'HR', 'and', 'RR', 'did', 'not', 'show', 'statistical', 'differences', 'between', 'groups', '.']	['O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The SAP , DAP , HR and RR did not show statistical differences between groups .
['Individual', 'groups', 'analysis', 'showed', 'significative', 'reductions', 'of', 'SAP', ',', 'DAP', 'and', 'HR', 'in', 'propranolol', 'group', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'B-I', 'O', 'O']	Individual groups analysis showed significative reductions of SAP , DAP and HR in propranolol group .
['The', 'CKMB', 'data', ',', 'ECG', 'alterations', 'and', 'coronary', 'arteriography', 'characteristics', 'were', 'similar', '.']	['O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O']	The CKMB data , ECG alterations and coronary arteriography characteristics were similar .
['Moisture-vapour-permeable', 'film', 'as', 'an', 'outpatient', 'burn', 'dressing', '.']	['B-I', 'I-I', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P']	Moisture-vapour-permeable film as an outpatient burn dressing .
['The', 'two', 'treatment', 'groups', 'were', 'closely', 'matched', 'in', 'age', ',', 'sex', ',', 'per', 'cent', 'of', 'BSA', 'burned', ',', 'and', 'in', 'burn', 'severity', 'and', 'locations', '.']	['O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	The two treatment groups were closely matched in age , sex , per cent of BSA burned , and in burn severity and locations .
['The', 'clinical', 'infection', 'rate', 'and', 'time', 'to', 'healing', 'were', 'similar', 'in', 'both', 'groups', '.']	['O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O']	The clinical infection rate and time to healing were similar in both groups .
['Patients', 'completed', 'a', 'questionnaire', 'before', 'and', '1', 'year', 'after', 'surgery', 'to', 'evaluate', 'symptoms', ',', 'function', ',', 'and', 'overall', 'satisfaction', '.']	['O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Patients completed a questionnaire before and 1 year after surgery to evaluate symptoms , function , and overall satisfaction .
['The', 'patients', 'in', 'the', 'SH', 'group', 'experienced', 'less', 'postoperative', 'pain/discomfort', 'as', 'scored', 'by', 'pain', 'during', 'bowel', 'movement', '(', 'P', '<', '0.001', ')', ',', 'total', 'analgesic', 'requirement', 'over', 'the', 'first', '3', 'days', '(', 'according', 'to', 'the', 'World', 'Health', 'Organization', '[', 'WHO', ']', 'class', 'II', 'analgesics', '[', 'P', '=', '0.002', ']', ';', 'class', 'III', '[', 'P', '=', '0.066', ']', ')', ',', 'and', 'per-patient', 'consumption', 'frequency', 'of', 'class', 'III', 'analgesics', '(', 'P', '=', '0.089', ')', '.']	['O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The patients in the SH group experienced less postoperative pain/discomfort as scored by pain during bowel movement ( P < 0.001 ) , total analgesic requirement over the first 3 days ( according to the World Health Organization [ WHO ] class II analgesics [ P = 0.002 ] ; class III [ P = 0.066 ] ) , and per-patient consumption frequency of class III analgesics ( P = 0.089 ) .
['A', 'clear', 'difference', 'in', 'morphine', 'requirement', 'became', 'evident', 'after', '24', 'hours', '(', 'P', '=', '0.010', ')', '.']	['O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	A clear difference in morphine requirement became evident after 24 hours ( P = 0.010 ) .
['Hospital', 'stay', 'was', 'significantly', 'shorter', 'in', 'the', 'SH', 'group', '(', 'SH', '2.2', '+/-', '1.2', '[', '0', ';', '5.0', ']', 'versus', 'MM', '3.1', '+/-', '1.7', '[', '1', ';', '8.0', ']', 'P', '<', '0.001', ')', '.']	['B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Hospital stay was significantly shorter in the SH group ( SH 2.2 +/- 1.2 [ 0 ; 5.0 ] versus MM 3.1 +/- 1.7 [ 1 ; 8.0 ] P < 0.001 ) .
['CONCLUSION', 'Stapled', 'hemorrhoidopexy', 'causes', 'significantly', 'less', 'postoperative', 'pain', '.']	['O', 'B-I', 'I-I', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O']	CONCLUSION Stapled hemorrhoidopexy causes significantly less postoperative pain .
['The', 'technique', 'is', 'reproducible', 'and', 'can', 'achieve', 'comparable', 'outcomes', 'as', 'those', 'of', 'the', 'MM', 'technique', 'as', 'long', 'as', 'the', 'well-described', 'steps', 'of', 'the', 'technique', 'are', 'followed', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The technique is reproducible and can achieve comparable outcomes as those of the MM technique as long as the well-described steps of the technique are followed .
['Its', 'effectiveness', 'in', 'relieving', 'symptoms', 'is', 'equivalent', 'to', 'conventional', 'surgery', ',', 'and', 'the', 'number', 'of', 'hemorrhoidal', 'prolapse', 'recurrences', 'at', '2', 'years', 'is', 'not', 'significantly', 'different', '.']	['O', 'B-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O']	Its effectiveness in relieving symptoms is equivalent to conventional surgery , and the number of hemorrhoidal prolapse recurrences at 2 years is not significantly different .
['Hemorroidopexy', 'is', 'applicable', 'for', 'treating', 'reducible', 'hemorrhoidal', 'prolapse', '.']	['B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Hemorroidopexy is applicable for treating reducible hemorrhoidal prolapse .
['In', 'this', 'study', 'we', 'examined', 'the', 'social', 'behaviors', 'of', '4-', 'to', '12-year-old', 'children', 'with', 'autism', 'spectrum', 'disorders', '(', 'ASD', ';', 'N', '=', '24', ')', 'during', 'three', 'tradic', 'interactions', 'with', 'an', 'adult', 'confederate', 'and', 'an', 'interaction', 'partner', ',', 'where', 'the', 'interaction', 'partner', 'varied', 'randomly', 'among', '(', '1', ')', 'another', 'adult', 'human', ',', '(', '2', ')', 'a', 'touchscreen', 'computer', 'game', ',', 'and', '(', '3', ')', 'a', 'social', 'dinosaur', 'robot', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O']	In this study we examined the social behaviors of 4- to 12-year-old children with autism spectrum disorders ( ASD ; N = 24 ) during three tradic interactions with an adult confederate and an interaction partner , where the interaction partner varied randomly among ( 1 ) another adult human , ( 2 ) a touchscreen computer game , and ( 3 ) a social dinosaur robot .
['The', 'median', 'neutrophil', 'count', 'at', '14', 'days', 'was', 'significantly', 'higher', 'in', 'the', 'GM', 'CSF', 'group', '(', '1.90', 'vs.', '0.46', 'x', '10', '(', '9', ')', '/l', ')', '.']	['O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The median neutrophil count at 14 days was significantly higher in the GM CSF group ( 1.90 vs. 0.46 x 10 ( 9 ) /l ) .
['Tumor', 'budding', 'is', 'an', 'independent', 'predictor', 'of', 'outcome', 'in', 'AJCC/UICC', 'stage', 'II', 'colorectal', 'cancer', '.']	['B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer .
"['For', 'multivariable', 'analysis', ',', 'Cox', ""'s"", 'proportional', 'hazards', 'regression', 'models', 'were', 'performed', '.']"	['O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	For multivariable analysis , Cox 's proportional hazards regression models were performed .
"['Cox', ""'s"", 'proportional', 'hazards', 'regression', 'models', 'proved', 'tumor', 'budding', 'to', 'be', 'an', 'independent', 'predictor', 'of', 'disease', 'progression', '(', 'hazard', 'ratio', '3.91', ',', '95', '%', 'confidence', 'interval', '1.3-11.77', ';', 'P', '=', '0.02', ')', 'and', 'cancer-related', 'death', '(', 'hazard', 'ratio', '5.90', ',', '95', '%', 'confidence', 'interval', '1.62-21.51', ';', 'P', '=', '0.007', ')', '.']"	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Cox 's proportional hazards regression models proved tumor budding to be an independent predictor of disease progression ( hazard ratio 3.91 , 95 % confidence interval 1.3-11.77 ; P = 0.02 ) and cancer-related death ( hazard ratio 5.90 , 95 % confidence interval 1.62-21.51 ; P = 0.007 ) .
['Early', 'versus', 'late', 'hCG', 'administration', 'to', 'trigger', 'ovulation', 'in', 'mild', 'stimulated', 'IUI', 'cycles', ':', 'a', 'randomized', 'clinical', 'trial', '.']	['O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Early versus late hCG administration to trigger ovulation in mild stimulated IUI cycles : a randomized clinical trial .
['OBJECTIVES', 'To', 'verify', 'non-inferiority', 'of', 'the', 'clinical', 'pregnancy', 'rate', 'of', 'Early', 'hCG', 'administration', '(', 'leading', 'follicle', 'sizes', 'within', '16.0-16.9', 'mm', 'in', 'diameter', ')', 'compared', 'to', 'Late', 'hCG', 'administration', '(', 'leading', 'follicle', 'sizes', 'within', '18.0-18.9', 'mm', 'in', 'diameter', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	OBJECTIVES To verify non-inferiority of the clinical pregnancy rate of Early hCG administration ( leading follicle sizes within 16.0-16.9 mm in diameter ) compared to Late hCG administration ( leading follicle sizes within 18.0-18.9 mm in diameter ) .
['Six', 'hundred', 'and', 'twelve', 'infertile', 'women', 'candidates', 'for', 'intrauterine', 'insemination', '(', 'IUI', ')', 'received', 'HP-hMG', '75', 'IU/day', 'SC', 'from', 'cycle', 'days', '4', 'to', '8', 'and', 'then', 'as', 'per', 'ovarian', 'response', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Six hundred and twelve infertile women candidates for intrauterine insemination ( IUI ) received HP-hMG 75 IU/day SC from cycle days 4 to 8 and then as per ovarian response .
['Ovulation', 'was', 'randomly', 'triggered', '(', 'hCG', '5000', 'IU', ',', 'IM', ')', 'when', 'the', 'leading', 'follicle', 'diameter', 'ranged', 'between', 'either', '16.0', 'and', '16.9', 'mm', '(', 'Early', 'hCG', 'group', ',', 'n=227', ')', 'or', '18.0', 'and', '18.9', 'mm', '(', 'Late', 'hCG', 'group', ',', 'n=207', ')', 'and', 'IUI', 'was', 'performed', 'approximately', '36', 'h', 'later', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Ovulation was randomly triggered ( hCG 5000 IU , IM ) when the leading follicle diameter ranged between either 16.0 and 16.9 mm ( Early hCG group , n=227 ) or 18.0 and 18.9 mm ( Late hCG group , n=207 ) and IUI was performed approximately 36 h later .
['Clinical', '(', '11.9', '%', 'versus', '12.1', '%', ')', 'and', 'ongoing', '(', '11.0', '%', 'versus', '8.6', '%', ')', 'pregnancy', 'rates', 'per', 'randomized', 'women', 'were', 'similar', 'in', 'the', 'two', 'groups', 'and', 'statistical', 'non-inferiority', 'of', 'clinical', 'and', 'ongoing', 'pregnancy', 'rates', 'was', 'demonstrated', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'B-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O']	Clinical ( 11.9 % versus 12.1 % ) and ongoing ( 11.0 % versus 8.6 % ) pregnancy rates per randomized women were similar in the two groups and statistical non-inferiority of clinical and ongoing pregnancy rates was demonstrated .
['CONCLUSION', 'These', 'results', 'suggest', 'that', 'hCG', 'administered', 'when', 'the', 'largest', 'follicle', 'size', 'reaches', '16.0-16.9', 'mm', 'leads', 'to', 'similar', 'clinical', 'and', 'ongoing', 'pregnancy', 'rates', 'as', 'when', 'it', 'reaches', '18.0-18.9', 'mm', 'in', 'IUI', 'cycles', '.']	['O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	CONCLUSION These results suggest that hCG administered when the largest follicle size reaches 16.0-16.9 mm leads to similar clinical and ongoing pregnancy rates as when it reaches 18.0-18.9 mm in IUI cycles .
['Managing', 'repetitive', 'behaviours', 'in', 'young', 'children', 'with', 'autism', 'spectrum', 'disorder', '(', 'ASD', ')', ':', 'pilot', 'randomised', 'controlled', 'trial', 'of', 'a', 'new', 'parent', 'group', 'intervention', '.']	['O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'O', 'O', 'O']	Managing repetitive behaviours in young children with autism spectrum disorder ( ASD ) : pilot randomised controlled trial of a new parent group intervention .
['We', 'report', 'the', 'acceptability', ',', 'feasibility', 'and', 'impact', 'on', 'child', 'functioning', 'of', 'a', 'new', '8', 'weeks', 'parent-group', 'intervention', 'to', 'manage', 'restricted', 'and', 'repetitive', 'behaviours', '(', 'RRB', ')', 'in', 'young', 'children', 'with', 'ASD', 'aged', '3-7', 'years', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	We report the acceptability , feasibility and impact on child functioning of a new 8 weeks parent-group intervention to manage restricted and repetitive behaviours ( RRB ) in young children with ASD aged 3-7 years .
['Fidelity', 'of', 'delivery', 'was', 'high', ',', 'and', 'attendance', 'was', '90', '%', '.']	['B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O']	Fidelity of delivery was high , and attendance was 90 % .
['BACKGROUND', 'In', '1998', ',', 'mandatory', 'folic', 'acid', 'fortification', 'of', 'white', 'flour', 'and', 'select', 'cereal', 'grain', 'products', 'was', 'implemented', 'in', 'Canada', 'with', 'the', 'intention', 'to', 'increase', 'dietary', 'folate', 'intakes', 'of', 'reproducing', 'women', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'B-P', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'B-P', 'I-P', 'I-P']	BACKGROUND In 1998 , mandatory folic acid fortification of white flour and select cereal grain products was implemented in Canada with the intention to increase dietary folate intakes of reproducing women .
['The', 'objective', 'of', 'this', 'study', 'was', 'to', 'determine', 'how', 'predictive', 'blood', 'folate', 'concentrations', 'and', 'folate', 'intakes', 'are', 'of', 'each', 'other', 'in', 'a', 'sample', 'of', 'well-educated', 'lactating', 'Canadian', 'women', 'exposed', 'to', 'high', 'levels', 'of', 'synthetic', 'folate', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	The objective of this study was to determine how predictive blood folate concentrations and folate intakes are of each other in a sample of well-educated lactating Canadian women exposed to high levels of synthetic folate .
['RESULTS', 'Median', 'blood', 'folate', 'concentrations', 'of', 'all', 'participants', 'were', 'well', 'above', 'plasma', 'and', 'RBC', 'folate', 'cut-off', 'levels', 'indicative', 'of', 'deficiency', '(', '6.7', 'and', '317', 'nmol/L', ',', 'respectively', ')', 'and', 'all', ',', 'except', 'for', '2', 'subjects', ',', 'were', 'above', 'the', 'cut-off', 'for', 'NTD-risk', 'reduction', '(', '>', '906', 'nmol/L', ')', '.']	['O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	RESULTS Median blood folate concentrations of all participants were well above plasma and RBC folate cut-off levels indicative of deficiency ( 6.7 and 317 nmol/L , respectively ) and all , except for 2 subjects , were above the cut-off for NTD-risk reduction ( > 906 nmol/L ) .
['Only', 'modest', 'associations', 'existed', 'between', 'total', 'folate', 'intakes', 'and', 'plasma', '(', 'r', '=', '0.46', ',', 'P', '<', '0.001', ')', 'and', 'RBC', '(', 'r', '=', '0.36', ',', 'P', '<', '0.01', ')', 'folate', 'concentrations', 'at', '16-wk', 'postpartum', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'B-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O']	Only modest associations existed between total folate intakes and plasma ( r = 0.46 , P < 0.001 ) and RBC ( r = 0.36 , P < 0.01 ) folate concentrations at 16-wk postpartum .
['CONCLUSION', 'Folate', 'intakes', ',', 'estimated', 'by', 'food', 'composition', 'tables', ',', 'and', 'blood', 'folate', 'concentrations', 'are', 'not', 'predictive', 'of', 'each', 'other', 'in', 'Canadian', 'lactating', 'women', 'exposed', 'to', 'high', 'levels', 'of', 'folate', '.']	['O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O']	CONCLUSION Folate intakes , estimated by food composition tables , and blood folate concentrations are not predictive of each other in Canadian lactating women exposed to high levels of folate .
['Clinical', 'and', 'radiographic', 'evaluation', 'of', 'guided', 'tissue', 'regeneration', 'in', 'the', 'treatment', 'of', 'class', 'II', 'furcation', 'defects', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P']	Clinical and radiographic evaluation of guided tissue regeneration in the treatment of class II furcation defects .
['PURPOSE', 'To', 'evaluate', 'the', 'treatment', 'outcomes', 'after', 'guided', 'tissue', 'regeneration', '(', 'GTR', ')', 'with', 'a', 'bioabsorbable', 'membrane', 'in', 'Class', 'II', 'furcation', 'defects', 'in', 'mandibular', 'molars', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O']	PURPOSE To evaluate the treatment outcomes after guided tissue regeneration ( GTR ) with a bioabsorbable membrane in Class II furcation defects in mandibular molars .
['METHODS', 'Nine', 'patients', ',', 'with', 'two', 'comparable', 'Class', 'II', 'furcation', 'defects', 'were', 'included', 'in', 'the', 'study', '.']	['O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	METHODS Nine patients , with two comparable Class II furcation defects were included in the study .
['Comparing', 'the', 'two', 'treatments', ',', 'no', 'statistically', 'significant', 'differences', 'were', 'found', 'in', 'PD', 'reduction', '(', 'GTR', ':', '1.67', 'mm', ';', 'OFD', ':', '2.51', 'mm', ',', 'P', '=', '0.26', ')', ',', 'CAL-v', 'gain', '(', 'GTR', ':', '0.62', 'mm', ';', 'OFD', ':', '1.16', 'mm', ',', 'P=', '0.37', ')', ',', 'and', 'GR', 'increase', '(', 'GTR', ':', '1.04', 'mm', ';', 'OFD', ':', '1.24', 'mm', ',', 'P', '=', '0.31', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Comparing the two treatments , no statistically significant differences were found in PD reduction ( GTR : 1.67 mm ; OFD : 2.51 mm , P = 0.26 ) , CAL-v gain ( GTR : 0.62 mm ; OFD : 1.16 mm , P= 0.37 ) , and GR increase ( GTR : 1.04 mm ; OFD : 1.24 mm , P = 0.31 ) .
['GTR', 'provided', 'complete', 'closure', 'of', 'the', 'furcation', 'defect', 'in', 'two', 'sites', 'and', 'superior', 'horizontal', 'clinical', 'attachment', 'level', 'gain', '(', 'GTR', ':', '2.27', 'mm', ';', 'OFD', ':', '1.01', 'mm', ',', 'P', '=', '0.05', ')', '.']	['B-I', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	GTR provided complete closure of the furcation defect in two sites and superior horizontal clinical attachment level gain ( GTR : 2.27 mm ; OFD : 1.01 mm , P = 0.05 ) .
['In', 'order', 'to', 'identify', 'healthcare', 'resource', 'use', 'patterns', 'associated', 'with', 'chronic', 'obstructive', 'pulmonary', 'disease', '(', 'COPD', ')', ',', 'resource', 'utilization', '(', 'RU', ')', 'data', 'collection', 'was', 'integrated', 'into', 'a', 'randomized', ',', 'double-blind', 'placebo-controlled', 'study', 'of', 'Viozan', '(', 'sibenadet', 'HCl', ')', '.']	['O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	In order to identify healthcare resource use patterns associated with chronic obstructive pulmonary disease ( COPD ) , resource utilization ( RU ) data collection was integrated into a randomized , double-blind placebo-controlled study of Viozan ( sibenadet HCl ) .
['Subsequent', 'data', 'were', 'collected', 'by', 'means', 'of', 'an', 'Interactive', 'Voice', 'Response', 'System', '(', 'IVRS', ')', 'at', '30-day', 'intervals', '(', '14', 'time', 'points', ')', 'during', 'the', 'study', 'and', 'in', 'the', 'follow-up', 'period', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Subsequent data were collected by means of an Interactive Voice Response System ( IVRS ) at 30-day intervals ( 14 time points ) during the study and in the follow-up period .
['Physicians', 'were', 'seen', 'to', 'be', 'the', 'most', 'common', 'source', 'of', 'care', 'for', 'patients', 'with', 'COPD', 'and', 'more', 'of', 'the', 'patients', 'with', 'severe', 'COPD', '(', 'stage', 'III', ')', 'than', 'mild', '(', 'stage', 'I', ')', 'were', 'seen', 'to', 'utilize', 'the', 'most', 'expensive', 'resources', '(', 'e.g', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Physicians were seen to be the most common source of care for patients with COPD and more of the patients with severe COPD ( stage III ) than mild ( stage I ) were seen to utilize the most expensive resources ( e.g .
['This', 'study', 'has', 'shown', 'that', 'use', 'of', 'an', 'IVRS', ',', 'even', 'in', 'elderly', 'patients', ',', 'is', 'an', 'effective', 'means', 'of', 'gathering', 'RU', 'data', 'over', 'long', 'periods', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	This study has shown that use of an IVRS , even in elderly patients , is an effective means of gathering RU data over long periods .
['Beliefs', 'underlying', 'the', 'intention', 'to', 'donate', 'again', 'among', 'first-time', 'blood', 'donors', 'who', 'experience', 'a', 'mild', 'adverse', 'event', '.']	['B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Beliefs underlying the intention to donate again among first-time blood donors who experience a mild adverse event .
['The', 'findings', 'provide', 'insight', 'into', 'those', 'messages', 'that', 'could', 'be', 'communicated', 'via', 'the', 'mass', 'media', 'or', 'in', 'targeted', 'communications', 'to', 'retain', 'first-time', 'donors', 'who', 'have', 'experienced', 'a', 'mild', 'vasovagal', 'reaction', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The findings provide insight into those messages that could be communicated via the mass media or in targeted communications to retain first-time donors who have experienced a mild vasovagal reaction .
['[', 'Initial', 'nuclear', 'magnetic', 'resonance', 'tomography', 'results', 'of', 'the', 'treatment', 'course', 'of', 'avascular', 'femur', 'head', 'necrosis', 'after', 'femoral', 'core', 'decompression', ']', '.']	['O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	[ Initial nuclear magnetic resonance tomography results of the treatment course of avascular femur head necrosis after femoral core decompression ] .
['The', 'vascular', 'femoral', 'head', 'necrosis', 'is', 'a', 'serious', 'illness', ',', 'especially', 'when', 'appearing', 'in', 'patients', 'aged', '30', 'to', '50', 'years', '.']	['O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	The vascular femoral head necrosis is a serious illness , especially when appearing in patients aged 30 to 50 years .
['Many', 'etiologic', 'factors', 'cause', 'a', 'femoral', 'head', 'necrosis', 'such', 'as', ',', 'for', 'example', ',', 'high-dose', 'steroids', ',', 'abuse', 'of', 'alcohol', ',', 'defect', 'of', 'bone', 'marrow', 'and', 'trauma', 'of', 'the', 'hip', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Many etiologic factors cause a femoral head necrosis such as , for example , high-dose steroids , abuse of alcohol , defect of bone marrow and trauma of the hip .
['The', 'stage', 'IIc', 'and', 'III', 'shows', 'an', 'evident', 'enhancement', 'in', 'contrast', 'media', 'in', 'MRI', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I']	The stage IIc and III shows an evident enhancement in contrast media in MRI .
['The', 'evaluation', 'of', 'the', 'signal', 'intensity', 'by', 'the', 'dynamic', 'screening', 'sequence', 'is', 'considered', 'as', 'an', 'objective', 'contribution', 'for', 'the', 'staging', 'of', 'the', 'femoral', 'head', 'necrosis', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	The evaluation of the signal intensity by the dynamic screening sequence is considered as an objective contribution for the staging of the femoral head necrosis .
['This', 'enables', 'one', 'to', 'differentiate', 'between', 'the', 'curable', 'stage', 'IIc', 'and', 'the', 'stage', 'III', ',', 'showing', 'the', 'beginning', 'of', 'breakdown', 'of', 'the', 'femoral', 'head', '.']	['O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-O', 'I-O', 'I-O', 'I-P', 'I-P', 'I-O', 'I-O', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	This enables one to differentiate between the curable stage IIc and the stage III , showing the beginning of breakdown of the femoral head .
['Aminocaproic', 'acid', 'versus', 'prednisone', 'for', 'the', 'treatment', 'of', 'traumatic', 'hyphema', '.']	['B-I', 'I-I', 'O', 'B-I', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P']	Aminocaproic acid versus prednisone for the treatment of traumatic hyphema .
['One', 'hundred', 'twelve', 'patients', 'who', 'sustained', 'hyphema', 'after', 'blunt', 'trauma', 'were', 'enrolled', 'in', 'a', 'double-blind', 'randomized', 'clinical', 'trial', 'to', 'determine', 'the', 'relative', 'efficacies', 'of', 'aminocaproic', 'acid', '(', 'Amicar', ')', 'and', 'systemic', 'prednisone', 'for', 'reducing', 'the', 'rate', 'of', 'secondary', 'hemorrhage', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O']	One hundred twelve patients who sustained hyphema after blunt trauma were enrolled in a double-blind randomized clinical trial to determine the relative efficacies of aminocaproic acid ( Amicar ) and systemic prednisone for reducing the rate of secondary hemorrhage .
['Sun', 'protection', 'behaviors', 'and', 'stages', 'of', 'change', 'for', 'the', 'primary', 'prevention', 'of', 'skin', 'cancers', 'among', 'beachgoers', 'in', 'southeastern', 'New', 'England', '.']	['B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Sun protection behaviors and stages of change for the primary prevention of skin cancers among beachgoers in southeastern New England .
['METHODS', 'Before', 'the', 'experiment', ',', '72', 'rats', 'were', 'randomly', 'allocated', 'to', 'receive', 'HBO', 'or', 'air', 'treatment', '.']	['O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I']	METHODS Before the experiment , 72 rats were randomly allocated to receive HBO or air treatment .
['SnPP', ',', 'on', 'the', 'contrary', ',', 'offset', 'the', 'effects', 'of', 'HBO', 'and', 'worsened', 'the', 'LPS-induced', 'lung', 'injury', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	SnPP , on the contrary , offset the effects of HBO and worsened the LPS-induced lung injury .
['Furthermore', ',', 'this', 'HBO', 'attenuation', 'of', 'iNOS', 'expression', 'involves', 'HO-1', 'induction', '.']	['O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Furthermore , this HBO attenuation of iNOS expression involves HO-1 induction .
['OBJECTIVE', 'One-third', 'of', 'the', 'total', 'population', 'seems', 'to', 'develop', 'minor', 'recurrent', 'aphthous', 'stomatitis', '(', 'RAS', ')', 'during', 'their', 'lifetime', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O']	OBJECTIVE One-third of the total population seems to develop minor recurrent aphthous stomatitis ( RAS ) during their lifetime .
['The', 'objective', 'of', 'the', 'present', 'study', 'was', 'to', 'investigate', 'whether', 'the', 'prevalence', 'of', 'RAS', 'decreased', 'with', 'perilla', 'oil', '(', 'rich', 'in', 'alpha-linolenic', 'acid', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The objective of the present study was to investigate whether the prevalence of RAS decreased with perilla oil ( rich in alpha-linolenic acid ) .
['METHODS', 'Thirty', 'subjects', '(', '8', 'men', 'and', '22', 'women', ')', 'who', 'had', 'minor', 'RAS', 'at', 'least', 'once', 'a', 'month', 'were', 'randomly', 'allocated', 'to', 'a', 'soybean', 'oil', 'group', 'or', 'a', 'perilla', 'oil', 'group', 'in', 'a', 'double-blind', 'manner', '(', 'experimental', 'phase', ')', 'after', 'a', 'run-in', 'phase', 'of', '4', 'mo', 'during', 'which', 'subjects', 'used', 'a', 'reference', 'oil', ',', 'the', 'most', 'popular', 'cooking', 'oil', 'in', 'Japan', ',', 'or', 'a', '50/50', 'mixture', 'of', 'soybean', 'oil', 'and', 'rapeseed', 'oil', '.']	['O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I']	METHODS Thirty subjects ( 8 men and 22 women ) who had minor RAS at least once a month were randomly allocated to a soybean oil group or a perilla oil group in a double-blind manner ( experimental phase ) after a run-in phase of 4 mo during which subjects used a reference oil , the most popular cooking oil in Japan , or a 50/50 mixture of soybean oil and rapeseed oil .
['Occurrence', 'and', 'needed', 'days', 'for', 'healing', 'of', 'minor', 'RAS', 'were', 'recorded', 'during', 'the', 'two', 'phases', 'and', 'compared', '.']	['B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Occurrence and needed days for healing of minor RAS were recorded during the two phases and compared .
['The', 'effect', 'of', 'cessation', 'of', 'raloxifene', 'treatment', 'on', 'bone', 'turnover', 'in', 'postmenopausal', 'women', '.']	['O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	The effect of cessation of raloxifene treatment on bone turnover in postmenopausal women .
['The', 'effect', 'of', 'cessation', 'of', 'raloxifene', 'therapy', 'on', 'bone', 'turnover', 'is', 'unknown', '.']	['O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The effect of cessation of raloxifene therapy on bone turnover is unknown .
['Our', 'aim', 'was', 'to', 'determine', 'the', 'effect', 'of', 'cessation', 'of', 'raloxifene', 'treatment', 'on', 'bone', 'turnover', 'and', 'bone', 'mineral', 'density', '(', 'BMD', ')', 'in', 'postmenopausal', ',', 'osteopenic', 'women', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'B-O', 'I-O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P']	Our aim was to determine the effect of cessation of raloxifene treatment on bone turnover and bone mineral density ( BMD ) in postmenopausal , osteopenic women .
['Women', 'aged', '50', 'to', '80', 'years', 'received', 'raloxifene', 'for', '96', 'weeks', 'and', 'were', 'then', 'randomized', 'to', 'continue', 'raloxifene', '(', 'group', '1', ',', 'n=20', ')', 'or', 'placebo', '(', 'group', '2', ',', 'n=20', ')', 'for', 'a', 'further', '96', 'weeks', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-I', 'I-I', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	Women aged 50 to 80 years received raloxifene for 96 weeks and were then randomized to continue raloxifene ( group 1 , n=20 ) or placebo ( group 2 , n=20 ) for a further 96 weeks .
['Continuation', 'of', 'raloxifene', '(', 'group', '1', ')', 'maintained', 'these', 'changes', '.']	['O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Continuation of raloxifene ( group 1 ) maintained these changes .
['Following', 'cessation', 'of', 'raloxifene', '(', 'group', '2', ')', ',', 'bone', 'markers', 'returned', 'to', 'baseline', 'levels', '(', 'by', '120', 'weeks', ')', '.']	['O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Following cessation of raloxifene ( group 2 ) , bone markers returned to baseline levels ( by 120 weeks ) .
['Bone', 'loss', 'following', 'cessation', 'of', 'raloxifene', 'therapy', 'at', '96', 'weeks', 'was', 'greater', 'than', 'in', 'the', 'control', 'group', ',', 'suggesting', 'accelerated', 'bone', 'loss', '.']	['B-O', 'I-O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P']	Bone loss following cessation of raloxifene therapy at 96 weeks was greater than in the control group , suggesting accelerated bone loss .
['The', 'beneficial', 'effect', 'on', 'bone', 'turnover', 'of', '96', 'weeks', 'of', 'raloxifene', 'was', 'lost', '6', 'months', 'after', 'cessation', 'of', 'treatment', '.']	['O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The beneficial effect on bone turnover of 96 weeks of raloxifene was lost 6 months after cessation of treatment .
['Effects', 'of', 'hydraulic', 'circuit', 'training', 'on', 'cardiovascular', 'function', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P']	Effects of hydraulic circuit training on cardiovascular function .
['Maximal', 'aerobic', 'power', '(', 'VO2max', ')', ',', 'with', 'simultaneous', 'measurement', 'of', 'stroke', 'volume', '(', 'SV', ')', 'and', 'cardiac', 'output', '(', 'CO', ')', ',', 'by', 'impedance', 'cardiography', ',', 'was', 'assessed', 'pre-', 'and', 'post-training', '.']	['B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Maximal aerobic power ( VO2max ) , with simultaneous measurement of stroke volume ( SV ) and cardiac output ( CO ) , by impedance cardiography , was assessed pre- and post-training .
['Following', 'training', 'VO2max', '(', 'ml.kg-1', 'min-1', ')', 'was', 'significantly', 'increased', 'in', 'all', 'training', 'groups', '(', '18.0', ',', '12.5', ',', 'and', '11.3', '%', 'for', 'cycle', ',', 'HCTsub', ',', 'and', 'HCTmax', 'groups', ',', 'respectively', ';', 'P', 'less', 'than', '0.05', ')', '.']	['O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Following training VO2max ( ml.kg-1 min-1 ) was significantly increased in all training groups ( 18.0 , 12.5 , and 11.3 % for cycle , HCTsub , and HCTmax groups , respectively ; P less than 0.05 ) .
['These', 'findings', 'suggest', 'that', 'both', 'maximal', 'and', 'submaximal', 'HCT', 'programs', 'can', 'elicit', 'improvements', 'in', 'cardiovascular', 'fitness', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O']	These findings suggest that both maximal and submaximal HCT programs can elicit improvements in cardiovascular fitness .
['In', 'all', '3', 'conditions', ',', 'LF/HF', 'ratio', 'decreased', 'from', 'Baseline', 'to', 'Heel', 'Stick', 'and', 'increased', 'to', 'Recovery', ';', 'no', 'differences', 'were', 'found', 'between', 'IC', 'and', 'two', 'KC', 'conditions', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'B-I', 'O', 'O']	In all 3 conditions , LF/HF ratio decreased from Baseline to Heel Stick and increased to Recovery ; no differences were found between IC and two KC conditions .
['PERSPECTIVE', 'This', 'study', 'showed', 'that', 'KC', 'has', 'a', 'significant', 'effect', 'on', 'reducing', 'autonomic', 'pain', 'responses', 'in', 'preterm', 'infants', '.']	['O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P']	PERSPECTIVE This study showed that KC has a significant effect on reducing autonomic pain responses in preterm infants .
"['In', '2003', '50', 'patients', 'treated', 'with', 'one', 'or', 'two', 'epidural', 'injections', 'have', 'been', 'selected', '""', 'ad', 'random', '""', 'and', '50', 'patients', 'treated', 'with', 'disc', 'coablation', '.']"	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-I', 'I-I', 'I-I']	"In 2003 50 patients treated with one or two epidural injections have been selected "" ad random "" and 50 patients treated with disc coablation ."
['Finally', ',', 'average', 'VAS', 'was', 'clearly', 'lower', '(', 'p', '<', '0.01', ')', 'after', 'coablation', 'as', 'compared', 'to', 'epidural', 'injections', '.']	['O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O']	Finally , average VAS was clearly lower ( p < 0.01 ) after coablation as compared to epidural injections .
['This', 'result', 'revealed', 'that', 'acupuncture', 'seemed', 'to', 'have', 'more', 'affect', 'on', 'OKT4+', 'cells', 'than', 'on', 'OKT8+', 'cells', '.']	['O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'B-O', 'I-O', 'I-O']	This result revealed that acupuncture seemed to have more affect on OKT4+ cells than on OKT8+ cells .
['From', 'our', 'study', 'we', 'believe', 'that', 'acupuncture', 'can', 'be', 'used', 'as', 'one', 'of', 'the', 'many', 'treatments', 'for', 'patients', 'with', 'cancer', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P']	From our study we believe that acupuncture can be used as one of the many treatments for patients with cancer .
['PURPOSE', 'This', 'randomized', 'group', 'experiment', 'compared', 'the', 'efficacy', 'of', '2', 'communication', 'interventions', '(', 'Responsive', 'Education', 'and', 'Prelinguistic', 'Milieu', 'Teaching', '[', 'RPMT', ']', 'and', 'the', 'Picture', 'Exchange', 'Communication', 'System', '[', 'PECS', ']', ')', 'on', 'spoken', 'communication', 'in', '36', 'preschoolers', 'with', 'autism', 'spectrum', 'disorders', '(', 'ASD', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	PURPOSE This randomized group experiment compared the efficacy of 2 communication interventions ( Responsive Education and Prelinguistic Milieu Teaching [ RPMT ] and the Picture Exchange Communication System [ PECS ] ) on spoken communication in 36 preschoolers with autism spectrum disorders ( ASD ) .
['RESULTS', 'PECS', 'was', 'more', 'successful', 'than', 'RPMT', 'in', 'increasing', 'the', 'number', 'of', 'nonimitative', 'spoken', 'communication', 'acts', 'and', 'the', 'number', 'of', 'different', 'nonimitative', 'words', 'used', 'at', 'the', 'posttreatment', 'period', '.']	['O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O']	RESULTS PECS was more successful than RPMT in increasing the number of nonimitative spoken communication acts and the number of different nonimitative words used at the posttreatment period .
['Considering', 'growth', 'over', 'all', '3', 'measurement', 'periods', ',', 'an', 'exploratory', 'analysis', 'showed', 'that', 'growth', 'rate', 'of', 'the', 'number', 'of', 'different', 'nonimitative', 'words', 'was', 'faster', 'in', 'the', 'PECS', 'group', 'than', 'in', 'the', 'RPMT', 'group', 'for', 'children', 'who', 'began', 'treatment', 'with', 'relatively', 'high', 'object', 'exploration', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Considering growth over all 3 measurement periods , an exploratory analysis showed that growth rate of the number of different nonimitative words was faster in the PECS group than in the RPMT group for children who began treatment with relatively high object exploration .
['In', 'contrast', ',', 'analogous', 'slopes', 'were', 'steeper', 'in', 'the', 'RPMT', 'group', 'than', 'in', 'the', 'PECS', 'group', 'for', 'children', 'who', 'began', 'treatment', 'with', 'relatively', 'low', 'object', 'exploration', '.']	['O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	In contrast , analogous slopes were steeper in the RPMT group than in the PECS group for children who began treatment with relatively low object exploration .
"['All', 'cavities', 'received', 'the', 'same', 'adhesive', 'system', 'and', 'were', 'restored', 'with', 'flowable', 'composite', 'according', 'to', 'manufacturer', ""'s"", 'instructions', '.']"	['O', 'B-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	All cavities received the same adhesive system and were restored with flowable composite according to manufacturer 's instructions .
['Teeth', 'were', 'submitted', 'to', 'thermal', 'cycling', 'and', 'immersed', 'in', '50', '%', 'silver', 'nitrate', 'solutions', 'for', '8', 'h', 'in', 'total', 'darkness', '.']	['O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Teeth were submitted to thermal cycling and immersed in 50 % silver nitrate solutions for 8 h in total darkness .
['CONCLUSIONS', 'It', 'can', 'be', 'concluded', 'that', 'no', 'significant', 'difference', 'was', 'noted', 'between', 'the', 'two', 'types', 'of', 'enamel', 'preparation', 'when', 'etching', 'was', 'performed', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O']	CONCLUSIONS It can be concluded that no significant difference was noted between the two types of enamel preparation when etching was performed .
['Dexmedetomidine', 'pretreatment', 'alleviates', 'propofol', 'injection', 'pain', '.']	['B-I', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P']	Dexmedetomidine pretreatment alleviates propofol injection pain .
['METHODS', 'Patients', 'undergoing', 'elective', 'surgical', 'procedures', 'were', 'randomly', 'allocated', 'into', 'seven', 'groups', 'of', '30', 'patients', 'each', '.']	['O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	METHODS Patients undergoing elective surgical procedures were randomly allocated into seven groups of 30 patients each .
['Patients', 'in', 'groups', 'V', ',', 'VI', ',', 'and', 'VII', 'received', 'DEX', 'as', 'above', ',', 'but', '5', 'minutes', 'before', 'propofol', 'injection', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I']	Patients in groups V , VI , and VII received DEX as above , but 5 minutes before propofol injection .
['There', 'were', 'no', 'differences', 'in', 'either', 'mean', 'arterial', 'pressure', 'or', 'heart', 'rate', 'at', 'any', 'time', 'point', 'after', 'DEX', 'injection', 'among', 'the', 'groups', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O']	There were no differences in either mean arterial pressure or heart rate at any time point after DEX injection among the groups .
['CONCLUSIONS', 'Pretreatment', 'with', 'intravenous', 'DEX', '1', 'µg/kg', '5', 'min', 'prior', 'to', 'injection', 'of', 'long-chain', 'triglyceride', 'propofol', 'is', 'effective', 'and', 'safe', 'in', 'reducing', 'the', 'incidence', 'and', 'severity', 'of', 'pain', 'due', 'to', 'propofol', 'injection', '.']	['O', 'O', 'O', 'B-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	CONCLUSIONS Pretreatment with intravenous DEX 1 µg/kg 5 min prior to injection of long-chain triglyceride propofol is effective and safe in reducing the incidence and severity of pain due to propofol injection .
['Shock', 'success', 'was', 'defined', 'as', 'return', 'of', 'sinus', 'rhythm', 'for', '>', '/=30', 'seconds', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O']	Shock success was defined as return of sinus rhythm for > /=30 seconds .
['CONCLUSION', 'The', 'low-tilt', 'biphasic', 'waveform', 'was', 'more', 'successful', 'for', 'the', 'internal', 'cardioversion', 'of', 'both', 'persistent', 'and', 'induced', 'AF', 'in', 'patients', '(', 'in', 'terms', 'of', 'leading', 'edge', 'voltage', ')', '.']	['O', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	CONCLUSION The low-tilt biphasic waveform was more successful for the internal cardioversion of both persistent and induced AF in patients ( in terms of leading edge voltage ) .
['AIM', 'In', 'our', 'randomized', 'prospective', 'study', ',', 'we', 'aimed', 'to', 'evaluate', 'the', 'efficiency', 'of', 'plasmakinetic', 'resection', 'of', 'prostate', '(', 'PKRP', ')', 'by', 'comparing', 'the', 'preoperative', 'and', 'postoperative', 'results', 'of', 'the', 'transurethral', 'resection', 'of', 'prostate', '(', 'TURP', ')', 'and', 'PKRP', 'techniques', 'which', 'we', 'administered', 'in', 'patients', 'with', 'benign', 'prostate', 'hyperplasia', '(', 'BPH', ')', 'in', 'our', 'clinic', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P']	AIM In our randomized prospective study , we aimed to evaluate the efficiency of plasmakinetic resection of prostate ( PKRP ) by comparing the preoperative and postoperative results of the transurethral resection of prostate ( TURP ) and PKRP techniques which we administered in patients with benign prostate hyperplasia ( BPH ) in our clinic .
['International', 'prostate', 'symptom', 'scores', '(', 'I-PSS', ')', ',', 'uroflowmetry', ',', 'measurement', 'of', 'residual', 'urine', 'amount', 'and', 'ultrasonography', 'were', 'performed', 'for', 'each', 'patient', 'both', 'preoperatively', 'and', 'postoperatively', '(', 'first', 'month', 'and', 'first', 'year', ')', '.']	['B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	International prostate symptom scores ( I-PSS ) , uroflowmetry , measurement of residual urine amount and ultrasonography were performed for each patient both preoperatively and postoperatively ( first month and first year ) .
['Operation', 'times', ',', 'urethral', 'catheterization', 'times', ',', 'preoperative', 'and', 'postoperative', 'Hb', ',', 'Htc', 'and', 'serum', 'Na', 'values', 'of', 'the', 'patients', 'were', 'compared', 'and', 'the', 'complications', 'of', 'the', 'groups', 'were', 'also', 'compared', '.']	['B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Operation times , urethral catheterization times , preoperative and postoperative Hb , Htc and serum Na values of the patients were compared and the complications of the groups were also compared .
['The', 'decrease', 'in', 'serum', 'Na', 'level', 'was', 'found', 'to', 'be', 'significantly', 'higher', 'in', 'the', 'TURP', 'group', '(', 'P', '<', '0.05', ')', '.']	['O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The decrease in serum Na level was found to be significantly higher in the TURP group ( P < 0.05 ) .
['The', 'operation', 'times', 'were', 'not', 'significantly', 'different', 'between', 'the', 'groups', '.']	['O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	The operation times were not significantly different between the groups .
['While', 'the', 'postoperative', 'catheterization', 'time', 'was', '75.7', 'h', 'in', 'TURP', 'group', ',', 'it', 'was', 'found', 'to', 'be', '42', 'h', 'in', 'PKRP', 'group', 'and', 'it', 'was', 'clear', 'that', 'catheterization', 'time', 'was', 'significantly', 'shorter', '(', 'P', '<', '0001', ')', '.']	['O', 'O', 'B-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	While the postoperative catheterization time was 75.7 h in TURP group , it was found to be 42 h in PKRP group and it was clear that catheterization time was significantly shorter ( P < 0001 ) .
['METHODS', 'The', 'relationship', 'between', 'ACE', 'genotype', 'and', 'the', 'response', 'to', '11weeks', 'of', 'resistance', 'exercise', 'training', 'was', 'determined', 'in', '37', 'CHF', 'patients', '(', 'New', 'York', 'Heart', 'Association', 'Functional', 'Class=2.3±0.5', ';', 'left', 'ventricular', 'ejection', 'fraction', '28±7', '%', ';', 'age', '64±12years', ';', '32:5', 'male', ':', 'female', ')', 'who', 'were', 'randomised', 'to', 'either', 'resistance', 'exercise', '(', 'n=19', ')', 'or', 'inactive', 'control', 'group', '(', 'n=18', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'B-I', 'I-I', 'I-I', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O']	METHODS The relationship between ACE genotype and the response to 11weeks of resistance exercise training was determined in 37 CHF patients ( New York Heart Association Functional Class=2.3±0.5 ; left ventricular ejection fraction 28±7 % ; age 64±12years ; 32:5 male : female ) who were randomised to either resistance exercise ( n=19 ) or inactive control group ( n=18 ) .
['RESULTS', 'At', 'baseline', ',', 'patients', 'who', 'were', 'homozygous', 'for', 'the', 'I', 'allele', 'had', 'higher', 'V˙O', '(', '2peak', ')', '(', 'p=0.02', ')', 'and', 'peak', 'power', '(', 'p=0.003', ')', 'compared', 'to', 'patients', 'who', 'were', 'homozygous', 'for', 'the', 'D', 'allele', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	RESULTS At baseline , patients who were homozygous for the I allele had higher V˙O ( 2peak ) ( p=0.02 ) and peak power ( p=0.003 ) compared to patients who were homozygous for the D allele .
['No', 'significant', 'genotype-dependent', 'changes', 'were', 'observed', 'in', 'V˙O', '(', '2peak', ')', ',', 'muscle', 'strength', ',', 'muscle', 'endurance', 'or', 'lactate', 'threshold', '.']	['O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O']	No significant genotype-dependent changes were observed in V˙O ( 2peak ) , muscle strength , muscle endurance or lactate threshold .
['The', 'acute', 'effects', 'of', 'fluid', 'intake', 'on', 'urine', 'specific', 'gravity', 'and', 'fluid', 'retention', 'in', 'a', 'mildly', 'dehydrated', 'state', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P']	The acute effects of fluid intake on urine specific gravity and fluid retention in a mildly dehydrated state .
['Many', 'athletes', 'arrive', 'at', 'training', 'sessions', 'and', 'competitions', 'in', 'a', 'mildly', 'hypohydrated', '(', 'HYPO', ')', 'state', 'and', 'are', 'instructed', 'to', 'drink', 'fluids', 'before', 'exercise', 'to', 'reach', 'a', 'euhydrated', '(', 'HYD', ')', 'state', '.']	['O', 'B-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Many athletes arrive at training sessions and competitions in a mildly hypohydrated ( HYPO ) state and are instructed to drink fluids before exercise to reach a euhydrated ( HYD ) state .
['Following', 'baseline', '(', '6', 'weeks', ')', ',', 'patients', 'entered', 'a', '19-week', 'double-blind', 'phase', ':', '6-week', 'titration', '(', '2', 'mg/week', 'increments', 'to', 'target', 'dose', ')', 'followed', 'by', 'a', '13-week', 'maintenance', 'period', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'I-I', 'O']	Following baseline ( 6 weeks ) , patients entered a 19-week double-blind phase : 6-week titration ( 2 mg/week increments to target dose ) followed by a 13-week maintenance period .
['Using', 'this', 'intent-to-treat', 'population', 'over', 'the', 'double-blind', 'phase', ',', 'the', 'median', 'percent', 'change', 'in', 'seizure', 'frequency', 'was', '-21.0', '%', ',', '-26.3', '%', ',', 'and', '-34.5', '%', 'for', 'placebo', 'and', 'perampanel', '8', 'and', '12', 'mg', ',', 'respectively', '(', 'p', '=', '0.0261', 'and', 'p', '=', '0.0158', 'for', '8', 'and', '12', 'mg', 'vs', 'placebo', ',', 'respectively', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'I-O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	Using this intent-to-treat population over the double-blind phase , the median percent change in seizure frequency was -21.0 % , -26.3 % , and -34.5 % for placebo and perampanel 8 and 12 mg , respectively ( p = 0.0261 and p = 0.0158 for 8 and 12 mg vs placebo , respectively ) .
['Fifty', 'percent', 'responder', 'rates', 'during', 'the', 'maintenance', 'period', 'were', '26.4', '%', ',', '37.6', '%', ',', 'and', '36.1', '%', ',', 'respectively', ',', 'for', 'placebo', ',', 'perampanel', '8', 'mg', ',', 'and', 'perampanel', '12', 'mg', ';', 'these', 'differences', 'were', 'not', 'statistically', 'significant', 'for', '8', 'mg', '(', 'p', '=', '0.0760', ')', 'or', '12', 'mg', '(', 'p', '=', '0.0914', ')', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'I-I', 'I-I', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-P', 'I-P', 'I-P']	Fifty percent responder rates during the maintenance period were 26.4 % , 37.6 % , and 36.1 % , respectively , for placebo , perampanel 8 mg , and perampanel 12 mg ; these differences were not statistically significant for 8 mg ( p = 0.0760 ) or 12 mg ( p = 0.0914 ) .
['Sixty-eight', '(', '17.5', '%', ')', 'patients', 'discontinued', ',', 'including', '40', '(', '10.3', '%', ')', 'for', 'adverse', 'events', '.']	['B-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O']	Sixty-eight ( 17.5 % ) patients discontinued , including 40 ( 10.3 % ) for adverse events .
['CONCLUSIONS', 'This', 'trial', 'demonstrated', 'that', 'once-daily', ',', 'adjunctive', 'perampanel', 'at', 'doses', 'of', '8', 'or', '12', 'mg', 'improved', 'seizure', 'control', 'in', 'patients', 'with', 'uncontrolled', 'partial-onset', 'seizures', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-O', 'I-O', 'I-O', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'I-P', 'O']	CONCLUSIONS This trial demonstrated that once-daily , adjunctive perampanel at doses of 8 or 12 mg improved seizure control in patients with uncontrolled partial-onset seizures .
['CLASSIFICATION', 'OF', 'EVIDENCE', 'This', 'study', 'provides', 'Class', 'I', 'evidence', 'that', 'once-daily', '8', 'and', '12', 'mg', 'doses', 'of', 'adjunctive', 'perampanel', 'are', 'effective', 'in', 'patients', 'with', 'uncontrolled', 'partial-onset', 'seizures', '.']	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-I', 'I-I', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']	CLASSIFICATION OF EVIDENCE This study provides Class I evidence that once-daily 8 and 12 mg doses of adjunctive perampanel are effective in patients with uncontrolled partial-onset seizures .
